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ABSTRACT 
Effects of Milk Processing on the Milk Fat Globule Membrane Constituents  
Xiomara E. Elías-Argote 
The milk fat globule membrane (MFGM) is avidly studied by many groups of 
scientists around the world due to its unprecedented nutritional and functional properties; 
however, limited research has been performed on the effects of milk processing on the 
chemical changes of the MFGM. Thus, this study highlights the changes that lipids and 
proteins undergo from the time milk leaves cow’s udders. Cooling (4 °C) was included 
along with subsequent pasteurization by different traditional thermal processes and cold 
pasteurization by pulse light ultra violet treatment. Cooling milk to 4 °C had a 
measureable effect on the MFGM composition, resulting in protein alterations, 
particularly to butyrophilin and adipophilin. Thermal treatments disturbed the native 
structures of molecules and increased the adsorption of milk and whey proteins on the 
globules, especially α-lactalbumin and β-lactoglobulin. As the heat intensity increased, 
the aggregation of fat globules became more pronounced due to protein interactions. 
Intrinsic MFGM proteins also varied in relative abundance during the processing steps. 
The concentrations of polar lipids did not change during processing, with the exception of 
phosphatidylserine, which decreased during the cooling and thermal treatments. Cold 
pasteurization (UV treatment) had a minimal effect on fat globules and MFGM proteins. 
Since the MFGM promises to deliver nutritional effects and more when included in food 
products, currently HTST pasteurization was shown to be the best method to process milk 
and obtain MFGM isolates for further supplementation. 
Keywords: milk fat globule membrane (MFGM), proteomics, thermal treatment, milk 
processing, UV-light treatment. 
TABLE OF CONTENTS 
LIST OF TABLES         xv 
LIST OF FIGURES    xiv 
I. INTRODUCTION 1 
II. LITERATURE REVIEW 5 
A. Brief Outline ............................................................................................................... 5 
B. Origin and Function of the Milk Fat Globule Membrane.......................................... 5 
C. Composition and Structure of the MFGM................................................................ 10 
1. Lipids of the Milk Fat Globule Membrane ........................................................ 14 
a) Phospholipids 16 
b) Sphingolipids 19 
2. Milk Fat Globule Membrane Proteins ............................................................... 23 
a) Butyrophilin 26 
b) Xanthine Oxidase 27 
c) Adipophilin 29 
d) Glycoprotein PAS6 and PAS7 30 
e) Mucins 31 
f) Lactoferrin 32 
g) Cluster of Differentiation (CD36) 33 
h) Fatty acid-binding protein (FABP) 34 
D. Health Benefits of the Milk Fat Globule Membrane................................................ 34 
1. MFGM in Infant Development .......................................................................... 35 
2. Anticancer Properties of the MFGM ................................................................. 35 
3. Antimicrobial and Antiviral Properties of the MFGM ...................................... 36 
E. Biochemical Properties of the MFGM in Food Products ........................................ 38 
1. Emulsifying and stabilizing properties of MFGM............................................. 38 
2. Potential delivery systems derived from MFGM............................................... 39 
viii 
 
3. Application of MFGM Components in Food Systems ...................................... 39 
F. Sources of the Milk Fat Globule Membrane: a Novel Dairy Product ..................... 41 
G. Isolation and Purification of the MFGM ................................................................. 43 
1. Laboratory Production of MFGM...................................................................... 43 
2. Commercial Production of MFGM.................................................................... 45 
a) Microfiltration 45 
b) Ultrafiltration 46 
c) Purification through Aggregation 47 
H. Physical and Chemical Effects of Processing on Fat Globules and MFGM........... 48 
1. Temperature Effect ............................................................................................ 48 
a) Cool Temperatures 48 
b) Thermal Temperatures 50 
2. Homogenization................................................................................................. 54 
3. Influence of Spray-drying .................................................................................. 57 
I. Cold Pasteurization-UV Pulsed Light Treatment...................................................... 58 
1. Bactericidal Effects of UV-light Treatment....................................................... 59 
2. Chemical Effects of UV-light Treatment........................................................... 60 
J. Methodology to Monitor the Biological Activity of the MFGM................................ 61 
K. Principles of Analysis Methods Utilized .................................................................. 62 
1. Cold Pasteurization ............................................................................................ 62 
2. Milk Analysis..................................................................................................... 63 
a) Analysis of Milk Lipids 63 
b) Fourier Transform Infrared (FTIR) Milk Analysis 65 
3. Particle Size Analysis ........................................................................................ 66 
4. Sodium Dodecyl Sulfate Polyacrylamide Electrophoresis (SDS-PAGE) ......... 67 
5. Liquid Chromatography and Proteomics ........................................................... 68 
ix 
 
L. Summary of Literature.............................................................................................. 70 
M. Justification for Present Research........................................................................... 71 
III. MATERIALS AND METHODS 73 
A. Milk Collection & Processing .................................................................................. 73 
1. Heat Pasteurization ............................................................................................ 73 
2. Cold Pasteurization- Pulsed UV Light............................................................... 74 
a) Microbial Reduction in Milk 74 
b) Milk Processing 75 
B. Physical Properties of the Milk Fat Globule Membrane ......................................... 75 
1. Milk Fractionation ............................................................................................. 75 
2. Milk Fat Globule Size Distribution.................................................................... 76 
C. Chemical Composition of Processed Milk ............................................................... 77 
1. Evaluation of Milk Composition ....................................................................... 77 
2. Fat Extraction-Mojonnier................................................................................... 78 
3. Determination of Phospholipids in the MFGM ................................................. 79 
a) Phospholipid Solid Phase Extraction (SPE) 79 
b) Phospholipid Separation & Quantification 80 
4. Measurements of S-S and SH group levels........................................................ 82 
D. Milk Fat Globule Membrane Extraction.................................................................. 83 
E. MFGM Protein Profile from One Dimensional Analysis......................................... 85 
1. Protein Homogenization .................................................................................... 85 
2. Protein Quantification........................................................................................ 85 
3. Sodium Dodecyl-Sulfate Polyacrylamide Gel Electrophoresis ......................... 86 
4. Protein Densitometry & Statistical Analysis ..................................................... 87 
5. LC-MS/MS Analysis ......................................................................................... 87 
x 
 
6. Database Searching and Criteria for Protein Identification ............................... 88 
F. Statistical Analysis.................................................................................................... 89 
G. MFGM Protein Profile from Two-Dimensional Analysis........................................ 89 
1. Protein Homogenization .................................................................................... 89 
2. Protein Precipitation........................................................................................... 90 
3. Protein Quantification........................................................................................ 91 
4. Isoelectric Focusing (IEF)-First Dimension ...................................................... 92 
5. SDS-PAGE-Second Dimension......................................................................... 92 
6. Sensitive Stepwise Colloidal Staining ............................................................... 93 
7. Fluorescent Staining-Sypro-Ruby...................................................................... 94 
8. 2-DE Gel Image & Statistical Analysis ............................................................. 95 
9. Protein Excision & Digestion from SDS-PAGE ............................................... 95 
10. Mass Spectrometry- Protein Identification with MALDI-TOF ......................... 97 
IV. RESULTS 99 
A. Microbial Reduction in Milk .................................................................................... 99 
B. Fat Globule Size Distribution in Milk Processing ................................................. 102 
C. Chemical Composition of Milk during Milk Processing........................................ 107 
1. Milk Composition by FTIR Analysis .............................................................. 107 
2. Isolation of Milk Fat Globule Membrane ........................................................ 108 
3. Changes in the Amount of Protein in the Milk Fat Globule Membrane.......... 110 
4. Changes in the Phospholipid of the Milk Fat Globule Membrane .................. 110 
5. Changes in the Sulfhydryl (SH) & Disulfide SS Groups................................. 117 
D. Protein Profile from One Dimensional Gels Coupled with LC/MS....................... 118 
1. Milk Fat Globule Membrane Protein Profile ................................................... 118 
xi 
 
2. MFGM Protein Quantification by SDS-PAGE Densitometry......................... 120 
3. MFGM Protein Identification through LC/MS................................................ 121 
E. MFGM Protein Profile from 2-Dimensional Gel Coupled with MALDI-TOF ...... 133 
1. Visualization of MFGM Proteins with Fluorescent Dye ................................. 133 
2. Visualization of MFGM Protein with Coomassie Blue................................... 134 
3. MFGM Protein Variation during Milk Processing .......................................... 135 
4. Identification of MFGM Proteins during Milk Processing.............................. 137 
V. DISCUSSION 146 
A. Effects of Milk Processing on the Physical Properties of the MFGM ................... 146 
B. Effects of Milk Processing on the Chemical Composition of the MFGM .............. 148 
1. Changes in Milk Composition ......................................................................... 148 
2. Effects on MFGM Isolates & Protein .............................................................. 149 
3. Effects on the Phospholipid Profile of the MFG ............................................. 151 
4. Changes in the Sulfhydryl (SH) and Disulfide (SS) Groups ........................... 154 
C. Effects of Milk Processing on the MFGM Proteins from 1DE Perspectives ......... 155 
1. Quantification of Protein Variation during Milk Processing........................... 155 
2. Identification of Proteins that Change in Milk Processing .............................. 157 
a) Proteins in Globlal Composition 157 
b) Proteins Identification in Molecular Weight Regions 165 
D. Effects of Milk Processing on the MFGM Proteins from 2DE Perspectives ......... 167 
VI. CONCLUSIONS & LIMITATIONS 168 
VII. DIRECTIONS FOR FUTURE RESEARCH 170 
VIII. REFERENCES 171 
IX. APPENDIX 200 
A. Protocols for Buffers .............................................................................................. 200 
xii 
 
1. 10X Phosphate Buffer Saline (PBS) ................................................................ 200 
2. Formic Acid Buffer.......................................................................................... 200 
3. 2-DE-gel Buffers.............................................................................................. 201 
a) Homogenization Buffer 201 
b) Immobilized pH Gradient (IPG) Rehydration Buffer 201 
c) Equilibration Buffer 202 
d) 10X SDS-PAGE Running Buffer 202 
e) Molecular Weight Standards for 2-D gels 202 
f) Agarose (0.8%) 202 
g) 10% TCA/Acetone 203 
h) Bromophenol Blue (0.1%) 203 
4. SDS-PAGE Gel Preparation ............................................................................ 203 
5. Sensitive Colloidal Staining Solution .............................................................. 204 
6. Protein Extraction Buffers for MALDI-TOF................................................... 204 
a) Destaining Buffer (25mM NH4HCO3/50% acetonitrile) 204 
b) Analyte Solution (0.1% TFA/ Acetonitrile 2:1) 204 
c) Promega Mass Spectrometry Grade Porcine Trypsin Gold 205 
d) Mass Spectrometry Peptide Standard 205 
e) Matrix Solution (0.2mg HCCA/mL 0.1%TFA/ Acetonitrile) 205 
f) Wash Buffer (10mM Ammonium Phosphate in 0.1%TFA) 206 
g) Recrystalization Buffer (Ethanol/acetone/0.1% TFA, 6:3:1 v/v/v) 206 
h) Tris-glycine buffer 206 
i) Tris-glycine/8M urea/ 17mM SDS buffer 206 
B. Microbial Reduction............................................................................................... 207 
C. MFGM Extraction .................................................................................................. 207 
D. MFGM Protein Quantification .............................................................................. 208 
E. Milk Composition ................................................................................................... 208 
F. Phospholipids in the MFGM .................................................................................. 209 
G. SH & SS Quantification ......................................................................................... 211 
xiii 
 
H. Particle Size Analysis............................................................................................. 212 
J. 1DE & Mass Tandem Spectrometry........................................................................ 214 
K. Two-Dimensional Statistical Data from Delta2D.................................................. 231 
 
xiv 
 
LIST OF TABLES 
Table 1. Factors that affect the composition and structure of the MFGM (Adapted      
from Ward et al. 2006, and Evers, 2004a). ........................................................... 13 
Table 2. Composition of milk lipids and their distribution among the milk fat         
globule (MFG) core, the milk fat globule membrane (MFGM), and the skim   
milk (adapted from Jiménez-Flores and Brisson, 2008; Michalski et al.,         
2006; Jensen, 2002) .............................................................................................. 16 
Table 3. Nutritional aspects of polar lipids of the MFGM (adapted from Dewettinck        
et al., 2008; Jiménez-Flores and Brisson, 2008; Rombaut et al., 2006). .............. 19 
Table 4.  MFGM Protein classification using proteomics techniques (adapted from 
Reinhardt and Lippolis, 2006). ............................................................................. 24 
Table 5.  Health benefits of MFGM components (adapted from Dewettinck et al.,     
2008; Fong et al., 2007; Jiménez-Flores and Brisson, 2008; Michalski and 
Caroline, 2006 ; Riccio, 2004; Pan et al., 2006; Spitsberg, 2005)........................ 24 
Table 6. Phospholipid and protein composition in dairy products (adapted from 
Dewettinck et al., 2008; Fong et al., 2007; Jiménez-Flores, 2009; Morin              
et al., 2006). .......................................................................................................... 41 
Table 7. Biochemical reactions of side chain groups of amino acid residues linked          
in the peptide chain (|) of proteins at high temperature (Adapted from          
Walstra et al. 2006)............................................................................................... 51 
Table 8. Parameters that describe the fat globule size distribution in milk. ................... 103 
Table 9. Parameters that describe the fat globule size distribution in 40% cream. ........ 105 
Table 10.  Parameters calculated from the size distributions of fat globules in              
skim milk. ........................................................................................................... 107 
xv 
 
Table 11.  Fat, lactose, total solid, and protein content of milk during milk         
processing. .......................................................................................................... 108 
Table 12. Linear equations of phospholipid standards and respective retention              
time (TR). ............................................................................................................. 112 
Table 13. Phospholipid content in fat globules............................................................... 115 
Table 14. Relative abundance of MFGM proteins during milk processing.................... 120 
Table 15. MFGM proteins identified by LC-MS/MS upon milk processing. ................ 122 
Table 16.  Proteins identified in region I ( higher than 150 kDa) of  MFGM            
isolates through LC/MS. ..................................................................................... 126 
Table 17. Proteins identified in region II (higher than 55 and less than 150 kDa)               
of  MFGM isolates through LC/MS.................................................................... 128 
Table 18. Proteins identified in region III (higher than 35 and less than 55 kDa)              
of  MFGM isolates through LC/MS.................................................................... 129 
Table 19. Proteins identified in region IV (less than 35 kDa) of  MFGM isolates     
through LC/MS. .................................................................................................. 131 
Table 20. Identified proteins in the proteome map from 4 °C milk sample versus            
the Fresh milk sample that vary during milk processing. ................................... 139 
Table 21. Identified proteins in the proteome map from Batch milk sample versus         
the Fresh milk sample that vary during milk processing. ................................... 141 
Table 22. Identified proteins in the proteome map from HTST milk sample versus        
the Fresh milk sample that vary during milk processing. ................................... 143 
Table 23. Identified proteins in the proteome map from UHT milk sample versus          
the Fresh milk sample that vary during milk processing. ................................... 145 
xvi 
 
Table 24. Microbial reduction in heat and cold pasteurization. Aerobic and           
coliforms petrifilms were incubated for 48 and 24 hrs respectively................... 207 
Table 25. Microbial reduction in UV pulsed light treatment. Aerobic and coliform 
petrifilms were incubated for 48 and 24 hrs respectively. .................................. 207 
Table 26. MFGM material (pellet) from samples. .......................................................... 207 
Table 27. Effect of milk processing on MFGM proteins................................................ 208 
Table 28. Milk composition for each independent trial. ................................................. 208 
Table 29. Phospholipid content+ indicated as mg of phospholipid per gram of milk ..... 209 
Table 30. Polar lipids quantification in milk during processing (trials II & III). ........... 209 
Table 31. Polar lipid quantification in milk during processing (trials II, III, and IV). ... 210 
Table 32. Phospholipids in total lipids (mg/100 g total lipids)....................................... 210 
Table 33. Polar lipids quantification in cream during processing (trials II & III). ......... 211 
Table 34. Effect of heat treatment on the amounts of free and total sulfhdryl (SH)         
and disulfide (SS) groups in the milk fat globule membrane. ............................ 211 
Table 35. Quantification of MFGM proteins by SDS-PAGE densitometry. .................. 213 
Table 36. LCMS results for Fresh, 4 C, and Batch treatments. ...................................... 214 
Table 37.B.  LC/MS results for HTST, UHT, and UV treatment................................... 218 
Table 38. Functional classification of MFGM proteins.................................................. 223 
Table 39. ANOVA-2 results utilizing Delta2D for all treatments against Fresh             
milk as a control ( p < 0.01)................................................................................ 231 
Table 40. ANOVA-2 results utilizing Delta2D for each treatment against Fresh            
milk as a control ( p < 0.01)................................................................................ 231 
 
 
xvii 
 
LIST OF FIGURES 
Figure 1. Milk Processing in the dairy industry.  Upon collection, milk is transferred       
to a storage unit at 4 °C where it awaits pasteurization for further processing 
(Adapted from Dairy Processing Handbook). ........................................................ 4 
Figure 2. Pathway of milk fat synthesis regulation in bovine mammary glands. This 
model incorporates the most recent information in milk droplet secretion and 
enzymes involved in milk fat synthesis (Taken from Bionaz et al., 2008) ............ 9 
Figure 3. Schematic representation of the structure of the milk fat globule membrane 
(Taken from Lopez et al. 2011). ........................................................................... 12 
Figure 4. Schematic representation of the different types of lipids seen in the milk          
fat globule membrane (Nelson and Cox, 2000). ................................................... 15 
Figure 5. Glycerophospholipid structure showing the glycerol backbone with two       
fatty acids (top). Different alcohol substituents that form polar lipid          
derivatives at the second alcohol via a phosphoester linkage (bottom table) 
(Nelson and Cox, 2000). ....................................................................................... 17 
Figure 6. Basic structure of sphingolipids, which are composed of a sphingosine         
base link to a fatty acid on its amide group and a headgroup (R) on its       
hydroxyl group (Top). Most common phosphosphingolipids and 
glycosphingolipid headgroups (bottom table) (Nelson and Cox, 2000). .............. 20 
Figure 7. Functions of sphingomyelin and metabolites as well as factors that can 
modulate sphingolipid metabolism and cell regulation (Adapted from Vesper      
et al. 1999). ........................................................................................................... 22 
Figure 8. Milk fat globule isolation in a laboratory and pilot plant setting. MFGM 
proteins can be purified using a four-step procedure: Step 1. cream (fat       
xviii 
 
globule) isolation; Step 2. washing of globules; step 3. Disruption of        
globules, and step 4. Membrane collection (Dewettinck et al., 2008).................. 44 
Figure 9.  Fat globule in raw milk (left, 7000x) with no change on surface and     
thermally treated globule (right; 63 °C, 30 min, 6000x) exhibiting deposits          
of casein proteins. Images captured with scanning electron microscopy     
(Adapted from Bermudez-Aguirre, D. et al. 2008) .............................................. 52 
Figure 10. Changes in the MFGM and fat globules as a function of thermal treatment     
in creams. A) Schematic representation of native fat globules or at low heat,     
and B) after high heat treatment, which adsops aqueous phase proteins,      
especially whey proteins (Taken from Gassi et al., 2008).................................... 54 
Figure 11. Effects of homogenization on milk fat globules.  Native fat globules lack 
adsorption of casein micelles and whey protein. Upon homogenization,         
serum proteins and casein attached to the interphase of fat droplets (top) and 
MFGM fragments are desorbed (bottom) (Adapted from Michalski and       
Januel, 2006). ........................................................................................................ 56 
Figure 12. Milk Collection and Processing....................................................................... 73 
Figure 13.  Analysis of milk phospholipids involves fat extraction from milk,       
isolation of PL from other simple lipids via solid phase extraction (SPE),          
and separation and quantification of the different phospholipid classes via   
HPLC. ................................................................................................................... 80 
Figure 14. Milk fat separation upon churning and centrifugation. Left. Actual         
conical tube containing cream layers. Right. Schematic representation. The 
buttermilk, which contains MFGM  proteins, was isolated for the next step          
in MFGM purification........................................................................................... 84 
xix 
 
Figure 15. Aerobic bacterial counts in pasteurized and UV pulsed light treated milk.     
The volume is shown in ml, and the irradiation time is in seconds (s).  Each 
second delivers three Joules/cm2. Counts after 48 hrs of incubation at 37 °C...... 99 
Figure 16. Coliform counts in pasteurized and UV pulsed light treated milk. The    
volume is shown in ml, and the irradiation time is in seconds (s).  Each second 
delivers three Joules/cm2. A 22% reduction is observed in the 7ml/9sec UV   
pulsed treated sample. Counts after 24 hrs of incubation at 37 °C..................... 100 
Figure 17.  Microbial reduction in aerobic bacteria in UV pulsed treated milk. The 
volume is shown in ml, and the irradiation time is in seconds (s).  Each          
second delivers three Joules/cm2. Counts after 48 hrs of incubation at 37 °C. 
Statistically significant difference in samples is denoted by  (p < 0.0001) ........ 101 
Figure 18. Microbial reduction in coliforms in UV pulsed treated milk. The volume        
is shown in ml, and the irradiation time is in seconds (s).  Each second          
delivers three Joules/cm2. Counts after 24 hrs of incubation at 37 °C................ 102 
Figure 19. Milk fat globule (MFG) size distribution (volume %) in milk as a            
function of particle diameter (µm). Data for Trial II. Similar results were   
observed with the other trials (I, III, and IV). Values are average of tree 
measurements...................................................................................................... 103 
Figure 20. Fat globule (FG) size distribution of 40% cream as a function of particle 
diameter (µm). Data are shown for Trial IV. Similar results observed for        other 
trials..................................................................................................................... 105 
Figure 21. Fat globule (FG) size distribution in skim milk showing residual fat     
globules aggregates and normal size fat globules............................................... 106 
xx 
 
Figure 22. MFGM isolates of samples collected during milk processing. Values    
represent the mean weight of dry membrane material of four independent 
experiments, expressed as mg of MFGM (pellet upon ultracentrifugation)          
per liter of milk.  Samples with different subscript are statistically significant 
different (p <0.0001). .......................................................................................... 109 
Figure 23. Final MFGM material isolated from milk following a modified protocol        
by Patton et al. (1986). From left to right: Fresh, UHT, and UV MFGM        
pellets. ................................................................................................................. 110 
Figure 24. Effect of milk processing on the amount of protein in the milk fat          
globule membrane. Values represent the mean of three independent    
experiments, expressed as mg of protein per 100 mg of MFGM pellet.       
Samples with different subscript are statistically significant different                    
(p <0.0001; n = 3 experiments;, n =3 measurement). ......................................... 110 
Figure 25. Normal-phase high performance liquid chromatography (HPLC)           
coupled with charged aerosol detector (CAD) chromatogram of           
phospholipid standards to quantify the PL from the MFGM, 
phosphatidylethanolamine (PE), phosphatidylinositol (PI),            
phosphatidylserine (PS), phosphatidylcholine (PC) and sphingomyelin           
(SM) with three peaks. ........................................................................................ 111 
Figure 26. Normal-phase liquid chromatography (LC) coupled with charged aerosol 
detector (CAD) chromatograms of (Black) PL standards and (Blue) 4 °C     
sample. PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, 
phosphatidylserine; PC, phosphatidylcholine; SM, sphingomyelin; NL,         
neutral lipids; PA, phosphatidic acid. ................................................................. 112 
xxi 
 
Figure 27. Polar lipid concentration (mg of PL per g of total lipids) in the milk fat 
globules. The PL means of two independent experiments are presented with      
the standard error of mean (s/•N)........................................................................ 114 
Figure 28. Concentration of PI and PS (mg of PL per g of total lipid) in the milk fat 
globules. These PLs are found in lower amounts in the MFGM. The means          
of two independent experiments are presented with the standard error of          
mean (s/•N). ........................................................................................................ 114 
Figure 29. Phospholipid content of milk fat globules presented as percentage                  
of the total phospholipids. The PL means of three independent experiments           
is presented with standard error of mean (s/•N). ................................................ 116 
Figure 30. Global representation of phospholipids in treated samples for three 
independent trials (II, III, and IV). PL content is presented as mean of three   
HPLC measurements (mg PL per g of fat). ........................................................ 117 
Figure 31. Effect of milk processing on the free and total sulfhydryl (SH) and        
disulfide (SS) groups of milk fat globule membrane protein ............................. 118 
Figure 32. Sodium dodecyl sulfate-PAGE pattern (4-12% gradient Bis-Tris         
NuPAGE gel) of milk fat globule membrane material isolated from different 
fractions of milk processing. 1&8) Novex Sharp Standards, 2) Fresh,                    
3) 4 °C, 4) Batch, 5) HTST, 6) UHT, and 7) UV. .............................................. 119 
Figure 33. Percentage of identified proteins in each milk treatment from the 102          
total characterized proteins identified by LC-MS .............................................. 126 
Figure 34. Representative 2-DE map of Batch (left) and high temperature short time 
(HTST) pasteurization treatments dyed with fluorescent dye, Sypro-Ruby.           
xxii 
 
A total of 100 µg of protein was loaded and stained with a 1:5 dilution of           
the dye................................................................................................................. 134 
Figure 35. Representative 2-DE map of MFGM proteins during milk processing.             
A 12.5% SDS-PAGE stained w sensitive colloidal. A) Fresh, B) 4 °C,                 
C) Batch, D) HTST, E) UHT, and F) UV........................................................... 135 
Figure 36. Protein expression change during milk processing. 2DE gels were       
compared using a statistical program. Each treatment was compared against      
the Fresh sample, and the change in protein expression is indicated as a 
percentage (Delta2D, p <0.01)............................................................................ 136 
Figure 37. Protein expression change during milk processing. 2DE gels were       
compared using a statistical program. All the treatments were compared       
against the Fresh sample (6 Treat), without UHT (5 Treat), and no heat 
application (Fresh, 4 °C, UV). The change in protein expression is             
indicated as a percentage. ................................................................................... 137 
Figure 38. Proteome map (Delta 2D) depicting 104 spots from the 4 ºC milk            
sample versus the Fresh milk sample (control). The proteome map           
represents average pixel volumes for each protein spot.  Labeled spots        
showed changes in abundance in response to cold storage temperature             
(two-way ANOVA , p < 0.01, total spots 305)................................................... 138 
Figure 39. Proteome map (Delta 2D) depicting 175 spots from Batch milk sample     
versus the Fresh milk sample (control). The proteome map represents          
average pixel volumes for each protein spot. Labeled spots showed             
changes in abundance in response to thermal treatment  (65 °C, 30 m;               
two-way      ANOVA , p < 0.01, total spots 344). .............................................. 141 
xxiii 
 
Figure 40. Proteome map (Delta 2D) depicting 128 spots from high temperature          
short time (HTST) milk sample versus the Fresh milk sample (control).            
The proteome map represents average pixel volumes for each protein spot.  
Labeled spots showed changes in abundance in response to thermal           
treatment (72 °C, 16 s; two-way ANOVA , p < 0.01, total spots 350)............... 143 
Figure 41.  Proteome map (Delta 2D) depicting 186 spots from ultra high         
temperature (UHT) milk sample versus the Fresh milk sample (control).           
The proteome map represents average pixel volumes for each protein spot.  
Labeled spots showed changes in abundance in response to high thermal 
treatment (121 °C, 3 m; two-way ANOVA , p < 0.01, total spots 277). ............ 144 
Figure 42.  Proteome map (Delta 2D) depicting 116 spots from cold pasteurization 
(pulsed ultraviolet, UV) milk sample versus the Fresh milk sample            
(control). The proteome map represents average pixel volumes for each        
protein spot.  Labeled spots showed changes in abundance in response to     
thermal treatment (1.0 Joules/cm2/pulse; two-way ANOVA , p < 0.01,             
total spots 344).................................................................................................... 146 
Figure 43. Fluctuation of milk and whey proteins in the MFGM during milk      
processing. Results obtained from SDS-PAGE densitometry (p < 0.0001,        
three independent trials, and three replicates)..................................................... 155 
Figure 44. Fluctuation of the main MFGM proteins during milk processing.             
Results obtained from SDS-PAGE densitometry (p < 0.0001, three       
independent trials, and three replicates).............................................................. 156 
xxiv 
 
Figure 45. Fluctuation of MFGM proteins during milk processing. Results obtained      
from SDS-PAGE densitometry. X unidentified protein band (p < 0.0001,        
three independent trials, and three replicates)..................................................... 157 
Figure 46. Functional category assignments for identified proteins. A total of 13 
categories were assigned based on information in Uniprot and NCBI............... 158 
Figure 47. Variation of proteins involved in lipid tranport/metabolism during milk 
processing. BTN (Frag), Butyrophilin (Fragment); AUP-1, Ancient        
ubiquitous protein 1; LS, Lanosterol synthase; 17-b HSDH, 17-beta 
hydroxysteroid dehydrogenase; S-4-a-C-3-D, Sterol-4-alpha-carboxylate 3-
dehydrogenase, decarboxylating; CYB5R3, CYB5R3 protein; LPAAT, 
Lysophosphatidic acid acyltransferase, zeta; AP E, Apolipoprotein E; LPL, 
Lipoprotein lipase; FABP (brain),  Fatty acid-binding protein, brain ................ 159 
Figure 48. Variation of proteins involved in immunity & defense during milk    
processing. ANX-A1, Annexin A1; IGK , IGK protein; GDCA,        
Glycosylation-dependent cell adhesion molecule 1; CD14, Monocyte 
differentiation antigen CD14; Ig (λ ), Immunoglobulin light chain, lambda       gene 
cluster; LPO, Lactoperoxidase............................................................................ 160 
Figure 49. Variation of proteins involved in membrane protein trafficking during         
milk processing. YKT6, Synaptobrevin homolog YKT6; ADP-RF, ADP-
ribosylation factor 1; STX3, STX3 protein; Rab-13, Ras-related protein           
Rab-13; R-ras, Related RAS viral (R-ras) oncogene homolog; Rab-5C,            
Ras-related protein Rab-5C; RAB35, RAB35 protein; Rab-8A, Ras-related 
protein Rab-8A.................................................................................................... 161 
xxv 
 
Figure 50. Variation in proteins involved in G-mediated cell signaling during milk 
processing. Ras-related C3, Ras-related C3 botulinum toxin substrate 1;           
Rap-1A, Ras-related protein Rap-1A; ADP-RF15, ADP-ribosylation             
factor-like protein 15; CDC42, CDC42 protein; NRAS, NRAS protein;        
RhoC, Rho-related GTP-binding protein RhoC; GNB G(i) a-1, Guanine 
nucleotide-binding protein G(i) subunit alpha-1................................................. 162 
Figure 51. Variation of proteins involved in protein synthesis, binding, and/ or        
folding during milk processing. 15 kDa SP, 15 kDa selenoprotein; Cofilin 1, 
Cofilin 1 (Non-muscle); HSC, 71 kDa, Heat shock cognate 71 kDa protein;    
RRL, Ribonucleotide reductase large subunit; HIST2H2BE, HIST2H2BE   
protein; Ankyrin, Ankyrin repeat domain 22; EF 1-a 1, Elongation factor             
1-alpha 1; DCK , DCK protein. .......................................................................... 163 
Figure 52. Variation in proteins involved in homeostatic regulation during milk 
processing. cGMP II PK, cGMP-dependant type II protein kinase; PP1201, 
PP1201 protein; SDR-1, Dehydrogenase/reductase (SDR family) member 1;    
ANX A5, Annexin A5; SA, Serum albumin....................................................... 164 
Figure 53. Protein identified in region I (> 150 kDa). Molecular weight is shown            
in parenthesis. cGMP-PK (87), cGMP-dependant type II protein kinase;             
LP (81), Lactoperoxidase; Acyl-CoA Syn (78), Acyl-CoA synthetase              
long-chain family member 1; Na-DPTP, Sodium-dependent phosphate      
transport protein 2B; SA (69), Serum albumin; MA-b-LG (20), Major         
allergen beta-lactoglobulin; GDCAM-1 (17), Glycosylation-dependent cell 
adhesion molecule 1; FABP (15), Fatty acid-binding protein. ........................... 165 
xxvi 
 
Figure 54. Protein identified in region II (>55 and < 150 kDa). Molecular weight             
is shown in parenthesis. GNBP-2 (37), Guanine nucleotide-binding protein 
G(I)/G(S)/G(T)  subunit beta-2; cGMP-KP (87), cGMP-dependant type II    
protein kinase; LS (83), Lanosterol synthase; ACR (55), Acetylcholine       
receptor subunit epsilon; 5'-Nase (63), 5'-nucleotidase; Na+/Glu T (73), 
Na+/glucose cotransporter; BTN (F, 14), Butyrophilin (Fragment)................... 166 
Figure 55. Proteins identified in region III (> 35 and < 55 kDa). Molecular weight           
is shown in parenthesis. GNBP-11 (42), Guanine nucleotide-binding             
protein subunit alpha-11; S-4-a-CD (40), Sterol-4-alpha-carboxylate                    
3-dehydrogenase; GNAI2 (40), GNAI2 protein; CD14 (40), CD14 protein;    
ANX- A2 (39), Annexin A2; ANX- A1 (39), Annexin A1; 17-b-HSD (38),        
17-beta hydroxysteroid dehydrogenase; CYB5R3 , CYB5R3 protein;           
STX3, STX3 protein. .......................................................................................... 167 
Figure 56. Milk processing effects on milk fat globules and milk fat globule       
membrane proteins. Globules are smaller in Fresh milk, and as processing 
proceeds, some triacylglycerides are released in cooling as well MFGM 
membrane. Thermal treatment enhances rearrangements between proteins          
and lipids of the membrane and promotes aggregation of globules and          
vesicle formation. Casein micelles and whey proteins are the main proteins       
that are adsorbed to the globule surface.............................................................. 169 
Figure 57. Fat globule (FG) size distribution of 40% cream as a function of             
particle diameter (µm). Data for Trial III............................................................ 212 
Figure 58. Fat globule (FG) size distribution of 40% cream as a function of             
particle diameter (µm). Data for Trial II. ............................................................ 212 
xxvii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1 
I. INTRODUCTION 
With consumers becoming more health-conscious, the demand for food products that 
deliver nutritional and functional benefits has increased. In the dairy industry, the interest 
in the milk fat globule membrane (MFGM) is no exception. This milk component was 
initially described in the 1970’s and 1980’s as the membrane that surrounds fat globules 
in milk, preventing coalescence and rancidity of lipids (Keenan et al., 1971; Mather and 
Keenan, 1975; Jarasch et al., 1977; Mather and Keenan, 1998; Patton, 2004; Singh, 2006; 
Dewettinck et al., 2008). In the last two decades, the nutraceutical properties of the 
MFGM have been explored (Argov et al., 2008a; Spitsberg, 2005). In fact, anticancer and 
antihypercholesterolemic activities, antimicrobial and antiviral properties such as 
inhibition of the ulcer-forming bacterium Helicobacter pylori and rotavirus, and 
suppression of diseases such as multiple sclerosis have been ascribed to the MFGM. In 
addition, in clinical studies, complementing infant food with MFGM and micronutrients 
leads to more copper and vitamin B12 uptake by infants (Lonnerdal et al., 2006). Also, 
MFGM complementation has reduced the incidence and prevalence of diarrhea in infants 
(Zavaleta et al., 2006). Contemporary research and innovation in the MFGM has been in 
the pharmaceutical field where liposome formation for the delivery of drugs, vitamins, 
and nutrients is being designed and tested (Bezelgues et al., 2009; Thompson and Singh, 
2006). 
The manufacture of butter and cheese generate by-products that have not found a 
place in the market or that are underutilized commercially although they have high 
nutritional and functional potential. In this category are buttermilk and butter serum, 
which have unprecedented nutritional and functional properties that could be capitalized 
upon when incorporated in innovative food products. The presence of the MFGM in these 
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food or dairy products promises to deliver more than nutritional benefits by including 
nutraceuticals for health and well-being; however, there is still a lot to know, test, prove 
and develop about this component of milk. 
Buttermilk originates during cream churning where the fat globules are destabilized 
with subsequent agglomeration and coalescence, displacing the MFGM and water-soluble 
components from cream into the aqueous phase. This by-product, known as sweet 
buttermilk, is the main commercial source of MFGM, which has a low cost but currently 
very limited market (Jiménez-Flores and Brisson, 2008; Jiménez-Flores and Higuera-
Ciapara, 2009; Lopez et al., 2010b). A second source is butter serum, which is popular in 
countries where butter is made from very high fat content cream (plastic cream), and 
there is very little traditional buttermilk production.  Currently, in the US industry, sweet 
buttermilk is mainly used in food products such as ice cream and bakery goods, with very 
limited use as surface-active ingredient (Dewettinck et al., 2008; Jinjarak et al., 2006; 
Sodini et al., 2006). In fact, in 2007 the use of buttermilk in the United States was mainly 
for baking to improve flavor and texture, representing 79.9% of the 49.8 million pounds 
of dry buttermilk sold.  The dairy industry also utilized buttermilk (13.9%) in products 
such as ice cream, recombined milk, and cheese, and about 3.4% was used for prepared 
dry mixes (American Dairy Products Institute, 2007). In 2008, 1,644 billion pounds of 
butter were produced in the United States, generating approximately the same amount of 
buttermilk (United States Department of Agriculture). We could be using this product to 
complement food and obtain the health benefits ascribed to MFGM constituents such as 
proteins and phospholipids (PL), which are present in concentrations of 32.9 and 2.03 
grams per 100 grams of dry buttermilk, respectively (Jiménez-Flores and Brisson, 2008).  
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The genesis of PL characterization in milk started in the 1960’s (Smith and Jack, 
1959; Sprecher et al., 1965; Webb et al., 1974). More recently, with the use of novel 
technologies, their physicochemical properties have been exploited, highlighting the 
emulsification and anti-foaming properties of MFGM. These lipids have been associated 
with enhanced health, especially those phospholipids present in specific animal tissues 
such as sphingomyelin and phosphatidylcholine, cerebrosides and gangliosides 
(considered important glycolipids). In fact, PL and their metabolites have important 
biological roles such as cell and membrane communication, myelination in the central 
nervous system, and as membrane receptors. Sources with high concentrations of PL such 
as the MFGM should be considered of high value by food technologists and efforts need 
to be made to include them in food products that not only to deliver essential nutrients but 
functional compounds. 
Despite all the health benefits offered by the milk fat globule membrane, little effort 
has been given by the technological community to incorporate MFGM constituents into 
food products, and the MFGM still remains the least understood component of nature’s 
most nutritious food: milk (Argov et al., 2008a).  With the latest techniques in biology, 
chemistry and physics, proteomics, genomics, glycomics (Tao et al., 2008) and other 
reliably objective physical and chemical tools the complex biological structure and 
interaction of fat globules and MFGM can be characterized in situ or with very little 
destructive manipulation and, thereby, provide knowledge of the native components that 
benefit mammalian neonates.  
This thesis gives a current view on the relevant discoveries that place the MFGM in a 
unique position for food and dairy products applications, and presents findings on the 
chemical, biochemical, and physical changes of the MFGM as a result of milk processing 
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throughout collection, storage, and pasteurization, as depicted in Figure 1. In addition, a 
revolutionary technology in cold pasteurization, pulsed UV-light, is introduced and 
compared with conventional heat pasteurization. Since heat pasteurization has high 
capital and operational costs, light treatment may become an alternate pasteurization 
technique for the dairy industry due to its efficiency and fast results in deactivating 
microorganisms, especially foodborne pathogens. However, little information is available 
about its effects on the conformational changes in proteins or the production of by-
products that could be carcinogenic or affect consumer acceptance. 
 
Figure 1. Milk Processing in the dairy industry.  Upon collection, milk is transferred to a 
storage unit at 4 °C where it awaits pasteurization for further processing (Adapted 
from Dairy Processing Handbook).  
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II. LITERATURE REVIEW 
A.  Brief Outline 
This review highlights the chemical, biochemical, and nutritional characteristics of 
the milk fat globule membrane as well as its dairy sources. It attempts to give an 
overview of the origin, composition, structure, health benefits, and technical aspects of 
the MFGM that have been identified for this novel ingredient as a potential nutraceutical. 
In addition, the effect of milk processing such as temperature, pressure, and irradiation on 
the structure and composition of the MFGM will be discussed as well as current 
methodologies for further noninvasive investigation. These facts are offered as a basic 
platform from which readers can find ideas and inspiration for furthering the knowledge 
and application of this milk component and resource.  
B. Origin and Function of the Milk Fat Globule Membrane 
Milk lipids are mainly composed of triacylglycerols (TAG) that accumulate within 
the bilayer of the rough endoplasmic reticulum (rER) of epithelial cells of the mammary 
glands where they start their journey towards the apical membrane (Nielsen et al., 1999; 
Bionaz and Loor, 2008). However, freeze-fracture electron microscopy further pinpointed 
that lipid droplets developed alongside the rER membrane. Regardless of the lipid droplet 
biogenesis, a membrane known as the milk fat globule membrane (MFGM) surrounds the 
lipids. This trilayer membrane acts as an emulsifier and prevents coalescence of fat 
droplets and lipase activity (Dewettinck et al., 2008). 
Newly-formed triacylglycerols are first assembled into microdroplets (Bionaz and 
Loor, 2008), which range in diameter from less than 0.5 µm to more than 4 µm, at the 
basal membrane of the secretory mammary cells (Keenan et al., 1971). A monolayer, 
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consisting of polar phospholipids and proteins, surrounds the assembled triacylglycerols, 
which do not form part of this monolayer (Wooding and Kemp, 1975).  As the 
microdroplets migrate through the cytoplasm, they coalesce to form bigger droplets 
called cytoplasmic lipid droplets (CLD). This formation is promoted by calcium and by 
ganglioside mediation (Mather and Keenan, 1998; Keenan and Mather, 2006; Jiménez-
Flores and Brisson, 2008). CLD accumulation may be promoted by decreased lipid 
storage in mammary adipocyte tissue (Russell et al., 2007). The CLDs then approach the 
apical surface, probably assisted by GTP-binding proteins (Spitsberg and Gorewit, 1997), 
are gradually enveloped in the membrane, and bud out of the secretory cells (Keenan and 
Mather, 2006; Mather, 2000; Dewettinck et al., 2008). It has been hypothesized that 
migration is assisted by microtubules; however, current research is inconclusive (Keenan 
and Mather, 2006). The apical membrane that surrounds MFG may represent a line of 
defense against pathogens at the mucosal surface of the mammary glands, so proteins 
associated with host defense may be associated with the MFGM (Smolenski et al., 2006). 
During the enveloping process, a distance of 10 to 20nm is kept between the outer 
surface of the droplet and the cytoplasmic face of the plasma membrane, which appears 
to be filled with electron-dense material when observed in micrographs. The origin of 
such material is still unknown (Keenan and Mather, 2006; Dewettinck et al., 2008). The 
formation of secretory vesicles that pick up microdroplets has also been suggested for 
milk fat globule (MFG) excretion, but cytochemical evidence favors the plasma 
membrane envelopment mechanism (Mather and Keenan, 1998; Keenan and Mather, 
2006). In fact, butyrophilin, an integral MFG protein, plays a role in globule secretion 
because it is highly expressed on the apical membrane and concentrated at budding 
locations (Robenek et al., 2006a; Keenan and Mather, 2006; Mather and Keenan, 1998; 
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Dewettinck et al., 2008). Molecular data suggest that butyrophilin, xanthine oxidase 
(XO), and the lipid droplet surface protein, adipophilin (ADPH) play a tripartite role in 
milk fat secretion according to their relative mRNA abundance (Bionaz and Loor, 2008). 
However, evidence from freeze-fracture replica immunolabelling (FRIL) has revealed the 
location of these proteins and contradicts the former hypothesis suggesting that milk lipid 
secretion is solely mediated by butyrophilin (McManaman et al., 2007). Despite this 
controversy, Bionaz et al. (2008) consolidated recent and detailed data on milk fat 
synthesis during lactation and introduced a pathway based on genomic data that depicts 
the role of proteins involved in fatty acid synthesis as well as milk droplet excretion 
(Figure 2). 
In the secreted milk, lipid globule diameter ranges from 0.15 µm to more than 15 µm 
with slight variation in their fatty acid composition between small (1 to 3 µm) and large 
(6 µm) globules (Michalski and Januel, 2006a; Fauquant et al., 2005). According to 
Fauquant et al. (2007), small MFG, ranging between 2.3 µm to 8.0 µm, have no 
significant difference in their phospholipid and sterol content. Later studies indicate that 
small milk fat globules (1.6 µm) contain almost three times more polar lipid, lower 
amounts of phosphatidylcholine and sphingomyelin, and larger curvature than large fat 
globules (6.6 µm). The latter ones are especially enriched in phosphatidylcholine. In 
addition, the fatty acid composition in small globules was enriched in C12:0, C14:0, 
C16:0, C18:1 trans, and C18:2 (Lopez et al., 2010a). Avalli and Contarini (2005) 
reported higher polar lipid content in cream obtained from natural creaming as supposed 
to cream from centrifugation, highlighting that such observations were due to the 
presence of small fat globules. Lopez et al. (2010a) attributed the variation in PL in 
different globule size to the mechanism of fat globule secretion or to the rearrangement in 
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the MFGM post-secretion from the mammary secretory cell and hypothesized that the 
greater curvature fat globules may exclude choline-containing polar lipids.  
The fat globule size depends on many factors such as cow breed and lactation stage. 
In fact, fat globules from Jersey cows are larger than those from Friesian cows, with 
average diameters of 4.5 µm and 3.5 µm, respectively (Singh, 2006). Argov et al. (2008) 
speculated that the distribution in diameter might imply a different role than just fat 
delivery to neonates (Kemsley, 2008). In fact, membrane vesicles consisting of 
phospholipids and proteins, with 30-100nm and 100-1000nm diameters, respectively 
known as exosomes and microvesicles, have been observed in milk without association 
of triglycerides and cholesterol (Silanikove et al., 2006; Argov et al., 2008b).  Their 
genesis and functions are unknown, but they have been associated with 
immunoregulation and antitumoral activities (Silanikove et al., 2006). Admyre et al. 
(2007) identified these vesicles as exosomes that have the capacity to influence immune 
responses in human breast milk. Argov et al. (2008) have designated them as lactosomes 
in human milk whereas Silanikove and Shapiro (2007) called them whey membrane 
particles (WMP) in bovine milk.  
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Figure 2. Pathway of milk fat synthesis regulation in bovine mammary glands. This model 
incorporates the most recent information in milk droplet secretion and enzymes 
involved in milk fat synthesis (Taken from Bionaz et al., 2008) 
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In approximately 1% of bovine fat globules, some cytoplasm will be entrapped 
between the bilayer membrane and the fat droplet surface, which forms a crescent or 
“signet “(Wooding et al., 1970). Keenan and Mather (2006) support the original 
suggestion by Patton (2004) that crescents might be a pathway for the introduction of 
hormones or other bioactive molecules in milk.  Knowledge about their molecular 
formation may help us decipher the mechanism that controls milk fat secretion, which is 
still an area of speculation. Also, there is a lot of emphasis on post-secretion modification 
of the MFGM, which may be the origin of membrane fragments seen in skim-milk; 
however, the extent of this event is uncertain (Mather and Keenan, 1998; Mather, 2000; 
Keenan and Mather, 2006; Singh, 2006). In fact, mechanical treatments like heating, 
homogenization, aeration, and agitation may enhance MFGM release into the serum 
phase (Rombaut et al., 2006a; Evers, 2004a). 
C. Composition and Structure of the MFGM 
The MFGM is a complex structure. It is 10-50 nm thick and contains phospholipids, 
sphingolipids, and specific membrane proteins (Figure 3). Phospholipids and proteins 
account for over 90% of the membrane’s dry weight (Singh, 2006). Some of the proteins 
are an integral part of the membrane such as xanthine oxidase and adipophilin, and others 
are peripheral or loosely attached within the trilayer membrane including butyrophilin 
and glycosylated proteins respectively (Dewettinck et al., 2008; Lopez et al., 2008). 
Recent studies with trypsin and pronase E shows that butyrophilin may be located on the 
exterior of the MFGM as well as adipophilin, and xanthine oxidase may have a dual 
position within the membrane (Vanderghem et al., 2011). 
The first membrane, derived from the rER, is a monolayer containing phospholipids 
and proteins that is in direct contact with the intracellular lipid core (Vanderghem et al., 
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2011). The second membrane is a bilayer containing glycosylated and non-glycosylated 
proteins, glycerophospholipids and sphingolipids, enzymes, cholesterol, and other minor 
components. Between the inner membrane and the bilayer, there is electron-dense coat 
rich in proteins (Lopez et al., 2008; Rombaut et al., 2006a). A glycocalyx forms a fourth 
layer, which acts as a source of specific bacterial and viral ligands and varies during 
lactation (Spitsberg and Gorewit, 1997; Wilson et al., 2008; Evers, 2004a). Interactions 
among milk constituents and other molecules occur mainly on this outer surface 
(Vanderghem et al., 2011). The structural composition of the oligossacharides in 
glygoproteins is designed as an innate protection to clear out unwanted pathogens from 
the gastrointestinal tract of the newborn offspring, especially those of human milk 
(Wilson et al., 2008). Studies have shown that the MFGM is not a continuous membrane 
(Kobylka and Carraway, 1973), and even some membrane material is destroyed during 
secretion leaving only the inner layer on parts of the fat globules (Robenek et al., 2006b; 
Vanderghem et al., 2011). 
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Figure 3. Schematic representation of the structure of the milk fat globule membrane 
(Taken from Lopez et al. 2011). 
The gross composition of the MFGM, reported in literature, differs as a result of 
isolation, purification, and techniques used in analysis (Keenan and Mather, 2006; 
Dewettinck et al., 2008; Evers, 2004a). Furthermore, the composition can be altered by 
physiological, chemical/enzymatic, and physical/mechanical factors (Evers, 2004b). The 
latter includes cooling, drying, separation, agitation, heating, and homogenization 
(Dewettinck et al., 2008; Lopez et al., 2008; Jiménez-Flores and Brisson, 2008; 
Michalski and Januel, 2006a). With respect to physiological factors, Lopez et al. (2008) 
observed large differences in the fatty acid (FA) composition of the phospholipids in the 
milk from cows fed a regular diet and a diet rich in polyunsaturated FA.  
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Table 1. Factors that affect the composition and structure of the MFGM (Adapted from 
Ward et al. 2006, and Evers, 2004a). 
Factor Effect Reference 
Chemical/Enzymatic 
Processing origin 
 
Bacterial origin 
Loss of membrane components, adsorption 
of milk plasma components 
Production of lipases, phospholipases, 
proteinases, or glycosidic hyrolyases may 
change MFGM 
 
 
 
(McPherson and Kitchen, 1983; Erwin 
and Randolph, 1975; Evers, 2004a) 
 
Physiological 
Diet, breed, stage of 
lactation 
Affect amount of membrane material, fat 
size distribution, and relative distribution 
of membrane components 
 
(Mondy and Keenan, 1993; Ye et al., 
2002; Murgiano et al., 2009; Reinhardt 
and Lippolis, 2008; Lopez et al., 2008) 
Physical/Mechanical 
(handling &processing) 
Air bubbles   
Ageing 
Cooling 
 
 
 
Pumping, stirring, agitation 
 
 
Homogenization 
 
 
 
 
 
 
 
Heating 
 
 
 
 
 
 
 
 
Spray-Drying 
 
 
Loss of membrane material 
Effects depend on temperature 
Loss of copper,  
loss of phospholipids,  
absoption of proteins 
 
Depends on the degree of air incorporated. 
High shear forces are required to change 
the MFGM in the absence of air 
Adsorption of serum protein, rupture of 
membrane 
 
 
Formation of PL or membrane vesicles 
Redistribution of protein and lipids in 
globules 
 
Adsorption of copper, whey proteins & 
caseins 
Aggregation of BTN and XO, 
loss of PAS 6/7 and phospholipids 
 
 
 
 
 
Reduce globule size and increase surface 
area for adsorption of serum proteins 
 
 
(Walstra and Jenness, 1984) 
Little is known 
(Anderson et al., 1972; Dickow et al., 
2011; Patton et al., 1980; Baumrucker 
and Keenan, 1973) 
 
(Mulder and Walstra, 1974; Stannard, 
1975) 
 
(Anderson et al., 1972; Cano-Ruiz and 
Richter, 1997; Mondy and Keenan, 
1993; Lee and Sherbon, 2002; Ye et al., 
2004a) 
(Michalski et al., 2002) 
(Keenan et al., 1983) 
 
 
(Koops and Tarassuk, 1959; Greenbank 
and Pallansch, 1961; Corredig and 
Dalgleish, 1996; Sharma and Dalgleish, 
1993; Kim and Jiménez-Flores, 1995; 
Houlihan et al., 1992; Sharma and 
Dalgleish, 1994; Lee and Sherbon, 
2002; Ye et al., 2002; Ye et al., 2004b; 
Garcia-Amezquita et al., 2009) 
 
(Landstrom et al., 2000; Ye et al., 
2007) 
 
A diet rich in polyunsaturated FA resulted in a significant decrease in saturated fatty 
acid content in milk, which enhances milk’s nutritional quality, especially for people with 
coronary heart disease risks (Lopez et al., 2008; Jensen, 2002). Enzymatic changes are 
due to microbial growth from both the cow’s udder and the external environment (Evers, 
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2004a), and according to Erwin and Randolph (1975), mastitis milk has lower amounts of 
phospholipid, higher levels of cholesterol, and changes in enzyme activity such as 
xanthine oxidase. Table 1 summarizes the factors that affect the structure and 
composition of MFGM, effects, and respective references. El-Loly (2011) has recently 
published the latest review on the MFGM, which includes composition, properties, and 
factors that affect MFGM constituents. 
1.   Lipids of the Milk Fat Globule Membrane 
Polar lipids, such as glycerophospholipids and sphingolipids, constitute less than 1% 
of the MFG total lipids; nevertheless, they function as intracellular signaling molecules, 
provide a framework structure, and have nutritional and functional properties such as 
emulsification (Jiménez-Flores and Brisson, 2008; Lopez et al., 2008). Research has also 
found a relationship between polar lipid consumption and enhanced health (Spitsberg, 
2005). Polar lipids are amphiphilic molecules comprised of a hydrophobic tail and a 
hydrophilic head. Their morphology is influenced by the presence of water (Fedotova and 
Lencki, 2008). On the MFGM, they are distributed heterogeneously and present in 
different percentages (Lopez et al., 2008; Dewettinck et al., 2008; Jiménez-Flores and 
Brisson, 2008).  
These phospholipids contain high levels of unsaturated long-chain fatty acids (FA) 
such as palmitic, stearic, and tricosanoic acids (Sánchez-Juanes et al., 2009; Singh, 2006; 
Carrasco-Pancorbo et al., 2009). No difference has been observed in the FA composition 
of MFGM phospholipids regardless of season (Fauquant et al., 2005); however, changes 
have been observed during lactation, especially an increase in medium-chain fatty acids 
and a decrease in polyunsaturated fatty acids (18, 20, and 22 carbons) as lactation 
progressed (Bitman and Wood, 1990). During milk processing, polar lipids migrate to 
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aqueous phases such as skimmed milk, buttermilk, and butterserum, making these 
products good sources for further purification, especially butterserum, which was 
enriched in sphingomyelin (Rombaut et al., 2006c). 
 
Figure 4. Schematic representation of the different types of lipids seen in the milk fat globule 
membrane (Nelson and Cox, 2000). 
Other lipids such as triglycerides (TG), diglycerides, monoglycerides, sterols, and 
sterol esters are mainly present in the milk fat globule core and function as energy storage 
(Table 2). Among these, triglycerides represent about 60% of the neutral lipids in the 
milk fat globules, and cholesterol accounts for 90% of the total sterols in milk fat 
globules (Mather, 2000; Keenan and Mather, 2006; Dewettinck et al., 2008; Rombaut et 
al., 2006c). Figure 4 classifies the different types of lipids found in the MFGM. Recently, 
bioactive sterols such as lanosterol, lathosterol, demosterol, stigmasterol, and β-sitosterol 
were identified (Fauquant et al., 2007). Other constituents are hexoses, hexosamines, and 
sialic acids, which are associated exclusively with proteins and glycosphingolipids 
(Keenan and Mather, 2006). Small globules contain more medium-chain fatty acids and 
less stearic acid within the triglyceride core (Fauquant et al., 2005). 
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Table 2. Composition of milk lipids and their distribution among the milk fat globule (MFG) 
core, the milk fat globule membrane (MFGM), and the skim milk (adapted from 
Jiménez-Flores and Brisson, 2008; Michalski et al., 2006; Jensen, 2002) 
Fraction in (%)  
Lipid Class 
Content in total  
Fat (g/kg) Globule core MFGM Skim phase 
Neutral glycerides 
  Triacylglycerol 
  Diacylglycerol 
  Mono-acylglycerol 
 
958–983 
2.8–22.5 
0.3–3.8 
 
100 
• 90 
Traces 
 
 
• 10 
Traces 
 
 
? 
Traces 
Free fatty acids 1.0–4.4 60 • 10 30 
Phospholipids† 
  Small globule (3 µm)a 
  Large globule (6 µm) 
2.0–11.1 
 
– 65 
28.4‡ 
36.9‡ 
35 
Cerebrosides 1.0 – 70 30 
Gangliosides 0.1 – • 70 • 30 
Sterols 
  Cholesterol 
  Cholesteryl ester 
 
3.0–4.6 
• 0.2 
80 10 
 
 
10 
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a)   Phospholipids 
Glycerophospholipids have a glycerol backbone with two fatty acids attached on 
positions sn-1 and sn-2. The third hydroxyl group has a phosphate group esterified to an 
organic compound such as choline or serine (Rombaut et al., 2006c) as observed in 
Figure 5. Phosphatidylcholine (PC) represents up to 35% of the total phospholipids and is 
a major constituent of cell membranes, which provides structure and maintains the 
permeability barrier (Dewettinck et al., 2008; Jiménez-Flores and Higuera-Ciapara, 
2009). Depending on the water concentration and temperature, PC can take on up to four 
morphologies including lamellar crystalline (L
c
), laminar β’(Lβ
’
), laminar α (Lα), and 
oblique β’(Pβ
’
) (Fedotova and Lencki, 2008).  
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Figure 5. Glycerophospholipid structure showing the glycerol backbone with two fatty acids 
(top). Different alcohol substituents that form polar lipid derivatives at the second 
alcohol via a phosphoester linkage (bottom table) (Nelson and Cox, 2000). 
Phosphatidylethanolamine (PE) makes up to 30% of the total phospholipids in 
MFGM and is mainly found in nerve tissue and brain, accounting for approximately half 
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of the phospholipid content in the latter. In fact, PE is implicated in optimal brain 
development and boosting memory (Zeisel, 2006). PE derived from MFGM is highly 
unsaturated (68%) with high levels of C18:1 and C18:2 and less C14:0 and C16:0 
compared to PE from whole milk (Sánchez-Juanes et al., 2009). Phosphatidylinositol (PI) 
and phosphatidylserine (PS) are anionic phospholipid present in lower amounts in the 
MFGM. PI acts as a substrate for several enzymes involved in cell signaling and can be 
phosphorylated to form phosphatidylinositol phosphate (PIP). PS is a negatively charged 
component of cell and blood platelets that assist in blood coagulation. In addition, PS 
may reduce the risk of dementia and cognitive dysfunction in the elderly, as presented in 
Table 3 (Dewettinck et al., 2008). The distribution of these phospholipids is 
asymmetrical throughout the MFGM (Deeth, 1997). PE, PS, and PI are concentrated in 
the inner surface whereas PC, sphingomyelin (SM), and glycosphingolipids such as 
cerebrosides and gangliosides are observed in the bilayer membrane (Deeth, 1997; Lopez 
et al., 2008). 
In the market, sour and sweet buttermilk and quark-skimmed cheese are the highest 
polar lipid-containing products (Jiménez-Flores and Brisson, 2008). With all the health 
benefits and biological roles that phospholipids and sphingolipids have, it will be 
beneficial to fortify food with these low-price products; however, it is important for the 
food technologist to know the structure of these molecules and understand their 
chemistry. Phospholipids are good emulsifiers but differ in properties. PC and PE tend to 
stabilize water-in-oil emulsions due to their low hydrophilic-lipophilic balance (HLB) 
value while SM, PI, and PS tend to form oil-in-water emulsions (Fedotova and Lencki, 
2008; Fedotova and Lencki, 2010). As Jiménez-Flores and Brisson (2008) stated, it is 
essential to understand the biological mechanism of nutritional delivery to incorporate 
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MFGM constituents into foods, so food scientists can formulate products that preserve 
the optimal structure of these lipids and deliver the proper nutrition and functionality. 
Table 3. Nutritional aspects of polar lipids of the MFGM (adapted from Dewettinck et al., 
2008; Jiménez-Flores and Brisson, 2008; Rombaut et al., 2006). 
Component PL %* Nutritional Aspects 
 
 
 
 
Sphingolipids and 
metabolites 
 
 
 
18.0-34.1ª 
Reduction of the number of aberrant crypt foci and 
adenocarcinomas 
Shift in tumor type (malignant ⇒ benign) 
Anticholesterolemic, especially from dairy origin 
Protection of the liver from fat- and cholesterol induced 
steatosis  
Suppression of gastrointestinal pathogens 
Neonatal gut maturation 
Myelination of the developing central nervous system 
Endogenous modulators of vascular function 
Associated with age-related diseases and the development of 
Alzheimer 
Sphingosine1-phosphate  Mitogenic 
 
Phosphatidylcholine (PC) 
 
19.2-37.3 
Support liver recovery from toxic chemical attack or viral 
damage 
Protects the human GI mucosa against toxic attack 
Reduction of necrotizing enterocolitis 
Alleviates orotic acid-induced fatty liver 
Lysophosphatidylcholine 
(lysoPC) 
2 Bacteriostatic and bactericidal capacity 
Strong gastroprotective role in the duodenal mucosa 
Phosphatidylethanolamine 
(PE) 
19.8-42.0 Maintains hemostasis 
Brain development & boost memory  
Phosphatidylinositol (PI) 5-11% Substrate in cell signaling 
Promotes plasma cholesterol transport and metabolism 
 
Phosphatidylserine (PS) 
 
1.9-10.5 
Restore normal memory on a variety of tasks 
Positive effects on Alzheimer patients 
Improve exercise capacity of exercising humans 
* Relative phospholipid content (g per 100 g of polar lipid including sphingomyelin) 
ª Sphingomyelin content 
 
b) Sphingolipids 
Sphingolipids are highly bioactive molecules characterized by a sphingoid base, 
which is a long-chain aliphatic amine (12-22 carbon atoms) (Rombaut et al., 2006c). 
Attachment of a fatty acid via a hydroxyl group forms a ceramide that is the basic unit for 
the formation of a sphingophospholipid such as sphingomyelin and lactosylceramide 
(Figure 6). The difference in headgroups as well as the length and saturation of the fatty 
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acid and sphingoid chains have contributed to the identification of more than 400 
sphingolipids (Duan, 2011). 
 
Figure 6. Basic structure of sphingolipids, which are composed of a sphingosine base link to 
a fatty acid on its amide group and a headgroup (R) on its hydroxyl group (Top). 
Most common phosphosphingolipids and glycosphingolipid headgroups (bottom 
table) (Nelson and Cox, 2000). 
Sphingomyelin (SM) is the most abundant sphingolipid (Duan, 2011) and constitutes 
up to one third of the MFGM polar lipid fraction (Dewettinck et al., 2008). It is 
composed of a phosphorylcholine headgroup and a fatty acid linked to the amide nitrogen 
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of the sphingoid long chain base. The high degree of saturation of the acyl chains 
facilitates complex formation with cholesterol (Figure 3) (Avalli and Contarini, 2005; 
Duan). This liquid-ordered state, also known as a lipid raft, affects membrane structure 
and function (Vesper et al., 1999; Duan, 2011; Lopez et al., 2010b). Lipid rafts are rigid 
domains implicated in cellular processes like signal transduction, endocytosis, and 
cholesterol trafficking (Lopez et al., 2008; Lopez et al., 2010b; Dewettinck et al., 2008). 
Other sphingoloipids present in lower percentages in the MFGM are glucosylceramide, 
lactosylceramide, and gangliosides. Galactosylceramide, ganglioside, and SM have only 
been identified in mammalian tissue but not in plant tissue (Duan, 2011). 
The metabolism of dietary and membrane sphingolipids, which mainly takes place in 
the middle region of the small intestine, generates ceramide, sphingosine, sphingosine-1-
phosphate, and ceramide-1-phosphate (Duan and Nilsson, 2009; Duan, 2011). Among 
these intermediate products, ceramide is the most important because other sphingolipids 
can be derived from it (Duan, 2011). These molecules act as bioactive lipid messengers 
that influence cellular functions such as growth, differentiation, apoptosis, response of 
mucosal cells to pathogens, and have anticancer activities, especially in colorectal, liver, 
and gastric cancer (Figure 7) (Duan, 2011). Foods high in sphingolipids are eggs and 
soybeans with over 2,200 µmol/kg and dairy products such as cream and cheese with 
over 1,300 µmol/kg (Yeh, 1984). For infants the only source of sphingolipids is milk, 
which has approximately 160 µmol/kg (Yeh, 1984; Duan, 2011). 
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Figure 7. Functions of sphingomyelin and metabolites as well as factors that can modulate 
sphingolipid metabolism and cell regulation (Adapted from Vesper et al. 1999). 
Sphingomyelin is primarily located in the outer membrane of the MFGM and is 
present in higher percentages in milk derived from cows fed with unsaturated fatty acids 
due to the presence of smaller globules and consequently more surface area (Lopez et al., 
2008). Some studies indicate that starter cultures may contribute to the amount of PL, 
especially sphingomyelin, present in dairy products and by-products (Umemoto and Sato, 
1973; Morin et al., 2006); however, another research group found similar sphingolipid 
concentrations in the raw material and the final fermented product, indicating that starter 
cultures do not contribute to SM in dairy foods (Ahn and Schroeder, 2002). In the 
contrary, they degrade some phospholipids, and thereby, explain the presence of 
phosphatidic acid in fermented foods. 
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SM has been shown to reduce aberrant crypt foci and the appearance of colon 
adenocarcinoma (Schmelz et al., 1996; Snow et al., 2010), to influence neonatal gut 
maturation (Duan, 2011; Duan and Nilsson, 2009), and to contribute to myelination of the 
developing rat central nervous system (Yeh, 1984; Dewettinck et al., 2008). Rats fed with 
milk sphingolipids had a significant reduction in plasma cholesterol levels and liver 
triacylglycerols (Nyberg et al., 2000; Watanabe et al., 2010). Sphingomyelin derived 
from dairy seems to be more efficient in reducing cholesterol levels than egg SM (Noh 
and Koo, 2004). The ceramide fraction of milk polar lipids had similar results in 
diabetes/obese model mice; it decreased the level of cholesterol and TAG in the liver and 
total cholesterol in the plasma (Watanabe et al., 2010).   
2.   Milk Fat Globule Membrane Proteins 
MFGM proteins constitute 1-2% of the total bovine milk protein, and depending on 
the milk source and how it is processed, 25-70% of the MFGM may be polypeptides, 
ranging in molecular weight (MW) from 15,000 to 240,000 Da (Dewettinck et al., 2008; 
Jiménez-Flores and Higuera-Ciapara, 2009; Riccio, 2004; Ye et al., 2002). Indeed, 
Murgiano et al. (2009) detected differences between Chianina and Holstein cattle in the 
amount of proteins associated with mammary gland development, lipid droplet formation, 
and host defense mechanisms. A detailed description and suggested nomenclature of the 
known and major MFGM proteins are presented by Mather (2000). Using proteomic 
techniques, Reinhardt and Lippolis (2006) identified 120 proteins, which were grouped 
into seven categories as seen in Table 4; however, studies by Fong and Norris have 
demonstrated eight predominant proteins in the MFGM: butyrophilin, adipophilin 
(ADPH), xanthine oxidase, cluster of differentiation 36, fatty acid-binding protein 
(FABP), lactadherin, mucin 1, and mucin 15 (Fong and Norris, 2009).  
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Table 4.  MFGM Protein classification using proteomics techniques (adapted from 
Reinhardt and Lippolis, 2006).  
Protein Functionality % 
Membrane/protein trafficking  23 
Cell signaling 23 
Fat transport and/or metabolism 11 
Transport 9 
Protein synthesis, binding &/or folding 7 
Immune functions 4 
Milk proteins: α-and –casein 2 
Unknown function 21 
 
Early studies demonstrated in-vitro intrinsic phosphorylation of butyrophilin and fatty 
acid binding protein (FABP) (Spitsberg and Gorewit, 1997). In fact, there have been 
detected about 28 enzymes in the MFGM including some protein kinases, oxidases, 5’-
nucleotidase, adenosine triphosphatase, and phosphodiesterase (Reinhardt and Lippolis, 
2006; Keenan and Mather, 2006). Half of these enzymes belong to the hydrolase class, 
and the most abundant enzymes are alkaline phosphatase and xanthine oxidase (Jarasch et 
al., 1977; Singh, 2006). The purpose of some enzymes is still unclear. It has been 
hypothesized that they might originate from the cytoplasmic crescents, making them 
transient MFGM proteins (Keenan and Mather, 2006; Mather and Keenan, 1998). The 
biological role of the MFGM-associated enzymes has been focused on their damaging 
effects, which makes their presence undesirable in dairy products because they might 
cause off-flavors or affect processing properties (Keenan and Mather, 2006). One fourth 
of the identified proteins still have unknown functions. Table 5 presents the health 
benefits attributed to MFGM proteins and components. 
Table 5.  Health benefits of MFGM components (adapted from Dewettinck et al., 2008; Fong 
et al., 2007; Jiménez-Flores and Brisson, 2008; Michalski and Caroline, 2006 ; 
Riccio, 2004; Pan et al., 2006; Spitsberg, 2005). 
 
Proteins 
MW 
(Kg/mol) 
 
Reported Heath Benefits/Functions 
Mucin 1 (MUC1)† 160 Antiviral action/Anti Rotavirus especially in neonates 
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Mucin 15 (MUC15 or PAS III)† 94-100 Antiviral action 
Butyrophilin (BTN)† 66 Suppression of multiple sclerosis 
Xanthine oxidase (XO) 150-155 Bactericidal agent 
Cluster of differentiation 
(CD36 or PAS IV)† 
78 Glycoproteins that act as receptors due to high sugar content 
Fatty acid binding protein 
(FABP) 
15 Cell growth inhibitor 
Anti-cancer factor (FABP as selenium carrier) 
BRCA1 and BRCA2 210 Inhibition of breast cancer 
Lactadherin (PAS 6/7)† 43-59 Role of epithelialization, cell polarization, cell movement 
and rearrangement, neurite outgrowth, synaptic activity in 
the central nervous system, protection against viral infection 
in the gut.  Phospholipid binding 
Adipophilin (ADPH) 52 Milk synthesis 
Other components*   
 β-Glucoronidase inhibitor  Inhibition of colon cancer 
Helicobacter pylori inhibitor  Prevention of gastric diseases 
Cholesterolemia-lowering factor  Anti-cholesterol activity 
Vitamin E and carotenoids  Anti-oxidants 
Phosphoproteins  Source of organic phosphorus and Ca-phosphate 
† Glycosylated protein 
* Phospholipids described in Table 4 
 
As mentioned before, the protein content also varies throughout the cow’s lactation 
phase (Ye et al., 2002). Two of the major proteins in the MFGM, xanthine 
oxidoreductase (XOR) and the mammary gland specific butyrophilin (BTN), fluctuate 
during the 300-day lactation period. They are high during the early and late stages 
compared with the mid-lactation. Despite the change in protein concentration, the fat 
globule size was not influenced, and the molar ratio (4:1, BTN:XOR) between these 
proteins remained the same throughout, suggesting a close interaction (Ye et al., 2002; 
Keenan and Mather, 2006; Singh, 2006). Further studies by Reinhardt and Lippolis 
(2008) characterized changes in the bovine MFGM proteome during transition from 
colostrum to mature milk. From day one (colostrum) to day seven (milk), 26 proteins 
were upregulated and 19 proteins were downregulated. Some of the most important 
MFGM proteins, including those regulated during the transition period, are discussed 
below. Among the upregulated proteins, mucin-1 and mucin-15 had the highest 
expression change with a 7-fold increase in mature milk (Reinhardt and Lippolis, 2008). 
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a) Butyrophilin 
Butyrophilin (BTN) is a glycosylated protein that is mainly found in the apical side of 
epithelial cells, in budding fat droplets, and in the inner coat of the MFGM (Franke et al., 
1981). Recent data also localizes BTN on the cytoplasmic side of the lipid monolayer 
(McManaman et al., 2007). Mather and Jack (1993) were the first ones to hypothesize 
that BTN has multiple origins, from the apical membrane and from intracellular sources. 
It is the most abundant protein of the MFGM, constituting about 40% by weight of the 
total MFGM proteins in milk from Holstein cows and approximately 20% from Jersey 
milk (Singh, 2006; Jiménez-Flores and Higuera-Ciapara, 2009). Its apparent molecular 
weight is 62-67 kDa with a 5% carbohydrate content (Mather and Jacks, 1993; Singh, 
2006). Fatty acids are also covalently bound to butyrophilin, which merits its name from 
the Greek butyros and philos, signifying “affinity for butter” (Keenan and Mather, 2006); 
palmitic, stearic, and oleic acid are the predominant protein-bound fatty acids in both 
BTN and XOR (Singh, 2006). Butyrophilin is part of the immunoglobulin (Ig) 
superfamily of adhesive and receptor proteins. Indeed, its N-terminus has two Ig-like 
folds, and the C-terminus comprises a B30.2 domain, which is predicted to have two Ig 
folds that function as a protein-binding domain (Keenan and Mather, 2006; Mather, 2000; 
Mather and Jacks, 1993).  
Butyrophilin is highly expressed during lactation and forms complexes with XO to 
envelop the nascent fat globule via adipophilin (Keenan and Mather, 2006). Freeze-
fracture localization studies have shown that milk fat secretion is controlled by 
interactions between butyrophilin present in plasma membrane and in the secretory 
granule phospholipid monolayer (Robenek et al., 2006a). Jeong et al. (2009) provides 
evidence that the cytoplasmic domain of butyrophilin binds to xanthine reductase as it 
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was originally hypothesized. In addition, it has been suggested that BTN transfers 
phosphorus groups to tyrosine residues in proteins, activating them and playing a critical 
role in controlling the physiological activity of proteins in the secretory cells and within 
the MFGM. The gene controlling the expression of the BTN gene (BTN1A1) is described 
in detail in Bionaz and Loor (2008). 
To date, the consumption of BTN continues to be a controversial topic due to its 
association with multiple sclerosis (MS), an autoimmune-mediated inflammatory disease 
that affects the central nervous system (Dewettinck et al., 2008; Rutter, 2006; Mather, 
1999). Some research suggests that dairy products exacerbate symptoms or even produce 
the disease because BTN resembles a polypeptide named myelin oligodendrocyte 
glycoprotein (MOG), a putative auto-antigen that induces experimental autoimmune 
encephalomyelitis (EAE). This disease has clinical symptoms similar to human MS 
(Dewettinck et al., 2008; Riccio, 2004); however, in other experiments, mice treated with 
BTN, either before or after MOG injections, did not show clinical manifestations of EAE 
(Dewettinck et al., 2008). Mather and Linington (1999) have modified BTN to suppress 
an autoimmune response, which can also be used to screen for MS susceptibility. BTN 
has also been associated with autism due its resemblance with neurospecific antibodies; 
however, its etiopathogenesis is unknown (Riccio, 2004). Until the role of BTN with 
respect to MS and autism is elucidated, dairy products should be included in our daily 
diet to receive its health benefit, as the etiology of these diseases is a combination of 
genetic susceptibility and environmental factors (Rutter, 2006).  
b)  Xanthine Oxidase 
Xanthine oxidoreductase (XOR) is a member of the moldyl hydroxylase family, 
which is widely expressed in tissues but has higher activity in bovine milk as compared 
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to goat, sheep, and human milk (Silanikove and Shapiro, 2007). Moreover, XOR is 
highly expressed during pregnancy and parturition (Keenan and Mather, 2006). It can be 
present as xanthine dehydrogenase (XD) and converted to xanthine oxidase (XO) by 
proteolysis or formation of disulphide bonds (Mather, 2000; Silanikove and Shapiro, 
2007; Spitsberg and Gorewit, 1998). It has been shown that plasmin activity is 
responsible for this interconversion, and the low-oxygen and low-enzyme environment of 
the inner-membrane decreases the conversion to XO, resulting in a mixed population of 
enzymes.  
XD is distributed in the CLD monolayer, with a non-enzymatic role in fat globule 
secretion (McManaman et al., 2007; Silanikove and Shapiro, 2007). Vanderghem et al. 
(2011) recently demonstrated that XO may be located both peripherally and within the 
MFGM. XD is not very stable in solution and reverts slowly to XO at pH 7.5 (Spitsberg 
and Gorewit, 1998). The active molecule is a homodimer with monomeric molecular 
masses of 150 kDa, which accounts for up to 20% of the coat proteins where XOR binds 
with high affinity to the carboxyl end of BTN. Each subunit contains one molybdenum, 
one flavin adenine dinucleotide, and two nonidentical iron-sulfur redox centers (Martin et 
al., 2004; Keenan and Mather, 2006; Mather, 2000).  
During MFGM isolation, XOR disperses in the supernatant but remains tightly bound 
to the membrane, and can be isolated using high salt and non-ionic detergents (Keenan 
and Mather, 2006; Mather, 2000). Keenan and Mather (2006) have proposed that the 
XDH/BTN complex associates with other proteins to mediate interactions between the 
lipid core and the membrane. Besides purine catabolism, XOR generates reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) such as nitric oxide (NO) and 
peroxynitrite that act as antimicrobial agents in the neonatal gut. Silanikove and Shapiro 
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(2007) concluded that XD is a source of freely available extra-membrane protein that 
plays an essential role in the development of innate immunity (Martin et al., 2004; 
Jiménez-Flores and Higuera-Ciapara, 2009). Specifically, 33% of the free XD is found in 
the outer surface of the MFGM, 46.7% in solution, and 20.5% in the outer surface of 
exosomes. This form may also affect the physicochemical oxidative properties of milk, 
especially during storage (Silanikove and Shapiro, 2007). 
c)   Adipophilin 
Adipophilin, also known as adipocyte differentiation-related protein (ADRP), is 
ubiquitously expressed in the presence of long chain free fatty acids, especially in the 
mammary glands and in differentiating pre-adipocytes (Chang and Chan, 2007). It is one 
of the five members of the perilipin family (Brasaemle, 2007), and ADPH is the human 
homolog. These proteins localize on the monolayer and bilayer that surround MFG 
(McManaman et al., 2007). Clusters of ADRP have been observed in the cytoplasmic 
leaflet of the rough endoplasmic reticulum where lipid droplet biogenesis might take 
place.  According to Robenek et al. (2006b), adipophilin is involved in the growth of 
lipid droplets, which are enclosed within endoplasmic reticulum (ER) cups. 
Immunofluorescence evidence by Russell et al. (2007) suggests that ADPR mediates 
lipid droplet accumulation in differentiating epithelial cells. In fact, its expression may be 
one of the factors that initiate lipid droplet accumulation (Russell et al., 2007).  
During preadipocyte differentiation, adipophilin is highly expressed, and the protein 
embeds itself in the periphery of the intracellular lipid droplets. As adipocytes mature, 
ADRP is replaced by proteins known as perilipins; however, this mechanism is absent in 
the epithelial cells of the mammary glands (Nielsen et al., 1999; Dewettinck et al., 2008). 
Perilipins are proteins localized in the periphery of intracellular lipid droplets and are 
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essential for droplet formation as well as lipolysis, but recent molecular evidence 
suggests that its role in mammary lipid droplet formation is not significant (Bionaz and 
Loor, 2008). 
 In the fat globules, adipophilin associates with the XOR/BTN complex and facilitates 
the envelopment of the globules with plasma membrane during milk fat droplet secretion 
(Nielsen et al., 1999). Proteomic data shows that these three proteins are upregulated 
individually during the transition period from colostrum to mature milk, indicating an 
early developmental shift in milk fat transport (Reinhardt and Lippolis, 2008). When the 
membrane is disrupted, adipophilin remains attached in the MFGM-associated coat 
material (Keenan and Mather, 2006). The apparent molecular weight of adipophilin is 52 
kDa, but calculations from the cDNA result in a lower molecular mass, suggesting post-
translational modification, especially acylation (Nielsen et al., 1999). Also, differences in 
mass and pI may be due to close associations with fatty acids, especially myristate, 
palmitate, stearate, and oleate (Mather, 2000; Vanderghem et al., 2008). 
d)   Glycoprotein PAS6 and PAS7 
Early studies by Welsch et al. (1990) demonstrated the presence of glycoproteins in 
true ruminants. It was postulated that such glycosylation plays a role in the guts of the 
newborns (Welsch et al., 1990). In 1992, Kim et al. characterized two main glycoproteins 
in the MFGM, PAS6 and PAS7. The name is derived from the staining technique, 
periodic acid Schiff glycoprotein (PAS), which is used to identify protein with sugars. 
Their respective molecular masses are 50 kDa and 47 kDa, and their polypeptide core are 
identical, suggesting that the difference in molecular weight is due to the N-linked 
carbohydrate moieties. Three glycosylation sites have been detected in PAS6 while PAS7 
only includes two sites (Kim et al., 1992; Hvarregaard et al., 1996). These molecules are 
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loosely attached to the MFGM and can be removed with salt treatment such as MgCl2 
(Singh, 2006; Mather, 2000).  
The human homologue, known as lactadherin, has been shown to bind to rotavirus 
and protect the gastrointestinal tract of newborn infants from infection (Keenan and 
Mather, 2006). Studies have demonstrated that this protein plays a crucial role in vascular 
endothelial growth factor (VEGF)-dependent neovascularization, inducing the growth of 
new blood vessels in-vitro and in-vivo (Silvestre et al., 2005). Later studies showed that 
alterations in lactadherin production/function might contribute to the initiation or 
progression of Alzheimer’s disease (Boddaert et al., 2007). The mouse homologue, milk 
fat globule factor-E8 (MFG-E8), has been involved in regulation of apoptotic neurons, 
and disruption in such mechanism may lead to neurodegenerative diseases (Fuller and 
Van Eldik, 2008; Elliott and Ravichandran, 2010). A mutation in this protein has also 
been implicated in atherosclerosis (Ait-Oufella et al., 2007). The bovine PAS-6/7 has 
been associated with lipid binding, specifically to phosphatidylserine, -inositol, -glycerol 
and phosphatidic acid. Such binding had a higher affinity towards MFGM polar lipids as 
supposed to a pure polar lipid fraction (Andersen et al., 1997). 
e)   Mucins 
Mucins are highly glycosylated proteins that might work as receptors on the surface 
of cells, especially epithelial cells, where they may inhibit adhesion of intestinal bacteria 
to host epithelial cell receptors by acting as competitive inhibitors (Wilson et al., 2008; 
Parker et al., 2010). The predominant mucin in bovine MFGM is related to the human 
mucin (MUC1), and because of allelic polymorphism, MUC 1 appears as a diffuse band 
from pooled milk with molecular weight ranging from 160 to 200 kDa. Wilson et al. 
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(2008) demonstrated that bovine and human MUC1 differs in their glycosylation, which 
implies a different protection against pathogens. 
 MUC 1 is incorporated onto the MFGM during the budding and release of lipid 
droplets at the cell surface (Mather, 2000), and milk processing such as cooling and 
stirring may contribute to its release from fat globules (Peterson et al., 1998). In vitro 
studies indicate that these glycosylated proteins prevent binding of H. pylori to mucosal 
cells (Peterson et al., 1998). In addition, Parker et al., (2010) determined that MUC 
inhibits bacterial binding to human intestinal cells, especially Gram (-) enteric bacteria 
such as E. coli and B. subtilis compared to Gram (+) bacteria.  Another glycosylated 
protein, MUC15 has also been characterized and shown to be present in the bovine 
MFGM as well as in nonfat containing fractions such as skim milk and whey. Its 
molecular weight is about 130 kDa, from which 65% represent the glycans (Pallesen et 
al., 2007). Both MUC can be used as prophylactic molecules to prevent illness caused by 
enteric pathogens by inhibiting bacteria’s ability to adhere to intestinal epithelial cells or 
displacing bacteria from cells after microbial binding has occurred (Parker et al., 2010); 
however, care must be taken during MFGM isolation as these proteins, especially MUC 
1, are readily dissociated from the fat globules into skim milk when milk is cooled and 
agitated (Singh, 2006).  
f)   Lactoferrin  
Lactoferrin is an iron-binding protein with varying degrees of glycosylation 
depending on the state of lactation and exhibiting a high degree of homology with 
transferrin. The actual concentration in milk differs in response to inflammation or 
infection (Farrell Jr et al., 2004; Baumrucker et al., 2006), but a decline has been 
observed during lactation (Reinhardt and Lippolis, 2008). When fully saturated with Fe3+, 
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lactoferrin is known as hololactoferrin whereas the iron deficient molecule is called apo-
lactoferrin. The iron-lactoferrin is resistant to proteolysis (Baumrucker et al., 2006), and 
iron dissociates only below pH 3.5 (Farrell Jr et al., 2004). Its first recognized biological 
function was binding to the outer membrane of gram (-) bacteria and causing the release 
of polysaccharides (Farrell Jr et al., 2004). In breast milk, a major portion of iron is 
bound to lactoferrin, which has a specific receptor on the membrane of the small intestine 
of infants (Suzuki et al., 2005).  
 Currently, lactoferrin is associated with antimicrobial activities due its iron-binding 
capacity, inhibition/modulation of cytokine activity by neutrophils, promotion of growth 
of epithelial cells, anti-inflammatory responses, and prevention of apoptosis (Baumrucker 
et al., 2006; Pan et al., 2006). Due to these biological activities, lactoferrin is purified in 
commercial scale and even included in infant formula (Arla, 2011) since milk processing 
has little effect on lactoferrin structure (Sánchez et al., 1992), and research has shown 
that MFGM fractions incorporated in food or supplements exert health-promoting 
properties (Lonnerdal et al., 2006; Zavaleta et al., 2006; Arla, 2011). 
g)   Cluster of Differentiation (CD36) 
CD36 has been identified in the MFGM, playing a role in milk fat excretion. It is a 
glycoprotein with an apparent molecular weight of 77 kDa containing about 24% 
carbohydrate (Singh, 2006). Genomic data indicates that CD36 also plays a role in fatty 
acid (FA) synthesis by importing FA from blood into milk fat globules. Indeed, its 
expression level increases during lactation, and CD36 may be the most important 
regulator in endothelial long-chain fatty acid transport (Bionaz and Loor, 2008). 
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h)   Fatty acid-binding protein (FABP) 
FAB proteins are well known for their role in fatty acid transport and lipid 
metabolism; however, recent studies have linked FAB proteins with cellular proliferation 
and differentiation, and cell growth inhibition including breast cancer cells (Spitsberg and 
Gorewit, 2002; Jiménez-Flores and Higuera-Ciapara, 2009). Studies by Spitsberg et al., 
(1995) indicate that FABP associate with CD36, a protein involved in fatty acid import 
(Bionaz and Loor, 2008), and are under hormonal regulation as shown by a correlation 
between level of FABP phosphorylation within the MFGM and the level of milk 
production (Spitsberg et al., 1995). Further research indicated that FABP associated with 
the cytoplasmic domain of CD36 (Spitsberg and Gorewit, 2002). 
D. Health Benefits of the Milk Fat Globule Membrane 
Progress in the knowledge of the composition and role of milk fat globule membrane 
components has led to the realization that some MFGM constituents possess biological 
properties beyond their nutritional significance. Spitsberg (2005), in his review, refers to 
the MFGM as a nutraceutical with nutritional and pharmaceutical potential. In fact, the 
MFGM has antimicrobial proteins, illness suppressors, micronutrient-binding proteins 
that bind compounds such as iron, zinc, copper, folate, and vitamin B1, and other 
components with anti-carcinogenic properties as seen in Table 5. Indeed, Wat et al. 
(2009) supplemented bovine PL to mice fed a high-fat diet, resulting in a reduction in 
liver weight, total liver lipid, and serum lipid levels, which might be of therapeutic 
benefit in humans with non-alcoholic fatty liver disease, especially obese and diabetic 
patients (Wat et al., 2009). 
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1.   MFGM in Infant Development 
In a clinical study, Lonnerdal et al. (2006) complemented infant food with bovine 
MFGM and micronutrients to evaluate its effect on children’s growth, nutrition, and 
morbidity. In a double-blind study with 6-11 month-old-infants (n=550), fortification of 
food was beneficial for the copper and vitamin B12 status among the subjects, which 
enhance growth and normal function of the brain and nervous system, respectively 
(Lonnerdal et al., 2006). This fortifying complementary food was introduced in the 
market by Arla as LACPRODAN MFGM-10 (Arla Foods Ingredients, Denmark). It is 
rich in lactoferrin and phospholipids resembling human milk. The latter has more 
sphingomyelin and lactoferrin (95-130 mg/L and 1.7-7 g/L, respectively) as compared to 
cow’s milk (25 mg/L and 20-200 mg/L, respectively) (Arla, 2011).  
In 2008, another clinical study was launched by the Umeá University in Sweden to 
determine the effects of MFGM-enriched formula with reduced energy and protein 
content on the growth and development of newborns (NCT00624689).  Breast-fed and 
formula-fed infants usually differ in their growth pattern, risk for obesity and 
cardiovascular disease, neurological development and morbidity in infections (Timby, 
2011). The study will conclude in 2016, but scientists expect to see minimal differences 
between breast-fed and formula-fed infants due to the bioactive compounds in the 
MFGM. 
2.   Anticancer Properties of the MFGM 
Many scientists have proposed the use of MFGM as a food supplement due to its 
effects on cancer cell growth (Spitsberg, 2005; Jiménez-Flores and Higuera-Ciapara, 
2009; Jiménez-Flores and Brisson, 2008). In fact, the fatty acid binding protein (FABP) 
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has been found to inhibit the growth of some breast cancer cell lines in vitro at very low 
concentrations (Spitsberg et al., 1995; Spitsberg and Gorewit, 2002). The breast-ovarian 
cancer susceptibility (BRCA1 and BRCA2) proteins, which regulate lipid synthesis via 
an interaction with acetyl-CoA carboxylase (Moreau et al., 2006b), have also been 
identified in the MFGM (Spitsberg and Gorewit, 1999; Vissac et al., 2002). These 
proteins inhibit the growth of various cell types and influence cellular proliferation and 
differentiation. Mutations on these genes may be responsible for a significant number of 
breast and ovarian cancers, and it is speculated that BRCA1 exerts its tumor suppressor 
function through a lipogenic mechanism (Moreau et al., 2006b). According to Spitsberg 
(2005), a MFGM-supplement will work by the consumption of MFGM material and 
subsequent release of peptides that can be absorbed in the digestive tract. The absorbed 
peptides can then exert their inhibitory action on cells undergoing carcinogenic 
transformation. 
In addition, several lipids found in the MFGM can act as intracellular signaling 
molecules. Sphingomyelin has been shown to possess anti-cancer properties (Table 3).  
Its metabolites, sphingosine and ceramide, mediate numerous imperative cell functions 
including regulating cell growth, development and differentiation. Studies have shown 
sphingomyelin to be effective in suppressing colon tumors and increasing the efficacy of 
chemotherapy (Lemonnier et al., 2003; Modrak et al., 2002). Recently, it was shown that 
an ingredient rich in bovine PL from the MFGM prevented intestinal cancer in rats (Snow 
et al., 2010). 
3.   Antimicrobial and Antiviral Properties of the MFGM 
Milk and colostrum contain several antimicrobial factors, especially low-abundance 
proteins in colostrum, which are transferred from the mother to the neonate and 
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contribute to the protection against infectious diseases (Yamada et al., 2002; Affolter et 
al., 2010). For many species, the milk-derived antimicrobial system is crucial for survival 
of the neonate in early lactation. The components of the MFGM are involved with anti-
infection or anti-adhesion processes, and hence with protection of the neonate from 
various viral and bacterial infections (Lopez et al., 2008).  Currently there is evidence 
that the protective effect of milk on viral infections is a complex mechanism involving 
MFGM components, which include glycosylated proteins (Wilson et al., 2008). Zavaleta 
et al. (2006) tested the antimicrobial and antiviral properties of bovine MFGM on the 
incidence and duration of diarrhea in infants.  In a double-blind study with 6-11 month 
old infants, MFGM fortification reduced diarrhea incidence and prevalence. 
The antimicrobial and antiviral activities of proteins and lipids are currently receiving 
increasing interest, especially in the context of the preparation of infant formula and 
medical food.  A review by Pan et al. (2006) summarized the current knowledge of the 
protein lactoferrin, most comprehensively studied for its beneficial immunological, 
antimicrobial and anticarcinogenic properties.  This review examined the potential 
mechanism of lactoferrin as a powerful inhibitor of viral infection. Bovine lactoferrin was 
found to be more effective against viral infections than human lactoferrin.  Isaacs et al. 
(1995) conducted an in vitro study in which fatty acids and monoglycerides were added 
to infant formula. They found that fatty acids and monoglycerides with chain lengths 
varying from 8 to 12 carbons were more antiviral and antibacterial than long chain 
monoglycerides (Isaacs et al., 1995). On the other hand, Sánchez-Juanes et al. (2009) 
failed to observe binding between individual PL and E. coli in in-vitro studies; therefore, 
they discard the idea that PLs may block the adhesion of pathogen to the gastrointestinal 
tract.  
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E. Biochemical Properties of the MFGM in Food Products 
1.   Emulsifying and stabilizing properties of MFGM 
MFGM is the native emulsifier in milk.  The food industry recognizes the amphiphilic 
nature of the components in MFGM, phospholipids and glycoproteins, all of which are 
found in buttermilk powder and are excellent emulsifying agents (Kanno et al., 1991; 
Corredig and Dalgleish, 1997a; Roesch et al., 2004). The water distribution properties of 
the MFGM (either purified or in dairy ingredients) aid in thickening formulations and 
foaming of processed foods.  However, the liability is lipid oxidation, causing the powder 
to go rancid in approximately six months. The major advantages of using buttermilk 
solids in functional food systems pertain to their significant antioxidant activity and 
buffering capacity (Wong and Kitts, 2003) and to their high phospholipid content, and 
their suppressive effect on certain pathogens (Jiménez-Flores and Higuera-Ciapara, 2009; 
Evers, 2004a). 
MFGM components have also been used to stabilize emulsions and enhance the 
absorption of fat-soluble nutrients such as vitamin D3 and vitamin A. It has been 
speculated that MFGM-stabilized microdispersions interact with bile salts and enzymes. 
Indeed, Bezelgues et al. (2009) utilized micelles (monolayers) stabilized with MFGM 
components to evaluate the capacity of liposoluble compounds to be incorporated into 
mixed micelles during digestion. Emulsions stabilized with MFGM had a 2-fold 
accumulation of tocopherol and lycopene when compared to emulsions stabilized with 
milk proteins, suggesting a nutritional application as absorption promoters of liposoluble 
nutrients in low-fat food products. Many researchers are starting to see that the value of 
buttermilk extends beyond emulsification to include the benefits of the MFGM 
components.   
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2.   Potential delivery systems derived from MFGM 
The rich content of phospholipids (PL) in the MFGM, and their unique chemical 
composition, facilitates the use of its constituents in the formation of liposomes, which 
are used in the pharmaceutical and cosmetic industries (Singh, 2006; Thompson and 
Singh, 2006). These are vesicles formed through the self-assembly of amphiphilic 
molecules such as PL, creating bilayers with an aqueous core. During their formation, 
hydrophobic molecules can be incorporated into the bilayer while hydrophilic molecules 
comprise the core (Singh, 2006). In the food industry, liposomes can be utilized to protect 
sensitive ingredients or to increase the efficacy of additives (Thompson and Singh, 2006); 
however, the popular methodologies to make liposomes are not feasible on a large scale 
due to kinetics and the use of detergents and solvents. Furthermore, the current PL 
sources, soy and egg, have high purification costs and a different composition to those PL 
from milk. Thus utilization of low-cost sources such as buttermilk or butter serum could 
alleviate the restrictions of liposome production. Thompson and Singh (2006) have 
successfully used microfluidization, which uses high pressure to force fluid into 
microchannels to overcome the limitations of other techniques (Thompson and Singh, 
2006). This method can generate a large volume of liposomes in a reproducible manner 
without promoting oxidation, and the inclusion of MFGM phospholipids increases 
liposome dispersion and stability (Thompson and Singh, 2006). 
3.   Application of MFGM Components in Food Systems 
MFGM components have been incorporated into food systems mainly as buttermilk 
(Vanderghem et al., 2010). The use of condensed sweet cream buttermilk at low levels of 
supplementation improved the yield of pizza cheese without affecting compositional, 
  
40 
rheological or sensory properties (Govindasamy-Lucey et al., 2006). Buttermilk, 
originating from raw or pasteurized cream was also integrated into casein matrixes to 
simulate cheese, resulting in increased yield due to the water-holding capacity of 
phospholipids (Morin et al., 2008). Fedotova et al. (2008) fortified butter with MFGM 
phospholipids, which stabilized crystal morphology; however, at elevated levels their 
addition caused a coalescence of the aqueous phase, creating water pockets that may 
affect sensory properties. A subsequent study by the same group showed that addition of 
PL increases butter hardness and reduces the tendency to oil-off at elevated temperatures. 
The optimal butter product contained a blend of 60-80% globule fat (Fedotova and 
Lencki, 2010). Recently, Vanderghem et al. (2010) has summarized the effect of the 
addition of buttermilk on the physico-chemical and technofunctional properties of food 
products. 
Another dairy product of interest is the milk produced during the first week of 
lactation, known as colostrum, which is free of caseins and rich in immunoglobulins and 
MFGM proteins (Affolter et al., 2010). One of the main proteins present is lactoferrin, 
which is correlated with beneficial immunological, antimicrobial, and anticarcinogenic 
properties.  Some current nutraceutical formulations utilize lactoferrin for the treatment 
of various ailments, including cardiovascular disease (Mao et al., 2007). Methods have 
been developed for the processing of colostrum to diminish the microbial load and obtain 
a stable and available product, which may be added to a variety of foods (Scammell, 
2001). In addition, milk oligosaccharides from human milk are linked to intestinal 
protection from pathogens (Wilson et al., 2008), and their potential use in infant formula 
is being considered, especially for premature infants who are susceptible to necrotizing 
enterocolitis (Kemsley, 2008). 
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F. Sources of the Milk Fat Globule Membrane: a Novel Dairy Product 
The industrial and potential health benefit properties of the MFGM components have 
led to its isolation and concentration from dairy products. The commercial source is 
sweet buttermilk, which is the aqueous phase resulting from butter churning that contains 
proteins, lactose, MFGM, and other minor constituents (Sodini et al., 2006; Rombaut et 
al., 2006a). Compared to skim milk and whole milk, buttermilk has seven times more 
phospholipids on a dry basis (0.28 g per 100g versus 2.03 g per 100 g, respectively) 
(Sodini et al., 2006). Despite its high content of MFGM components and low cost, 
buttermilk has very limited commercial value (Jiménez-Flores and Brisson, 2008; 
Jiménez-Flores and Higuera-Ciapara, 2009; Singh, 2006). There are also other sources of 
buttermilk such as cultured (sour) and whey buttermilk, derived from churning of 
cultured cream and whey cream; however, they do not have high demand in the industry. 
Sodini et al. (2006) analyzed buttermilk’s functional properties including protein 
solubility, viscosity, emulsification, and foaming and compared them to skim milk and 
whey. The fat content was higher in buttermilk, but the presence of MFGM components 
imparted greater emulsification and lower foaming capacity to sweet, sour, and especially 
whey buttermilk as compared to skim milk and whey. The functional properties of the 
buttermilk were pH-dependent with the exception of whey buttermilk, whose 
functionality makes it ideal for low pH foods (Sodini et al., 2006). 
Table 6. Phospholipid and protein composition in dairy products (adapted from Dewettinck 
et al., 2008; Fong et al., 2007; Jiménez-Flores, 2009; Morin et al., 2006). 
Phospholipids (g/100g) Protein Percentage‡ in  
Product Wet basis Dry basis Product Dry 
Raw milk 0.035 0.28 3.3 - 
Skim milk 0.02 0.28 3.41 7.55 
Cream 0.19 0.40 3.16 - 
Isolated MFGM 0.65 6.5* 1.8 60* 
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Butter 0.19 0.23 0.85 - 
Sweet Buttermilk 0.16 2.03 3.31 32.95* 
Butterserum 1.25 11.54 - - 
Fresh acid buttermilkª 0.31 1.86 3.31 - 
Acid buttermilk whey 0.10 1.84 0.99 84.7* 
Whey buttermilk powder (WBP) * - 14.81* - 47.39* 
SPE-WBP*b  60.59*  72.69* 
Cheddar cheese 0.15 0.25 - 24.89 
Cheddar cheese whey 0.02 0.26 3.49 35.2 
‡Average from several sources and laboratory data. 
*Numbers from corresponding author’s laboratory data 
ª Sour buttermilk 
b
 Solid phase extracted (SPE) whey buttermilk powder (WBP) 
 
Besides sweet buttermilk, other sources such as sour and whey buttermilk have been 
characterized as denoted in Table 6. Among them, butter serum offers the highest 
concentration of phospholipids on a dry basis and has promise to become a potential 
source of MFGM (Rombaut et al., 2006a). However, in any of these sources, other milk 
proteins ‘dilute’ the concentration of MFGM components. Thus, much research has been 
undertaken to adapt filtration techniques such as microfiltration and ultrafiltration to 
concentrate or purify MFGM without the use of chemical solvents.  At the same time, the 
effects of homogenization and heat treatment on the native structure of the MFGM and 
the potential implications these may impart on product functionality and nutrition need to 
be evaluated. 
Another source of MFGM is butter serum, a by-product of anhydrous milk fat 
production.  It can be made by either separation of butter upon melting and 
centrifugation, or homogenization of 75% cream until phase inversion is induced, 
creating butter serum (Rombaut et al., 2006b). The phospholipid content in this fraction 
is five times higher than that of buttermilk (11.54g per 100g on dry basis, see Table 1). 
Two more MFGM-enriched milk fractions are whey protein concentrate (WPC) and 
buttermilk protein concentrate (BMP), which have been characterized in terms of their 
protein composition (Affolter et al., 2010).  Affolter et al. (2009) found 244 proteins in 
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WPC and 133 in BMP, from which 28 in these two fractions can be accounted for in the 
research performed by Reinhardt et al. (2006). Nevertheless, the main problem with 
MFGM purification is the presence of caseins and whey proteins, which has triggered the 
quest for novel purification techniques involving membranes. 
G. Isolation and Purification of the MFGM 
1.   Laboratory Production of MFGM 
The yield and composition of the MFGM, as mentioned previously, depends on the 
technique utilized for its isolation from cream, buttermilk, or whole milk. Loosely bound 
proteins and especially the amount of skim milk proteins, varies in the final MFGM 
fraction (Singh, 2006; Keenan and Mather, 2006). Also, the concentration of 
triacylglycerols differs due to cross-contamination from the globule core (Keenan and 
Mather, 2006; Mather, 2000). On micro- and macro-scales, MFGM proteins are purified 
using a common four-step procedure that involves cream separation, cream wash, globule 
disruption, and membrane collection (Mather, 2000; Dewettinck et al., 2008).  
The fat globules are first isolated out of the milk by centrifugation with a 
physiological buffer layer that also washes the fat globules, eliminating the second step 
and increasing yield of MFGM material (Patton and Huston, 1986). Alternatively after 
centrifugation, the globules can be washed two or three times with buffers (Anderson and 
Brooker, 1974; Basch et al., 1985; Keenan and Mather, 2006); nevertheless, some 
membrane disruption and loss of at least 16% of the membrane proteins occurs 
(Anderson and Brooker, 1974). In addition, cream washing affects the densities of the 
lipoportein complexes (Houlihan et al., 1992). To minimize MFGM loss, a milk salt 
buffer or sucrose is usually added to increase the density of serum (Singh, 2006). Then, 
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the globules are disrupted by either churning (agitation), cycles of freezing and thawing, 
treatment with detergents, or by suspension in polar and aprotic solvents (Keenan and 
Mather, 2006). This step may lead to loss of proteins such as XOR or BTN due to their 
dispersion in the salt/detergent phase. Once the membrane is disrupted, the proteins can 
be collected by ultra-centrifugation, protein precipitation at low pH, or induction of 
aggregation with ammonium sulfate followed by centrifugation (Singh, 2006; Keenan 
and Mather, 2006). The pathways used to isolate MFGM in a laboratory setting or in a 
pilot plant are detailed and compared in Figure 8. 
   
Figure 8. Milk fat globule isolation in a laboratory and pilot plant setting. MFGM proteins 
can be purified using a four-step procedure: Step 1. cream (fat globule) isolation; 
Step 2. washing of globules; step 3. Disruption of globules, and step 4. Membrane 
collection (Dewettinck et al., 2008). 
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2.   Commercial Production of MFGM 
On a commercial-scale MFGM isolation is more suitable from buttermilk, whey 
serum, or acid serum. Acid and whey serums have 0.5 to 1.03% (in dry-matter) residual 
fat that interferes with whey protein concentrate production (Glass and Hedrick, 1977); 
therefore, side purification techniques have been developed to obtain MFGM material 
and facilitate concentration of whey proteins (Rombaut and Dewettinck, 2007). 
Currently, microfiltration and ultrafiltration are the most widely used techniques to purify 
or concentrate milk fat.  
a)   Microfiltration 
Microfiltration features a pressure-driven membrane filtration, with pressure less than 
one bar and membrane pore size between 10-1-101 µm, which is commonly used for the 
removal of bacteria and separation of macro molecules (Corredig et al., 2003; Morin et 
al., 2006). In the dairy industry, this is employed to remove lipids from whey for 
production of whey protein concentrate (WPC). With regard to MFGM purification, 
casein makes microfiltration difficult even after the use of casein micelle dissociating 
agents such as citrate. Corredig and Dalgleish (2003) used sodium citrate to dissociate 
casein micelles resulting in a MFGM concentrate of approximately 60% (w/w) protein 
and 35% (w/w) lipid. However, citrate dissociation requires the use of diafiltration to 
wash out minor constituents, and results in high permeate losses (Rombaut et al., 2006b). 
Morin et al., (2004) demonstrated that microfiltration alone cannot achieve optimal 
separation of lipids and protein for the production of novel ingredients. The pore size of 
the membrane and temperature also influenced the final product as well as the starting 
material (Morin et al., 2004). 
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Despite permeate loss, citrate treatment and microfiltration resulted in a MFGM 
isolate that showed better creaming stability than whole buttermilk concentrate. Such 
effects were attributed to the compositional difference between these two ingredients 
(Roesch et al., 2004). Morin et al. (2006) fractionated buttermilk and whey buttermilk 
using microfiltration, resulting in two-fold and 50% increases in phospholipid 
concentration, respectively. Another study by the same group used washed cream to 
remove some of the caseins and whey proteins that disturb milk fractionation. A two-fold 
increase in the permeation flux was observed as well as a 66% increase in the 
phospholipid content compared to regular cream buttermilk (Morin et al., 2007a).  
Rombaut et al. (2006b) suggested coagulation of casein by acid or rennet addition, 
followed by MFGM purification using ultrafiltration or microfiltration techniques. 
Michalski et al. (2006) patented a microfiltration method to isolate fat globules with 
different diameters. This technique results in large globules (6 µm) that can be churned 
easily for butter making (Fauquant et al., 2007). Finding effective ways to utilize the by-
products of microfiltration, such as the citrate-containing permeate and the precipitated 
caseins, should be an active area of research to find relevant applications in foods (Singh, 
2006). 
b)   Ultrafiltration 
Ultrafiltration is utilized to concentrate large and macromolecules such as the proteins 
in milk and whey. It uses pressure of 1-10 bar and membrane pore sizes between 10-2-10-1  
µm. Despite its functionality, this technique has not been fully used to purify MFGM 
components. Early attempts in the utilization of ultrafiltration resulted in the production 
of buttermilk concentrate with a high protein content (12.87%) and excellent rheological 
as well as emulsifying properties (Real del Sol and Corrales, 1991). Our group is 
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currently exploring ultrafiltration to obtain whey buttermilk powder in conjunction with 
supercritical fluid extraction (SFE). The use of SFE as a solvent to extract non-polar 
lipids has revolutionized the solvent-extraction methods because it does not leave solvent 
residues in the final product. This technique concentrates the phospholipids but does not 
separate out proteins from them (Singh, 2006). Spence et al. (2009) utilized 
microfiltration and SFE to remove triglycerides and concentrate the phospholipid content 
in buttermilk powder, generating powders with a 70% decrease in total lipids (Spence et 
al., 2009). Rezende-Costa et al. (2010) produced a whey buttermilk powder enriched in 
phospholipids utilizing ultrafiltration/diafiltration and SFE. The total lipid content was 
reduced by 57%, and the protein was increased up to 53% (Rezende-Costa et al., 2010). 
Such techniques can concentrate the phospholipids and MFGM protein content from 
cheese or butter-by-products, and the resulting fractions can later be incorporated into 
food matrixes or pharmaceuticals. 
c)   Purification through Aggregation 
MFGM fragments can also be purified through precipitation from cheese whey. 
Attebery (1968) patented the use calcium in conjunction with pH adjustment and 
moderate heat treatment to clarify whey (Attebery, 1968); such method was later applied 
to all types of whey (Fauquant et al., 1985; Maubois et al., 1987). Rombaut et al. (2007) 
optimized these settings to purify MFGM fragments from acid buttermilk cheese whey. 
Their findings indicate that MFGM recovery is highly dependent on pH and less 
dependent on temperature and calcium addition. An optimal treatment at 55 °C, pH 7.7, 
and 0.205 g of calcium/L of whey resulted in a 91% recovery of whey polar lipids and 
minimum whey protein association in the aggregates (Rombaut and Dewettinck, 2007). 
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With similar techniques, MFGM material can be isolated from whey protein concentrate 
production and be used in food products. 
H. Physical and Chemical Effects of Processing on Fat Globules and MFGM 
Drinking milk undergoes a series of processing steps that physically and chemically 
affect the composition and characteristics of the MFGM.  Other milk-derived products 
such as buttermilk and butterserum also endure similar conditions that result in MFGM 
damage; therefore, a lot of research has been done to characterize such changes (Table 4), 
but without a general definition of the MFGM, measuring these alterations in a constant 
manner may be difficult. In his review, Evers (2004) was the first one to clearly define 
the MFGM in order to provide methodologies to measure the damage to fat globules and 
the membrane (Evers, 2004b). What follows is a summary of the main milk handling 
practices that affect this membrane and their effects. 
1.  Temperature Effect 
a) Cool Temperatures 
Temperature treatments are aimed at preventing spoilage, preserving foods, and 
increasing the quality of products by either inhibiting microbial growth, killing 
microorganisms, or inactivating enzymes (Walstra et al., 2006; Huppertz and Kelly, 
2006). The intensity of the treatment depends on the combination of temperature and 
duration to establish specific product or ingredient properties. In the dairy industry, milk 
goes through cycles of cooling and heating depending on the final product, and these 
conditions have an effect on the fat globules, especially the proteins and lipids of the 
MFGM.  
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At low temperatures, milk globules undergo mainly physical changes. A cream layer 
tends to form, which is minimized by regular stirring and by aeration. The latter, in 
conjunction with temperature fluctuations, contributes to cycles of fat crystallization and 
melting, which leads to fat globule disruption and clumping. During cold storage, milk fat 
globules tend to rise in large clusters at a higher rate than individual globules due to the 
presence of immunoglobulin IgM (Huppertz and Kelly, 2006). Such phenomenon is 
known as cold agglutination and requires a heat-labile component, IgM, which functions 
as a cold-agglutinin, and a homogenization-labile skim milk membrane (SMM), which 
consists of lipoprotein particles present in the aqueous phase of milk. Fat globules 
agglutinate by interacting with IgM alone, but extensive clustering is seen in the presence 
of SMM, which acts a cross-linking agent and interacts with IgM only (Huppertz and 
Kelly, 2006). 
In regards to globule size, batch pasteurization or indirect ultra-high temperature 
(UHT) heating of milk at 90-150 °C does not influence the volume surface-weighted 
mean diameter d
vs
. In contrast, direct UHT decreases d
vs
 as the temperature increases 
(Huppertz and Kelly, 2006). Coalescence of fat globules is prevented by the presence of 
the polar head of phospholipids in the MFGM. Removal of such entities results in oiling-
off (Huppertz and Kelly, 2006). Indirect UHT treatment can cause aggregation of fat 
globules.   
Furthermore, when fresh milk is cooled, the association of proteins to the MFGM 
changes (Hohe et al., 1985; Steffensen et al., 2004). The casein proteins, especially β-
casein, dissolve from the casein micelles and go into the serum phase and may be 
incorporated onto the fat globules (Walstra, 1969). Cooling milk also induces the release 
of MFGM phospholipids into the serum phase (Baumrucker and Keenan, 1973) as well as 
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the liberation of xanthine oxidase from the MFGM and the migration of copper from the 
fat globules to the milk plasma (Huppertz and Kelly, 2006). Cool temperatures induces 
the binding to lipoprotein lipase (LPL) and increases the activity of this one, especially 
after three to five hours after milking when heparin in present (Sundheim and Bengtsson-
Olivecrona, 1985).  No further association of LPL with the MFGM is observed beyond 
this point (Dickow et al., 2011). The activity of xanthine oxidase also increases in cooled 
milk (Steffensen et al., 2004). 
b) Thermal Temperatures 
Milk pasteurization lowers the rate of deterioration caused by microbial and 
enzymatic action. During heating, the loss of oxygen decreases the rate of oxidation 
reactions, and the amount of inorganic phosphate increases by hydrolysis of phospholipid 
esters, especially those of casein micelles, and phospholipids (Walstra et al., 2006; 
Huppertz and Kelly, 2006). Acylglycerols are also hydrolyzed and interesterified, and 
lactones and methyl ketones are formed from fat (Walstra et al., 2006).  
With respect to proteins, free sulfhydryl groups are formed as shown in Table 7, 
reactions 2 and 4. Lactose and proteins also undergo Maillard reactions, as denoted by 
reaction 8, and provide a brownish color to milk. Most of the serum proteins are 
denatured and rendered insoluble, especially β-lactoglobulin, which becomes covalently 
bound to kappa casein and to some proteins of the fat globule membrane (Walstra and 
Jenness, 1984). 
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Table 7. Biochemical reactions of side chain groups of amino acid residues linked in the 
peptide chain (|) of proteins at high temperature (Adapted from Walstra et al. 2006). 
Rxn Reactant Direction Product 
 
1 
|__CH2CONH2 + H2O 
  Asparagine+ 
 
→ 
|__CH2—COO- + NH4+ 
Aspartic acid 
 
2 
|__CH2__SH- + -OH-    
  Cysteine 
 
←→ 
|__CH2—S-- + H2O    
  Charged sulhydryl group 
 
3 
|__CH2__S-- + -S__CH2__| 
  Cysteine 
Oxidation-> 
<-Reduction 
|__CH2—SS__CH2__| + 2e 
           Cystine 
 
4 
A |__CH2__S__S__(CH2) __|   
B |__CH2__S- 
 Sulfhydryl exchange 
 
←→ 
A |__CH2__S- 
B |__CH2__S__S__CH2__| 
 
5 
|__CH2__S--  
  Cysteine 
 
→ 
|=CH2   +   HS- 
Dehydroalanine 
 
6 
|=CH2          +       HS__CH2__| 
Dehydroalanine     Cysteine 
 
→ 
|__CH2__S__CH2__| 
    Lanthionine 
 
7 
|__(CH2)4__NH3+     + H2C=|   + OH- 
Lysoalanine++ 
 
→ 
|__(CH2)4__NH__CH2__| + H2O 
       Lysoalanine 
 
8 
|__CH2__COOH + H2N__(CH2)4__| 
Aspartic Acid         Lysine 
 
→ 
|__CH2__CO__NH__(CH2)4__| + H2O 
            Isopeptide 
 
8 
|__(CH2)4__NH2- +  C6H12O6           
      Lysine            Glucose 
 
→ 
|__(CH2)4__NH C6H11O5 + H2O 
       Amadori product 
+   Rxn occurs with glutamine residues 
++ Rxn occurs with histidine residues 
 
The composition of the MFGM is further altered by thermal treatment and 
homogenization due to protein denaturation and interactions with serum proteins (Lee 
and Sherbon, 2002). Upon heat treatment, a layer of whey protein, especially β-
lactoglobulin and α-lactalbumin, deposits on the MFGM, possibly through intermolecular 
disulfide bonding (Kim and Jiménez-Flores, 1995; Michalski and Januel, 2006a; Singh, 
2006).  Bermudez-Aguirre et al. studied the surface of fat globules microscopically in 
raw and thermosonificated milk.  According to their findings, heat and ultrasonic waves 
are responsible for disintegrating MFGM and the release of triacylglycerols. Fat globules 
with a rougher surface (Figure 9) are observed in heat-treated samples due to MFGM 
disintegration and interaction with casein micelles. Also, smaller fat globules are seen 
after thermosonification (Bermúdez-Aguirre et al., 2008). 
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Figure 9.  Fat globule in raw milk (left, 7000x) with no change on surface and thermally 
treated globule (right; 63 °C, 30 min, 6000x) exhibiting deposits of casein proteins. 
Images captured with scanning electron microscopy (Adapted from Bermudez-
Aguirre, D. et al. 2008) 
 If milk is heated after homogenization, then β- and α-lactoglobulins absorb to the 
casein micelles already incorporated onto the membrane (Ye et al., 2004b), making the 
outside membrane more resistant to coalescence (Bermúdez-Aguirre et al., 2008). The 
exact mechanism of protein interaction has not been elucidated; however, it has been 
speculated that it could be via sulfydryl-disulfide interchange (reaction 4 in Table 7) or 
by displacement of the original MFGM material (Michalski and Januel, 2006a; Singh, 
2006).  The MFGM’s association with β-lactoglobulin starts at 60-65 °C and increases 
with heating time until a plateau level of about 1.0 mg/g of fat is reached (Corredig and 
Dalgleish, 1996; Ye et al., 2004b; Ye et al., 2004c); this accounts for 1% of the β-
lactoglobulin found in milk. There is no evidence on the specific MFGM proteins that 
associate with β-lactoglobulin (Singh, 2006).   
Association of α-lactalbumin displays a similar mechanism but less protein is 
absorbed onto the membrane. Also, small amounts of κ-casein seem to interact with the 
  
53 
MFGM when milk is heated above 80 °C; such interaction may be bridged by the already 
absorbed β-lactoglobulin. According to Kim et al. (1995), higher temperature treatments 
(140 °C for 16 s) cause less casein adsorption, but studies in direct and indirect UHT 
determined adsorption of caseins and whey proteins, especially κ-casein and β-
lactoglobulin in the MFGM (Hillbrick et al., 1999). On the other hand, Dalgleish and 
Bank believed that presence of casein on the surface of fat globules may originate from 
partial homogenization, and their data did not support the association of κ-casein onto the 
MFGM (Dalgleish and Banks, 1991). Later studies by Ye et al. indicated that κ-casein 
facilitates the adsorption of casein micelles to fat globules through disulfide bonding 
between κ-casein and MFGM components in heated milk (65-95 °C, 10 min) (Ye et al., 
2004c). Other proteins affected during heating are PAS 6 and 7, which migrate into the 
serum phase and begin to aggregate at temperature above 80 °C (Houlihan et al., 1992; 
Kim and Jiménez-Flores, 1995; Lee and Sherbon, 2002; Ye et al., 2004c); however, in 
the absence of whey protein, PAS 7 is stable (Ye et al., 2002). Ye et al. (2002) 
hypothesized that PAS 7 forms a complex with β-lactoglobulin to later migrate to serum 
phase. 
Heating also decreases the triacylglycerol content of the MFGM and promotes 
migration of copper from plasma to fat globules. With regard to polar lipids, there is 
inconclusive evidence for a correlation between the concentration of PLs and heat 
treatment (Huppertz and Kelly, 2006). Morin et al. (2006) found that production of 
buttermilk from pasteurized cream results in buttermilk with higher lipid content. In 
addition, the total MFGM protein that can be isolated from cream depends on the heat 
treatment (Morin et al., 2007a; Ye et al., 2002). In fact, cream processed at 50 °C for 10 
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min results in approximately 50% MFGM protein loss and formation of aggregates via 
intermolecular disulfide bonds in the absence of serum proteins (Ye et al., 2002). Gassi et 
al. (2008) also observed formation of fat globules aggregates in cream that underwent 
high heat treatment (70 °C, 2 hr followed by 30 s at 88 °C, and 94 °C for 80 s). 
Modifications in the MFGM proteins involve alterations in interfacial properties resulting 
in fat globule aggregation. Figure 10 represents a schematic representation of these 
changes in the MFGM and consequently in the fat globules upon heat treatment.  
 
Figure 10. Changes in the MFGM and fat globules as a function of thermal treatment in 
creams. A) Schematic representation of native fat globules or at low heat, and B) 
after high heat treatment, which adsops aqueous phase proteins, especially whey 
proteins (Taken from Gassi et al., 2008).  
2.   Homogenization 
In the dairy industry, homogenization is performed to counteract creaming and 
provide stability toward partial coalescence during the product’s shelf life. Coalescence is 
prevented by reducing the diameter of the fat globules due to the application of high 
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pressures (8-20 MPa) through a valve needle (Michalski et al., 2002; Walstra and 
Jenness, 1984). Droplets of fat globules are deformed and possibly disrupted by shear 
stress, inertial forces, and cavitation, which cause particles to coalesce and have a bigger 
surface areas where adsorption of proteins occurs. Temperatures between 42 to 72 °C are 
applied during homogenization to increase efficiency; nevertheless, most processes are 
performed at 60°C (Michalski et al., 2002). The type of homogenizer, the homogenizing 
pressure, and temperature are some of the main factors that affect globule size (Michalski 
et al., 2002; Walstra et al., 2006). 
The main effect of homogenization is the disruption of casein micelles, displacement 
of MFGM components to the skim milk, and casein adsorption onto the newly formed 
interface of the fat globules as denoted on Figure 11 (Michalski and Januel, 2006a). The 
amount of adsorbed proteins increases with homogenization pressure; however, the 
protein composition of the MFGM is not affected by homogenization alone but also 
significantly by the heat treatment applied before homogenization (Cano-Ruiz and 
Richter, 1997). Furthermore, the phospholipid content appears to decrease in the new 
membrane (McPherson and Kitchen, 1983). Keenan et al. (1983) reported a loss in total 
lipids, polar lipids, and cholesterols decreased in homogenized milk samples compared to 
unprocessed samples, but the phospholipid distribution remained the same (Keenan et al., 
1983). Homogenization also seems to improve the digestibility of milk; however, 
premature babies have better digestion of human milk fat globules than the homogenized 
lipid droplets of infant formula (Favé et al., 2004).   
Homogenized milk appears to be responsible for allergic reactions. Michalski et al. 
(2006) explains that allergenic milk proteins absorb onto the new increased surface area, 
or perhaps homogenization exposes proteins that may trigger putative allergenic effects. 
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Xanthine oxidase (XO) is one of these proteins, and it has also been associated with 
atherosclerosis. Controversial findings indicate that XO liberated during homogenization 
favors the development of coronary diseases, but Spitsberg (2005) and Michalski (2006) 
argue that populations with high intake of buttermilk or cheese rich in MFGM are not 
associated with coronary mortality.  Other authors claim that MFGM proteins provoke 
autoimmune and neurological diseases such as diabetes I and multiple sclerosis 
(Michalski and Januel, 2006a). Despite the controversy, there is a plethora of research 
highlighting the health effects of MFGM proteins.   
 
Figure 11. Effects of homogenization on milk fat globules.  Native fat globules lack 
adsorption of casein micelles and whey protein. Upon homogenization, serum 
proteins and casein attached to the interphase of fat droplets (top) and MFGM 
fragments are desorbed (bottom) (Adapted from Michalski and Januel, 2006).    
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3.   Influence of Spray-drying  
Products are usually dried to increase their storage stability, reduce packaging 
requirements, and reduce shipping weights (Landstrom et al., 2000). In the dairy 
industry, spray drying is the most common method used to concentrate milk solids, due to 
milk’s seasonal variations, and to produce milk-derived powders, especially whole milk 
powder (WMP) and skim milk powder (SMP) as fresh milk substitutes (Schuck, 2002; 
Ye et al., 2007; Singh and Ye, 2010). Milk must undergo heat treatments, 
homogenization, evaporation, and spray drying to produce powders. First, the liquid 
product is atomized at the top of the drying chamber and mixed with dry heated air (180-
220 °C), which evaporates the moisture in the droplets.  Atomization provides a large 
surface area but damages fat globules by shear, causing changes in the fat globule surface 
protein layer. Since thermal evaporation damages the MFGM, milk to be evaporated is 
usually homogenized to deposit casein on the fat globules and make the membrane 
stronger for spray-drying (Morin et al., 2007b).  
Rennie et al. (1999) correlated small particle size with stickiness and powder 
deposition in dairy powders. WMP had twice the powder cohesion than SMP as 
temperature increased from 30 to 65 °C due to the presence of fat. Ye et al. (2007) 
investigated the behavior of milk fat globules during spray drying of whole milk, and 
concluded that upon spray-drying, the average fat globule size (d32) of powders was 
smaller than the initial products and formation of large globules (4-80 µm) occurred.  In 
regard to phospholipids, spray-drying decreases the PL content in buttermilk powders, 
probably due to complex formations between PL and MFGM proteins from the heat 
treatment, rapid evaporation, and increased ionic strength created by spray drying  (Morin 
et al., 2007b). In conclusion, milk powder undergoes a lot of processing that causes 
  
58 
physical and chemical interactions among milk components, and such interactions 
determine the functional properties for powder reconstitution in water and consumers’ 
acceptability (Schuck, 2002; Ye et al., 2007; Singh and Ye, 2010).  
I. Cold Pasteurization-UV Pulsed Light Treatment 
As an effort to reduce the risk of foodborne illnesses associated with pathogens, 
especially E. coli O157:H7, Salmonella, and Campylobacter, the U.S. Department of 
Agriculture (USDA) approved the use of irradiation in food products in 1963.  Currently, 
in the United States irradiation is applied to meat and poultry and includes the use of 
gamma rays, electron beams, and x-rays in government-approved irradiation facilities 
(USDA). More than 40 food products are irradiated in 37 countries including wheat and 
wheat powder, spices, fresh shell eggs, fresh produce, and recently apple juice in 
countries such as Canada (Health Canada).   
For half a century, irradiation has been used to treat food products because no 
significant changes have been observed. In fact, the American Medical Association and 
the United Nations' World Health Organization endorsed the use of this technique due to 
its efficient antimicrobial effects (USDA). Data collected on apple juice concluded that 
the only degradation products that would occur from UV treatment of juice/cider are by-
products that occur naturally from sunlight (Health Canada). With such findings, 
irradiation must find its way into the dairy industry to substitute for heat pasteurization of 
milk, of which in 2010, 193 billion pounds were produced in the United States totaling 
$31.4 billion in cash receipts from marketing (Milk Production, Disposition, and Income 
2010 Summary, USDA). It is expected that UV light treatment will minimize the number 
of spores in USA milk powder and increase its commercialization in other countries that 
currently reject products that do not meet their standards.   
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1.   Bactericidal Effects of UV-light Treatment 
UV-light has a broad range of antimicrobial effects including vegetative cells, 
especially with spore-formers and pathogenic bacteria, fungi, and yeast (Krishnamurthy 
et al., 2004; Elmnasser et al., 2007; Smith et al., 2002; Anderson et al., 2000). In 
addition, microorganisms do not develop resistance to UV treatments (Elmnasser et al., 
2007). Chang et al. (1985) investigated the effect of continuous UV-light sterilization on 
E. coli, S. typhi, S. sonnei, S. faecalis, and S. aureus and concluded that these 
microorganisms have different resistances to UV-light. All of them were inactivated with 
7 mW-sec/cm2 energy to get a 3-log10 reduction with the exception of S. faecalis that 
required more energy (Chang et al., 1985).   
Smith et al. (2002) used pulsed UV treatment to inactivate S. aureus and concluded 
that a minimum dose of 12.6 J/cm2 is needed to achieve a 2-log10 reduction.  In addition, 
they observed a decrease in spore-forming bacteria colonies.  Krishnamurthy et al. (2004) 
also conducted inactivation of S. aureus with a pulsed UV-chamber, finding similar 
results but emphasizing that the volume and the distance between the UV source and the 
sample as well as energy intensity and time are important in opaque products such as 
milk. Differences on the microbial lethality between gram-negative and gram-positive 
bacteria were also investigated and attributed to the composition in bacterial cell wall and 
their protective and repair mechanisms.  Gram (-) microorganisms such as S. enteritidis 
and E. coli are more susceptible to pulsed-UV light than gram (+) B. cereus (Anderson et 
al., 2000).  
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2.   Chemical Effects of UV-light Treatment 
Extensive work has been done on the bactericidal effects of UV-light, but there is still 
little information available on the effects of light treatment on the conformational 
changes in milk proteins or the production of by-products that could be carcinogenic or 
affect consumer acceptance. Elmnasser et al. (2008) concluded that pulsed-light 
treatment does not contribute to conformational changes in milk proteins besides the 
aggregation of β-lactoglobulin, which results in the formation of dimmers with molecular 
weight of 36 kDa due to disulfide bonding. Light treatment may change the polarity of 
microenvironments, making some amino acids such as tryptophan more exposed to 
hydrophilic areas and changing protein folding and aggregation as seen in fluorescence 
spectrophotometry of intrinsic tryptophan. Such alteration can be measured by 
fluorescence by exciting a sample at 290 nm and scanning between 305-450nm. In 
addition, a decrease in riboflavin concentration, a marker for oxidation that involves 
radical formation and consequent protein and lipid degradation, resulted in a decrease of 
the maximum emission wavelength; nevertheless, the authors concluded that there was an 
absence of oxidation reactions of proteins by lipids (Elmnasser et al., 2008). 
On the other hand, goat milk treated with an UV fluid processor resulted in lipid 
oxidation, as denoted by an increase in thiobarbituric acid (TBA) and acid degrees values 
(ADV); however, these changes were not enough to detect organoleptic differences in 
treated samples.  Volatiles such as pentanal, hexanal, and heptanal were detectable in 
treated samples after 1.3 mJ/cm2 energy (Matak et al., 2007). Furthermore, temperature 
increments have been observed during prolonged UV treatment, and without the proper 
cooling system, the quality and nutritional profile of foods may be compromised 
(Elmnasser et al., 2007). 
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J. Methodology to Monitor the Biological Activity of the MFGM 
With the advances in the scientific and technological fields, there are new tools to 
monitor the biological activity of MFGM in foods, which can increase our knowledge of 
the membrane structure, especially before processing. Such findings will allow us to 
select methods to preserve the native structure of the MFGM and set standards for 
generating a product similar to what the neonate receives. Among the latest technologies, 
atomic force microscopy, confocal microscopy, and laser tweezers have captivated the 
attention of scientists due to their ease of use, non-invasive methodology, and plethora of 
results. 
Atomic force microscopy (AFM) has similar resolution to that of electron microscopy 
(Evers, 2004b). It allows the visualization of monolayer domain formation, binding 
events, as well as membrane-membrane interactions, among other features (Jiménez-
Flores and Brisson, 2008). It has been used to characterize the structure and properties of 
the MFGM. In fact, Gallier et al. (2010) monitored the physical behavior of phospholipid 
monolayers from various dairy products using atomic force microscopy and found that 
milk processing alters the phospholipid and fatty acid composition in the MFGM and 
consequently the physical behavior of PL monolayers.  
Confocal laser scanning microscopy, lipophilic probes, and fluorescent lectin wheat 
germ agglutinin (WGA) were first utilized to investigate the organization of the MFGM 
in milks from animal species (Evers et al., 2008). With the same confocal technique, 
Lopez et al. (2010b) revealed the heterogeneous organization of the MFGM, especially 
the lateral structure of polar lipids, glycolipids, and glycoproteins. The MFGM surface, 
especially the phospholipid monolayer, has been characterized by microscopic techniques 
at our facility (Gallier et al., 2010a).  
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The use of laser tweezers, also known as optical tweezers, has been applied in the 
MFGM field. This technique arises from the principle that small particles/objects can be 
imprisoned in the center of a strongly focused laser beam, experiencing a restoring force 
if they try to leave the high intensity volume. The optical tweezer system has been used 
for direct manipulation of a variety of micrometer-sized objects and for force 
measurement in the pico-Newton (pN) region (Jiménez-Flores and Brisson, 2008). In 
fact, Argov et al. (2008) utilized laser tweezers Raman spectroscopy to characterize 
submicron-sized particles in human milk. They observed a significant difference in the 
triacylglycerol composition of human fat globules, depending on their diameter, 
especially in nanoparticles (less than 1 µm), implying that these components have other 
functions besides fat delivery. Such findings open the door to nanoscience, which can 
help us reveal the association between food structure and functionality. Furthermore, our 
research group has used laser tweezers to objectively measure binding force between 
lactic acid bacteria and the MFGM (Brisson et al., 2010).   
K. Principles of Analysis Methods Utilized 
1.   Cold Pasteurization 
Cold pasteurization is a nonthermal method that utilizes broadspectrum 
electromagnetic energy to inactivate microorganisms. Its efficiency depends on the 
intensity (J *cm-2) and the number of pulses delivered, which inhibits bacterial replication 
by damaging DNA as pyrimidine dimmers are formed (Krishnamurthy et al., 2004; Oms-
Oliu et al., 2008).  Microbial cells can also be disintegrated by the UV photothermal 
effects, which might cause instantaneous overheating of the cellular constituents and 
rupture of the cell membrane (Oms-Oliu et al., 2008).  
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UV-light sterilization can currently be accomplished using two models: a continuous 
UV-light or pulsed UV-light treatment.  According to research, pulsed UV-light seems to 
be more efficient in deactivating microorganisms due to the intensity of the energy 
delivered in short-duration pulses.  Continuous UV-light has poor penetration depth and 
low emission power as compared to pulsed UV-light.  The emission power achieved by 
the continuous system ranges from 100 to 1,000 W whereas the pulsed system may have 
a peak of 35 MW (Oms-Oliu et al., 2008). The Food and Drug Administration (FDA) 
approved the use of the latter technology in 1996, and since then, different systems have 
come to the market. The SteriPulse-XL system generates UV/Visible light with a xenon 
flashlamp that delivers up to 505 Joules per pulse (1.27 Joules/cm2) at a rate of 3 pulses/s, 
providing short pulses (360 µs width) that prevent excessive heat buildup.   
2.   Milk Analysis 
a)   Analysis of Milk Lipids 
The analytical procedure to determine lipid compounds involves lipid extraction from 
a protein matrix, analytical separation, identification, and quantification (Carrasco-
Pancorbo et al., 2009). In the dairy industry, fat extraction and quantification is mainly 
performed by the standard Mojonnier method (Association of Official Analytical 
Chemists, AOAC, 989.05). However, this procedure has its limitations due to the use of 
ammonium hydroxide to denature proteins in conjunction with heat to evaporate solvents, 
which can lead to oxidation and hydrolysis of phospholipids (Rombaut et al., 2006c). In 
addition, the Mojonnier method may not be efficient in extracting all the phospholipids 
(Morin et al., 2007b). Cold methods such as the Folch method are preferred to purify fat 
from tissue, utilizing chloroform/methanol to extract lipids in low-fat products and saline 
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aqueous solution to wash out non-lipid components (Folch et al., 1957). Its efficiency in 
extracting lipids is higher, but its reproducibility is lower than the Mojonnier method 
(Avalli and Contarini, 2005). In addition, the solvents used in the Folch method are 
highly toxic, and to extract the equivalent of fat in the Mojonnier method, larger volumes 
of these solvents will be needed using Folch’s protocol (Min and Ellefson, 2010).  
Phospholipids are further concentrated for analysis through differences in their 
polarities via solid phase extraction (SPE), which fractionates analytes according to their 
affinity between a solid and a mobile phase (Descalzo et al., 2003). Bitman et al. (1984) 
utilized SPE columns to separate neutral lipids from polar lipids using hexane/ether and 
chloroform/methanol/water, respectively (Bitman et al., 1984). Vaghela and Kilara 
(1995) presented a protocol to purify phospholipids using methanol preceded by the use 
of chloroform/isopropanol and acetic acid in ether to eliminate more neutral lipids and 
free fatty acids, but aminopropyl SPE columns were utilized instead (Vaghela and Kilara, 
1995). In 2005, Avalli and Contarini introduced a protocol similar to Bitman, but the 
ratio of hexane/ether differed to extract more neutral lipids from the final product (Avalli 
and Contarini, 2005).  In a comparison study, the previous three methods were used to 
extract PLs from buttermilk. Bitman samples were enriched in phosphatidylcholine, 
sphingomyelin, and saturated lipids while Avalli and Vaghela samples eluted more 
phosphatidylethanolamine and phosphatidylinositol than Bitman’s samples. Such 
difference in the phospholipid profile played a role in the type of lipid monolayer films 
observed under fluorescence microscopy (Nelson and Rios, 2007).  
Phospholipid analyses have traditionally been performed in thin layer 
chromatography (TLC) or gas chromatography (GC) (Sprecher et al., 1965; Descalzo et 
al., 2003); however, the former is tedious and laborious (Fagan and Wijesundera, 2004), 
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and the latter requires extensive derivatization. Thus, high performance liquid 
chromatography (HPLC) has become the method of choice for separation and 
quantitative determination of the different classes of phospholipids (Rombaut et al., 
2005; Rombaut et al., 2006c; Vaghela and Kilara, 1995). This technique has been 
employed in direct mode or with on-line pre-concentration using a cation-anion exchange 
or silica guard column to separate the major PL (Fagan and Wijesundera, 2004; Carrasco-
Pancorbo et al., 2009). 
HPLC is most commonly coupled with UV or evaporative light scattering detector 
(ELSD) for PL detection (Rombaut et al., 2005). While UV is limited to compounds that 
possess a chromophore, ELSD is more efficient for detecting non-volatile compounds 
such as phospholipids because it is a universal mass detector. With the aid of a nebulizing 
gas, the solvent evaporates, and the analyte atomize, scattering a laser beam at the end of 
a heating tube to a sensitive photomultiplier (Carrasco-Pancorbo et al., 2009). A new 
detector, charged aerosol detector (CAD), offers the same sensitivity as ELSD without 
the trouble of instrument parameter optimization such as temperature adjustments (Bailey 
et al.; Moreau, 2006a). It has a high-voltage corona needle to charge molecules, so the 
response is independent of the analyte’s structure (Bailey et al.; Crafts et al.). In addition, 
CAD has a nearly linear mass-to-peak area relationship for many types of lipids (Moreau, 
2006a). A comprehensive review on analytical techniques for lipid is presented by 
Carrasco-Pancorbo et al. (2009). 
b)   Fourier Transform Infrared (FTIR) Milk Analysis 
Conventional dairy analyses generate high waste volumes, have expensive labor 
costs, and require a lot of time to obtain results for laboratories or production 
environments.  In order to increase the efficiency of these facilities, infrared milk 
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analyzers (IRMA) emerged to reduce cost (Biggs, 1967; Van de Voort et al., 1987). Later 
developments introduced fourier transform infra-red (FTIR) as an analytical technique in 
industrialized countries due to its speed, accuracy, quick sample preparation, and 
relatively low cost (Rodriguez-Otero et al., 1997). This analytical method is based on 
infrared spectroscopy, which measures the absorption of different frequencies of infrared 
radiation by solids, liquids, and gases (Wehling, 2010; Barbano and Clark, 1989). When 
molecules absorb IR energy at a particular wavelength, chemical bonds vibrate at 
different frequencies, which can be used to identify characteristic functional groups in a 
sample (Wehling, 2010).  
Mid-IR spectroscopy (4000 cm-1 to 400 cm-2) revolutionized the dairy industry with 
FTIR spectroscopy because it performs qualitative and quantitative analysis of 
ingredients and finished foods (Rodriguez-Otero et al., 1997; Barbano and Clark, 1989). 
It is currently an AOAC and an International Dairy Foundation (IDF) accepted method 
(Rodriguez-Otero et al., 1997). Currently, the Foss Milkoscan FT2 is widely used in the 
dairy industry for simultaneous milk composition analysis of lactose, protein, and fat 
(Rodriguez-Otero et al., 1997). 
3.   Particle Size Analysis 
Laser diffraction techniques are utilized to determine the particle sizes distribution in 
wet or dry samples (Xu, 2001). They are non-destructive and non-intrusive techniques 
capable of measuring particles in the size range 0.02 to 2000 microns (Kippax). Modern 
laser diffraction instruments, such as the Coulter LS-230, target a laser beam through a 
sample, which scatters the incident light onto a Fourier lens (Kippax). The benefits of this 
technique are the wide dynamic measuring range, flexibility of samples, rapid data 
acquisition, and high repeatability.  
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4.   Sodium Dodecyl Sulfate Polyacrylamide Electrophoresis (SDS-PAGE) 
A protein mixture can be separated and visualized by SDS-PAGE according to the 
protein’s electrophoretic mobility. This technique was first used in the 1950’s to separate 
proteins, and later the use of reducing agents and detergents such as β-mercaptoethanol 
and sodium dodecyl sulfate (SDS), respectively, were included to isolate protein subunits. 
Since then, SDS-PAGE has evolved to separate proteins with simple and quick staining 
protocols and high protein recovery. In 1975, O’Farrell introduced high-resolution two-
dimensional gel electrophoresis (2DE). This technique separates proteins first by 
isoelectric focusing and secondly by molecular weight in SDS-PAGE (O'Farrell, 1975). 
2DE has the advantages of high-resolution separation, estimation of molecular weight, 
quantification of individual proteins, and visualization of the sample’s proteome 
(O'Donnell et al., 2004; Hamdan and Righetti, 2005). Protein expression requires 
comparison of gels after staining and statistical analysis (Lindmark-Mansson et al., 
2005). Some disadvantages include the modest detection limit, detection of only highly 
abundant proteins, and poor results in extreme pH as well as high and low molecular 
weights (Hamdan and Righetti, 2005).  
The staining techniques have also been important in protein visualization. According 
to Candiano et al. (2004), staining procedures can be divided into four categories: organic 
dyes, silver stains, negative stains, and fluorescent stains. The latter group includes 
SYPRO Ruby, with a sensitivity of up to 0.5-1.0 ng protein /mm2 but requires UV 
excitation to visualize the proteins. Among the organic dyes, there exist Coomassie Blue 
R-250 and Coomassie Bue G-250, which bind one mg of protein per 1.2 and 1.4 mg of 
dye, respectively (Candiano et al., 2004). The most sensitive protocol is silver staining 
that relies on the reduction of ionic to metallic silver onto the protein surface. However, 
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irreproducibility and dependence on other parameters makes this stain rather erratic. The 
most common dye used is Coomassie blue, but it is limited at detecting glycosylated 
proteins, which require a periodic acid-Schiff (PAS) reagent method to detect oxidizable 
carbohydrate groups. In proteomics, Coomassie Blue is preffered due to its high 
sensitivity, simple use, and fewer preparation steps, but protocols have been adapted to 
have a more sensitive colloidal stain for proteome analyses (Candiano et al., 2004; 
Westermeier, 2006). 
5.   Liquid Chromatography and Proteomics 
In 1995, M. Wilkins introduced the term proteomics from the word “proteome,” 
which indicates “the entire protein complement expressed by a genome, or by a cell or 
tissue type” (Takahashi and Isobe, 2007). This field of science developed from the need 
to identify, quantify, and characterize the structure, biochemical activity, and 
functionality of all the proteins in an organism or specimen and from the necessity to 
establish how these properties vary in time or physiological state (Gagnaire et al., 2009; 
Hamdan and Righetti, 2005). This technique became even more popular as protein 
sequence databases increased, along with arising revolutionary equipments in 
spectrometry (Gagnaire et al., 2009). Nowadays, proteomics is mostly performed to 
identify and quantify proteins or modifications such as glycosylation that change in time 
(Reinhardt and Lippolis, 2008; Beddek et al., 2008). In the dairy field, the first proteomic 
studies were performed to characterize milk and whey proteins (Lindmark-Mansson et 
al., 2005; Manso et al., 2005). Current research focuses on low-abundance and/or 
bioactive proteins such as those in the MFGM (Yamada et al., 2002; Smolenski et al., 
2006; Gagnaire et al., 2009; Reinhardt and Lippolis, 2008).  
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There are two approaches for protein identification, the top-down and bottom-up 
approach. In the first approach, complex protein mixtures are digested into peptides from 
which fragmentation data is obtained and match to a predicted spectra from peptide 
amino acid sequence (Takahashi and Isobe, 2007). The top down approach is more 
challenging because the intact mass of a protein is measured, followed by protein 
fragmentation, and identification from the fragmentation pattern.  
Proteins are usually separated in 1D or 2D electrophoresis gels, cation/anion 
exchange, or isolectric focusing to decrease the complexity of the dynamic range of 
proteins (Takahashi and Isobe, 2007). Upon separation, isolated protein or spots are 
digested with trypsin, and peptides are separated and identified with mass spectrometry 
(MS). In MS, the samples are introduced, ionized, separated, and detected. Nonvolatile, 
high-molecular-weight compounds such as peptides and proteins can be ionized by 
matrix-assisted lasser-desorption/ionization (MALDI) or electrospray ionization (ESI) 
(Hamdan and Righetti, 2005; Takahashi and Isobe, 2007). MALDI is a solid-phase 
technique utilized on silicon chips that detects singly-charged ions and is usually coupled 
with a high mass range analyzer such as a time of flight (TOF) mass analyzer. MALDI-
TOF requires fairly pure samples, so it is commonly used in conjunction with protein 
fractionation with 1DE or 2DE (Hamdan and Righetti, 2005). Identification of proteins is 
performed by peptide mass fingerprinting (PMF), which compares a list of experimental 
peptide masses with a theoretical list of peptide masses in protein databases. On the 
contrary, ESI generates gas-phase ions from liquid samples, and it is usually coupled with 
on-line chromatographic techniques, such as reversed phase HPLC and anion exchange, 
to identify ions via quadrupoles and quadrupole ion traps. These instruments are more 
readily configured as tandem mass spectrometers for mass-selecting and fragmenting 
  
70 
single components of a mixture (Hamdan and Righetti, 2005). Despite its sensitivity, ESI 
has limited application in the analysis of complex mixtures unless high-resolution 
chromatographic equipments are utilized (Hamdan and Righetti, 2005; Takahashi and 
Isobe, 2007). 
Current research attempts to identify minor milk proteins using both direct liquid 
chromatography-tandem mass spectrometry and 2DE followed by MALDI-TOF 
(Smolenski et al., 2006). Molecules involved in host defense have been of special interest 
in the dairy field, and the need to quantify changes during milk lactation has driven many 
scientists to come up with more sensitive techniques to achieve such goals. O’Donnell et 
al. (2004) provides a good review of proteomics techniques and the challenges faced in 
milk proteomics. 
L. Summary of Literature 
Fat lipid formation has been reviewed along with the origins of the crescent milk fat 
globule membrane, which is constituted of proteins and polar lipids. These components 
are associated with health and well-being benefits and even nutraceutical properties, 
which emphasizes the importance of studying the MFGM to its fullest. However, further 
research to optimize the extraction of MFGM from the richest sources, buttermilk and 
butter serum, is necessary to maximize the yield. Therefore, the latest procedures in 
filtration were presented to recover intact MFGM constituents. Also, the technical aspects 
and methodologies that reveal the MFGM composition with minimal invasion were 
summarized to provide alternate techniques to study the effects of milk processing, such 
as cooling, thermal treatment, and homogenization.  
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M. Justification for Present Research 
The milk fat globule membrane is part of the most nutritional product that nature has 
provided: milk; however, its health-promoting and neutraceutical properties are still 
unknown to most consumers. A lot of research has been done in characterizing the milk 
fat globule membrane. Yamada et al. (2002) first attempted to identify low-abundance 
protein in colostrum and mature milk, identifying specific proteins to each set of milk. 
Later, developmental changes in the transition from colostrum to milk were published 
(Reinhardt and Lippolis, 2008) as well as milk glycax using proteomics techniques 
(Wilson et al., 2008). The latest work profiled the metabolic proteomic of bovine 
mammary tissue (Beddek et al., 2008), but even with the plethora of studies about the 
health benefits of MFGM proteins and phospholipids, no work has been performed in 
studying the damage that MFGM constituents undergo during milk processing in the 
same line of milk.  
With this study, an in depth characterization of the effects of milk processing on the 
milk’s constituents, especially proteins and polar lipids, was performed utilizing 
established methodologies and sensitive proteomic techniques such as LC/MS and 2-DE 
gels coupled with MALDI-TOF. Furthermore, protocols for the study of MFGM were 
established for future research, to determine the best source of MFGM for commercial 
production, and for incorporation into the food products.  
The knowledge obtained from the effect of milk processing on the MFGM will 
further expand our understanding of the fundamentals that will allow the design of an 
optimal processes to maintain the function of the MFGM throughout the line of 
production and absorption of nutrients in the human intestine and receive benefits similar 
to the ones neonates acquire.  
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III. MATERIALS AND METHODS 
A. Milk Collection & Processing 
Milk was collected from Cal Poly’s milking parlor before it reached the cooling tank 
and kept at room temperature until analysis were done; this, sample was denoted “Fresh.” 
Then, the milk was left in the cooling unit for 72 hrs, and processing was performed as 
shown in Figure 12. Three independent replicates were performed in different weeks 
 
 
 
Figure 12. Milk Collection and Processing. 
1.   Heat Pasteurization 
Milk processing was conducted at Cal Poly’s pilot plant. Batch pasteurization was 
done in a double walled vessel (Groen DN/RA-60) where steam was applied until the unit 
reached 63 °C and maintained for 30 min. Temperature was monitored with a 
thermometer. The milk was immediately placed at 4 °C after processing. High 
temperature short time (HTST) pasteurization was performed with a heat plate exchanger 
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(APV, SR II, Cropoco, Inc) controlled with Hardy instrument software (HI2151/20 WC). 
The conditions were 72 °C for 16 seconds followed by immediate cooling to 4 °C.  Ultra 
high temperature (UHT) pasteurization was performed in an autoclave (2540E, Tuttnauer 
Brinkmann). Milk was placed in 500ml pyrex glass bottles and heated to 121 °C for 3 
minutes.  
2.   Cold Pasteurization- Pulsed UV Light  
Cold pasteurization was performed according to Elmnasser et al. (2008) and 
Krishnamurthy et al. (2004)’s descriptions, using a SteriPulse-XL system (RS-3000C, 
Xenon Corp., USA) equipped with a lamp housing with 16 in quartz flashlamp type C 
(XL-1957), a sterilization chamber (LH840 LMPHSG), a liteMark-XL 1000 light 
monitor, and a controller (RC-847). The system was located under a hood to ventilate 
ozone being produced. The milk sample, five to ten mL, was pipetted into a glass bottom 
petri dish (9 cm diameter, Pyrex, USA) and placed at the midpoint of the flashlamp 
(7.9cm depth x 20.3 cm wide). To receive the maximum energy, the petridish was located 
4.5 cm (1.76 in) from the face of the sterilization chamber’s window, which has an 
intensity of approximately 1.0 Joules/cm2/pulse. 
a)   Microbial Reduction in Milk 
To determine the best settings to reduce the microbial population in a non-transparent 
liquid such as milk, microbial studies were performed on UV treated milk and compared 
to raw milk. Two parameters were analyzed, the volume of the fluid placed in the petri 
dish since this determines the depth penetration of the lamp and the exposure time. 
Volumes in the range from five to ten mililiters were tested in combination with 
treatment time of two up to nine seconds. Microbial reduction in aerobic and 
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E.coli/coliform counts were enumerated using 3M™ Petrifilm™ Aerobic Count Plates 
and 3M™ Petrifilm™ E. coli Count Plates (EC), respectively, after 24 and 48 hrs of 
incubation. Dilutions were made with butterfield phosphate buffer (D599, Hardy 
Diagnostics, USA), and the samples were plated in duplicates and incubated at 25 °C. 
One-way ANOVA tests were performed using MiniTab (v.16.1.0, Minitab Inc., State 
College, PN) to find difference (p< 0.05) among samples. Paired comparisons between 
means were carried out using the Tukey’s test when a significant difference was 
observed. 
b)   Milk Processing 
Milk that was kept in the cooling unit for 72 hrs was utilized for this experiment and 
maintained cold throughout the pulsed UV light treatment.  Seven mL of milk were 
placed in a petridish and given five pulses of UV light for a total of 5,970 Joules (15 
Joules/cm2) of energy. Three petridishes were located on the tray along the midpoint of 
the flashlamp, and their product consolidated. A final volume of 800 mL of UV-treated 
milk was collected and kept at 4 ºC until needed. 
B. Physical Properties of the Milk Fat Globule Membrane 
1.   Milk Fractionation 
To separate cream, 35 g of processed milk was measured in ultracentrifuge tubes 
(357002, Beckman, CA) and transferred to a pre-chilled Beckman L7-35 Ultracentrifuge 
at 7,000 rpm for 30 min at 4 ºC (Basch et al., 1985). Upon centrifugation, the cream was 
scooped out with a spatula and placed on a Whatman #1 filter paper (No. 100150) for 5 
min and later placed into a 15 mL falcon tube.  The skim milk was decanted into clean 
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falcon tube containing a net (hair net) to prevent cream chunks from entering the final 
fluid.  Cream and skim milk were kept at room temperature previous to analysis. 
2. Milk Fat Globule Size Distribution  
Particle size diameter distribution of whole milk, skim milk, and 40% cream were 
determined according to the method described by Menard et al. (2010) using a laser 
diffraction particle size analyzer in the Polarization Intensity Differential Scattering 
(PIDS) optical mode (Beckman Coulter, model LS 230, CA). The analysis chamber was 
filled manually with one liter of deionized water containing 16 mL of 35 mM 
EDTA/NaOH pH 7 buffer (>99% disodium salt dehydrate, Sigma) for a final 
concentration of 0.1 mL buffer per liter of water. The instrument was allowed to adjust 
for electrical offsets and align the laser prior to measuring background, which was 
measured for 60 sec. Sample loading was conducted for 90 seconds. The obscuration rate 
was held 10% for milk during the runtime. For whole and skim milks, one mL of 35mM 
EDTA buffer was added to 10 mL of milk five min before measurements (Mènard et al., 
2010).  For cream, 35 mM EDTA buffer was use to make the final cream concentration 
40% (w/v). The pump speed for all the samples was 50%; laser power, 80%; run length, 
60 s, and temperature, 23 to 25°C. 
Standard parameters were calculated by the software (Coulter LS Software v.3.29 
August 2003), and measurements were conducted in triplicate.  Five parameters were 
calculated to describe the milk fat globule size distribution in milk, cream, and skim milk. 
The volume-weighted average diameter (d4,3), which is defined by Equation 1 as: 
 
d4,3 =
nid
4
i∑
nidi
3∑
 (Eq. 1) 
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 Where ni is the number of fat globules of diameter (di). The second parameter is the 
volume–surface average diameter (d3,2), described by Equation 2.  
 
d3,2  =
nid
3
i∑
nidi
2∑
 (Eq. 2) 
 
The modal diameter (mode) was measured to represent the most important population 
of fat globules in volume. The fourth parameter is the specific surface area (SSA), which 
is shown via Equation 3:  
 SSA = 6ϕ
d3,2
 (Eq. 3) 
Where φ  is the volume fraction of milk fat, and the size distribution width was 
calculated using Equation 4 as indicated below. For this equation, d
v,0.9 ,dv,0.1, and dv,0.5 
represent the diameter below which lies 90%, 50%, and 10%, respectively, of the globule 
volume. 
 Span = dv0.9 − dv0.1
dvo.5
 (Eq. 4) 
 
C. Chemical Composition of Processed Milk 
1.   Evaluation of Milk Composition 
The protein, casein, lactose, fat, and total solids content of processed milks were 
deterined with a Milkoscan FT2 (Foss, Eden Prairie, MN) utilizing Foss Integrator 
software package version 1.5.0 (Foss). Prior to the analysis, the instrument was calibrated 
with DQCI Servies: Dairy Quality Control California Milk Standards (DQCI, Mounds 
View, MN). The samples were warmed to 40 ºC for five minutes before measurements, 
and each sample was conducted in triplicates. 
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2. Fat Extraction-Mojonnier  
Milk fat was extracted using the Mojonnier method (AOAC Method 989.05) (Min 
and Ellefson) with slight modifications to prevent phospholipid degradation.  All the 
reagents were analytical grade and purchased form Fisher Scientific. Prior to extraction, 
each sample was warmed to 38 ºC for five min to assure a complete homogenization of 
sample. Five mL of milk (25 ºC) were weighed in a Mojonnier extraction flask (EW-
34590-65, Cole-Parner, IL) followed by addition of warmed water (38 ºC) and mixing for 
30 sec. The sample was shaken vigorously for 45 sec after each chemical addition with 
the exception of ammonium hydroxide, which was done for 30 sec. To neutralize acids 
and denature proteins, 1.5 mL of NH4OH (A669-212) were added. Gel formation was 
prevented by adding 10 mL of 95% ethanol (A407-4), and the lipids were dissolved by 
the addition of 25 mL of ethyl ether (E199-4). A couple drops of a 1% phenolphthalein 
solution (SP62) were added to distinguish between the organic and inorganic phases. 
More lipids were extracted with 25 mL of petroleum ether (E120-4), which also removed 
moisture from the organic phase. The sample was spun down in a Garver electrifuge 
(308M, Garver Manufacturing, IN) for 45 sec. The organic phase was decanted in a pre-
weighed Mojonnier fat tin, which was previously dehydrated at 100 ºC for 30 min and 
placed in a dessicator.  A second extraction was performed without the addition of 
ammonium but with 5 mL of ethyl alcohol, 15 mL of ethyl ether, and 15 mL of petroleum 
ether. The solvents were then evaporated on a hot plate at approximately 60 ºC and 
transferred to a pre-warmed isotemp vacuum oven (281A, Fisher Scientific, CA) for 30 
minutes at 60 ºC with at least 20 in Hg vaccum. The tins were transferred to the 
dessicator and allowed to cool down before weighing them. The milk fat was transferred 
to a 4-ml amber vial with the addition of chloroform/methanol (2:1, v/v) to a final 
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concentration of 100 mg/mL. Nitrogen gas was introduced into the vial for 5 sec to 
reduce fat oxidation, and the samples were kept at -15 ºC until needed. 
3.  Determination of Phospholipids in the MFGM 
a)   Phospholipid Solid Phase Extraction (SPE) 
Milk phospholipids were obtained from the extracted fat according to the method 
described by Bitman et al. (1984). The reagents were of analytical grade and purchased 
from Fisher Scientific. The amber vials containing fat were allowed to thaw and placed in 
a 50 mL round bottom flask to evaporate the solvents in a rotatory evaporator with a 
diagonal condenser (Labconco Corp.). The water bath was kept at 45 ºC to prevent lipid 
degradation, especially with sphingomyelin. Approximately 0.1 g of fat was utilized to 
load 2g/12 ml Strata Si-1 Silica (55um, 7A) solid phase extraction tubes (8B-S012-KDG, 
Phenomenex). The cartridges were placed in a SPE 12-position vacuum manifold (AH0-
6023, Phenomenex), and 9-mL glass tubes were placed under the columns, which were 
first cleaned by adding 20 ml of chloroform and conditioned by adding 10 ml of hexane.  
The fat was then transferred onto the columns with two mL of hexane, and an extra two 
mL volume of hexane was added to rinse any residue and added to the column. The lipids 
were allowed to be absorbed onto the columns for approximately five minutes, and the 
hexane was allowed to drip by gravity. Neutral lipids (fraction 1) were eluted with 40 ml 
hexane/ethyl ether (1:1 v/v) by gravity or by applying vacuum at approximately 5 in Hg. 
This fraction was discarded, and the glass tubes were replaced with clean ones to elute 
the phospholipid fraction (fraction 2) with 20 ml methanol, which removes 80% of the 
PL. The eluent was transferred into pre-weighed round bottom flasks, and the remaining 
PL was eluted with 20 ml of chloroform/methanol/water (3:5:2) (fraction 3). The second 
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and third fractions were consolidated and evaporated under vacuum with a rotatory 
evaporator to evaporate organic solvent with the previous settings. The round bottom 
flasks were then immersed in liquid nitrogen to freeze the water containing PL and placed 
in a freeze dryer holder (75408, Labconco Corp.) to sublimate the solvent using a freeze 
dry system (Freezon 4.5, Labconco Corp.) for three hours or until a white residue was 
observed. The PL powder was dissolved in one ml of chloroform/methanol (2:1, v/v), 
transferred to amber vials, and stored at -20 ºC. 
b)   Phospholipid Separation & Quantification 
For identification purposes, pure polar lipids such as L-α phosphatidylcholine (PC), 
L-α phosphatidylethanolamine (PE), L-α phosphatidylinositol (PI), L-α phosphatidyl-L 
serine (PS), and sphingomyelin (SM) from bovine brain were purchased from Sigma 
Aldrich. Chloroform, methanol, and formic acid were of HPLC grade from Fisher 
Scientific.  Samples were collected and analyzed as indicated in Figure 13. 
 
Figure 13.  Analysis of milk phospholipids involves fat extraction from milk, isolation of PL 
from other simple lipids via solid phase extraction (SPE), and separation and 
quantification of the different phospholipid classes via HPLC. 
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Phospholipid separation was performed by high performance liquid chromatography 
(HPLC) according to the methodology described by Rombaut et al. (2005). A Shimadzu 
prominence ultra flow liquid chromatography system (LC-20AB, Shimadzu, USA Inc.) 
consisted of a communication bus module (CBM-20A, Shimadzu), an autosampler (Sil-
20A HT, Shimadzu), a degasser (DGU-20A3, Shimadzu), and a column oven (CTO-20A, 
Shimadzu) connected to a charge aerosol detection (CAD) detector (Corona Plus, 
Dionex, USA). Nitrogen was used as a carrier gas at a backpressure of 2.4 bar. A 150mm 
x 3.0 mm Prevail silica column with a 3 µm particle diameter (Part N. 99341, Grace 
Division, USA) and a 7.5mm x 3.0 mm guard silica column with a 5.0 µm particle 
diameter (Prevail™ All-Guard™ Part N. 99354, USA) were used. The column and guard 
column were equilibrated at 40 °C.  Samples were kept at room temperature, and 10 µl 
were injected. The injection loop was rinsed with chloroform/methanol (2:1, v/v) in 
between injections. The phospholipid elution was performed with a linear gradient with 
87.5: 12: 0.5 (v/v/v) chloroform; methanol; triethylamine (TEA) buffer (pH 3, 1 M 
formic acid) at t = 0 min with a flow at 0.5 mL/m. The TEA buffer was prepared by 
making a formic acid buffer of 1 M, which was neutralized with triethylamine to a final 
pH of 3 (see Appendix A.2). At t=16 min, the mobile phase was 100% eluent B (28: 60: 
12, v/v/v). The mobile phase was brought back to 100% eluent A at t=17 min, and the 
column was equilibrated until the next injection at 28 min (Rombaut et al., 2005).  
The data was collected and analyzed using LCSolution (Shimadzu). Identification of 
phospholipids was carried out by comparison with the retention time of pure standards. 
For each PL, calibration curves were created from the area values obtained by injecting 
10 µL of serially diluted solutions of PE (25-300 µg), PI (2.5-30 µg), PS (1.67-20 µg), PC 
(21-250 µg), and SM (25-300 µg). A solution of chloroform/methanol (2:1, v/v) was 
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utilized for the solutions. All the samples and standards were run in triplicates, and a 
linear regression equation (y = a + bx) was applied to each phospholipid standard. 
4.   Measurements of S-S and SH group levels 
The S-S and SH group levels in the MFGM were determined according to the method 
of Beveridge et al. (1974) with slight modifications by Lee and Sherbon (2002). To 
determine free SH groups, 0.5 ml of MFGM suspension was mixed with 2.5 ml of 5 g 
SDS/ per liter of Tris-gly-8M urea (Appendix A.6.h) (Cui et al., 2009) in a polycarbonate 
ultracentrifuge bottle (357002, Beckman, CA). Then, 20 µl of Ellman’s reagent at 
4mg/ml (5,5’-dithiobis-2, 2’-nitrobenzoic acid (DTNB) in Tris-glycine buffer) were 
added, and the mixture was allowed to stand for 1 hour at 25 °C. There was no need to 
clarify solution with the addition of chloroform, but the mixture was centrifuged at 5000g 
for 5 min at 25 °C to avoid solids. The absorbance of the supernatant was measured at 
412 nm with a spectrophotometer, and the SH groups were quantified using Equation 5. 
    Free SH  µM        =  73.53 x Abs 412 x (6.04) (Eq. 5) 
  g MFGM proteins           mg/ml of protein 
 
 The term A412 is the absorbance at 412 nm, 6.04 is the dilution factor of the sample, 
and 73.53 is derived from the conversion from molar to µM/mL and from mg solids to g 
solids (106) over the molar absorptivity of the Ellman’s reagent (1.36 x 104) (Beveridge et 
al., 1974). The total SH was quantified by mixing 0.2 ml of MFGM homogenate with one 
of 5 g SDS/ per liter of Tris-gly-8M urea 8M and 20 µl of β-mercaptoethanol. After 
incubation for 1hr at 25 °C, 10 ml of a solution of 12% (w/v) trichloroacetic acid (TCA) 
was added and incubated for 1 hr at 25 °C. The solution was then centrifuged at 5000 g 
for 15 min, and the precipitation was resuspended in six ml of TCA, and centrifuged at 
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5000 g for 15 min to remove β-mercaptoethanol. A second wash was repeated with 6 ml 
of TCA followed by centrifugation. The precipitate was dissolved in 3 ml of 8 M urea 
and 5g SDS/l in tris –glycine buffer, and 30 µl of Ellman’s reagent was added followed 
by incubation for 1 hour at room temperature. There was no need to add chloroform, but 
centrifugation was performed for 5 min at 5000xg. The total SH (SH+ reduced SS) were 
quantified using Equation 6. 
   Total SH   µmol    =  73.53 x Abs 412 x 15   (Eq. 6) 
  g MFGM proteins         mg/ml of protein 
 
The term 15 is the dilution of the sample in the final volume. The S-S groups were 
calculated from the difference in free SH from total SH as indicated by equation 7. 
   SS group   µmol     =  Total SH –Free SH   (Eq. 7) 
   g MFGM proteins                     2 
  
D. Milk Fat Globule Membrane Extraction 
Milk was brought to room temperature before MFGM extraction, which was 
performed according to the method of Patton and Huston (1986) with some 
modifications. The density of serum was increased by adding sucrose to milk at 5 g per 
100 ml, and the solution was allowed to dissolve completely for 10 m. Fifteen mL of 
phosphate buffer saline (PBS) (1X) (see Appendix A.1) were placed in a 50 mL conical 
centrifuge tube, and 35 mL of the dense milk was carefully deposited underneath the 
buffer layer using a 25 mL disposable pipette (Patton and Huston, 1986). The conical 
tubes were carefully placed in a centrifuge (Eppendorf 5810R) and spun down at 4,000 
rpm (3200 x g) for 20 min at 21 °C to collect the cream (Basch et al., 1985). The cream 
layer was removed with a spatula and placed in a 50 mL tube. The cream was 
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resuspended with cold (4 °C) 1X PBS to a final 40% (w/v) solution, and Tween 80 
(Fisher, T164) was added to a final 0.2% (w/v) concentration. The mixture was blended 
for 45 sec using a commercial blender (Waring Blender 51BL31) in high setting and a 
pre-chilled (4 °C) steel cup (Eberbach Corporation). The churned cream was placed 
inside an isotemp bath (Isotemp205, Fisher Scientific, CA) at 42 °C for 30 min and spun 
down in a pre-warmed centrifuge (Eppendorf 5810R) at 4,000 rpm for 20 min at 40 °C.  
Centrifugation separated the cream into buttermilk, which contains the MFGM proteins, 
and oil layers are depicted in Figure 14.  
 
 
 
 
 
 
 
 
 
 
Figure 14. Milk fat separation upon churning and centrifugation. Left. Actual conical tube 
containing cream layers. Right. Schematic representation. The buttermilk, which 
contains MFGM  proteins, was isolated for the next step in MFGM purification. 
The unsaturated and saturated fat layers were discarded with a Pasteur pipette, and the 
aqueous portion of the churned cream was isolated using a 25 mL plastic pipette and 
transferred into a clean 50 mL conical tube. Then, sodium citrate was added to 
disintegrate casein micelles at 2% (w/v) and gently agitated to dissolve the citrate 
Aqueous MFGM w/ 
Protein   (Buttermilk) 
Oil (unsaturated fat) 
 Oil (saturated fat) 
Interface 
Pellet 
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completely. The buttermilk was incubated overnight at 4 °C to break emulsions. Upon 
incubation, the buttermilk solution was transferred to a polycarbonate ultracentrifuge 
bottle (357002, Beckman) and spun down for two hours in a pre-chilled (4 °C) Beckman 
L7-35 Ultracentrifuge at 25,000 rpm (50,000x g).  The aqueous phase was decanted 
without disturbing the pellet, and any remaining saturated fat was removed manually. The 
pellet was washed with 25 mL of cold 1X PBS to remove any remaining detergent, and 
the tube was placed back in the centrifuge with the same settings for 45 min. Upon 
centrifugation, the aqueous phase was discarded, and the dry pellet was transferred to a 
1.5 mL microcentrifuge vial and stored at -4 °C.  
E. MFGM Protein Profile from One Dimensional Analysis 
1.   Protein Homogenization 
The MFGM protein pellet was put into solution by adding cold 1X PBS into 
siliconized microcentrifuge at a final concentration of 0.1 mg/uL. Then, the solution was 
sonicated using a Sonic Dismembrator (500, Fisher Scientific) with a CE Branson 
microtip (102C, Fisher Scientific) using three cycles of 12 seconds at 10% amplitude.  
The vial containing the homogenized pellet was kept in ice during sonication to avoid 
local heating, and the tip was washed with acetone and deionized water between samples. 
The homogenized solution was stored at -15 °C. 
2.   Protein Quantification 
Protein concentration was determined using a BCATM protein assay kit (23227, Pierce, 
USA), which is based on bicinchoninic acid (BCA) for colorimetric detection and 
quantitation of total protein. Briefly, a standard curve was constructed from bovine serum 
albumin (BSA). An aliquot of 25µL of sample or standard was pipetted into a microplate 
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well, and 200 µL of working reagent was added followed by mixing on a shaker for 30 
sec. The plate was transferred to an incubator at 37 °C for 30 min and cooled before 
reading absorbance at 562 nm using a spectrophotometer. Samples and standards were 
prepared in duplicates. 
3.   Sodium Dodecyl-Sulfate Polyacrylamide Gel Electrophoresis 
The stock MFGM protein solution was diluted to 1.6 µg/ µL using filtered 1X PBS 
buffer before SDS-PAGE analysis. Protein samples were prepared for reduced gel 
electrophoresis using NuPAGE Novex reagents (Invitrogen, CA). Five µL of sample 
was mixed with 2.5 µL NuPAGE LDS sample buffer (4X) (NP008), one µL uL NuPAGE 
reducing agent (10X) (NP0004), and 5 µL nanopure water to a final concentration of 0.8 
µg/ µL. The samples were heated at 70 ºC for 10 minutes and immediately cooled down 
to room temperature with top water. An aliquot of 12 µL of the reduced sample was 
loaded into 1.0 mm x 12 well NuPAGE 4-12% Bis-Tris gel (NP0322), which was 
mounted onto XCell Surelock Mini-Cell chamber (EI0001). Novex Sharp pre-stained 
protein standards (LC5800S), 10 µL, were included in each gel. The cell was filled with 
1X NuPAGE MOPS SDS running buffer (NP0001) containing 500 µL of NuPAGE 
antioxidant (NP0005) at a concentration of 5 µL/mL. The cell unit was connected to a 
BioRad power unit (PAC300, BioRad) and run at 200 V for approximately 50 minutes. 
The gel was then transferred to a clean container and washed with nanopure water three 
times for 5 min. SimplyBlue safe staining solution (LC6060) was added and incubated 
overnight on a rotatory incubator (Max 2000 E-class, Barnstead, IA) at room 
temperature. Upon staining, the gels were washed with nanopure water three times for 5 
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minutes, and images were captured with an Epson Scanner (Epson Expression 1680) in 
conjunction with Epson Scan Software in professional mode.  
4.   Protein Densitometry & Statistical Analysis 
Quantiy One 1-D Analysis Software (v.4.6.3, BioRad) was used to quantify protein 
bands. Trace quantity (peak density x area) was utilized to compare the band intensities 
in each sample per treatment batch.   
5.   LC-MS/MS Analysis 
LC-MS/MS was performed on 1DE gels at UC Davis Genome Center Proteomics 
Core Facility. First, four sections were excised from a 1DE gel using a razor over a gel 
sheet (165-7018, BioRad) to avoid contamination: higher than 150 kDa, between 150 and 
55 kDa, between 55 and 35 kDa, and less than 35 kDa. These samples were sent to UC 
Davis for protein identification. Briefly, the gel sections were digested overnight with 
trypsin, and the peptides were purified for further analysis as described by the Proteome 
Center (Tran). A Thermo Finnigan LTQ ion trap mass spectrometer (Thermo Fisher) 
coupled with a paradigm HPLC (Michrom Bioresources, Auburn, CA, USA), and a 
Michrom captive spray ionization source were utilized for peptide identification. The 
digested peptides were loaded onto a trap column (Zorbax300SB-C18, 5 µm, 5×0.3 mm, 
Agilent Technologies, Santa Clara, CA, USA) and desalted online followed by elution 
from the trap column using an increasing gradient of organic solvent (B) (A=0.1% 
Formic Acid, B= 100% Acetonitrile) onto a reverse-phase Michrom Magic C18AQ (200 
µm×150 mm) column at a flow rate of 2µL per min. Peptide elution started with 2%B-
35%B for 30 min, 35%B to 80%B for two min, and held at 80%B for one min. Eluent B 
decreased from 80%B to 2%B over 1.5 min, and the column was re-equilibrated at 2%B 
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for 26.5 min. The complete run was 60 min, and the following parameters were selected: 
spray voltage 1.8kV, heated transfer capillary 180°C, full scan mass range of each sample 
was 350-1400 mass to charge (m/z) ratio, and the MS/MS data was collected using 35% 
normalized collision energy for collision-induced dissociation and an isolation width of 
1.0. 
6.   Database Searching and Criteria for Protein Identification 
For database searching, tandem mass spectra were extracted by Bioworks version 3.2. 
All MS/MS samples were analyzed using X! Tandem (The GPM, thegpm.org; version 
TORNADO (2010.01.01.4)). The program was set up to search Uniprot Human complete 
proteome database (December 2010) and the cRAP common laboratory artifacts database 
along an equal number of reverse decoy sequences assuming the digestion enzyme 
trypsin. Tandem was searched with a fragment ion mass tolerance of 0.40 D and a parent 
ion tolerance of 1.8 Da. The iodoacetamide derivative of Cys (carbamidomethyl) was 
specified in X! Tandem as a fixed modification. For variable modifications, deamination 
of asparagine and glutamine, oxidation of methionine and tryptophan, sulfone of 
methionine, tryptophan oxidation to formylkynurenin of tryptophan and acetylation of the 
N-terminus were specified. 
For protein identification, Scaffold (version Scaffold_3_00_05, Proteome Software 
Inc., Portland, OR, USA) was used to validate MS/MS based peptide and protein 
identifications. This software verifies peptide identifications assigned by SEQUEST and 
Mascot using the X!Tandem database searching program. Scaffold then probabilistically 
validates these peptide identifications using Peptide Prophet algorithm (Keller et al., 
2002) and derives corresponding protein probabilities using Protein Prophet algorithm 
(Nesvizhskii et al., 2003). Peptide identifications were accepted if they could be 
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established at greater than 70.0% probability as specified by the Peptide Prophet, and 
protein identifications were accepted if they could be established at greater than 95.0% 
probability and contained at least 2 identified peptides. Proteins that contained similar 
peptides and could not be differentiated based on MS/MS analysis alone were grouped to 
satisfy the principles of parsimony. Using the above critereia the false discovery rate 
(FDR, Decoy; Target) was calculated as 0.1% on the peptide level and 3.4 % on the 
protein level using a target-decoy (reverse) search strategy (Tabb, 2007). Protein function 
was determined using www.uniprot.org and http://www.ncbi.nlm.nih.gov.  
F. Statistical Analysis 
Statistical analyses were conducted for milk composition (FTIR), MFGM extraction, 
particle size distribution, phospholipids, and 1DE SDS-PAGE band intensity, using the 
General Linear Model (GLM) command in Minitab. Week was a random effect, and 
treatment was a fixed effect. Differences between the treatment means were compared at 
the 5% level of significance using Tukey’s method. In addition, a histogram of residuals, 
normal plot of residuals, residuals versus fits, and residuals versus order were used to test 
model adequacy and normality. 
G. MFGM Protein Profile from Two-Dimensional Analysis 
1.   Protein Homogenization 
The reagents for 2D analysis were of electrophoresis purity grade from BioRad unless 
otherwise stated. The working homogenization buffer was prepared fresh by adding 50µL 
of immobilized pH gradient (IPG) buffer (0.5% ampholyte) and 62mg dithiothreitol 
(DTT) (40mM) per 10 ml of homogenization buffer (7M urea, 2M thiourea, 1% ASB-14, 
40mM Tris base, 0.001% bromophenol blue, 0.5% ampholyte, and 40mM DTT, see 
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Appendix A.3.a). An aliquot of 1.2 ml of homogenization buffer was added per 100 to 
150 mg of MFGM protein pellet. The membrane was homogenized gently using pellet 
pestles (749515, Kontes, NJ) into a 1.5 ml centrifuge tube until no fragments of tissue 
were visible. The samples were kept at room temperature. Homogenized membrane was 
transferred into 2mL siliconized microcentrifuge (02-681-321, Fisher Scientific) tubes 
and allowed to sit on the bench at room temperature for one hour to solubilize the 
proteins. Upon incubation, samples were centrifuged at room temperature for 30 min at 
13,500 rpm.  Solutions were decanted into fresh siliconized tubes, and the solids were left 
behind and discarded. 400 µL aliquots were prepared in 2ml siliconized microcentrifuge 
tubes to proceed with a precipitation step.  
2.   Protein Precipitation 
To precipitate proteins, 10% trichloroacetic acid (TCA)/acetone solution (kept at       -
20 °C) was added at 4x times the volume of protein solution.  Thus, 1.6 ml of cold 10% 
TCA/acetone (see Appendix A.3.g) was added to each 400 µl aliquot of protein solution. 
Microtubes were votexed briefly and stored overnight at -20 ºC. Upon incubation, 
microcentrifuge tubes were spun down at 4ºC in a pre-cooled centrifuge (Microfuge 22R, 
Beckman Coulter) for 15 minutes at 13,5000 rpm. The acetone mixture was decanted into 
a waste container, and 1.6mL of cold 100% acetone (kept at -20 ºC) was added to each 
tube to wash out TCA and any contaminants out of the protein pellet.  The pellets were 
broken down by vortexing twice for 10 seconds.  The centrifuge tubes were immediately 
transferred to the pre-chilled centrifuge and spun at 4 ºC for 15 minutes at 13,500 rpm. 
The acetone solution was immediately decanted into a waste container, and the tubes 
were air-dry for a few seconds. To rehydrate the precipitated proteins, 0.4 mL of fresh 
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working IPG rehydration buffer (7M urea, 2M thiourea, 2% CHAPS, 2% NP-40, 0.002% 
bromophenol blue, 0.5% ampholyte and 100mM DTE, see Appendix A.3.b) was added to 
each tube and vortexed for about 10 sec. Working IPG rehydration buffer was prepared 
by adding 6.25 µL of IPG buffer and 20 mg DTE per 1.25 mL of IPG rehydration buffer. 
Samples were allowed to sit at room temperature for one hour and vortexed every 10 min 
for 10 sec to bring the proteins into solution. The tubes were then centrifuged at room 
temperature for 10 min at 13,500 rpm. The protein solutions were pooled into a clean 
siliconized microcentrifuge, and any gelatinous pellet was discarded. Solutions were 
stored at -80ºC until needed. 
3.   Protein Quantification 
Protein quantification was performed by using a 2D Quant kit (80-6483-56, GE 
Healthcare, NJ, USA) according to the manufacturer’s instructions. Briefly, the 
precipitated sample first was diluted 1:10 by adding 4.5 µl of protein solution into 40.5 µl 
of nanopure water.  A standard curve was prepared using bovine serum albumin (BSA). 
Samples and standards were prepared in duplicates in siliconized microcentrifuge tubes.  
To precipitate the proteins out of solution, 500 µL of precipitant was added to each 
sample and standard followed by a brief vortex. The microtubes were then incubated for 
3 min at room temperature, and upon incubation, 500 µL of coprecipitant was added. The 
tubes were mixed by inversion and spun down at 10,000xg for 5 min to sediment the 
protein. Following centrifugation, the supernatant was decanted without disturbing the 
protein pellet.  To dissolve the precipitated protein, 100 µL of copper solution and 400 µL 
of nanopure water were added to each microtube followed by a quick vortex. The 
solutions were then incubated at room temperature for 15-20 min, and their absorbances 
were read at 480 nm by transferring 200 µL of solution into a 96-well plate in triplicate. 
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4.   Isoelectric Focusing (IEF)-First Dimension 
Protein solutions were diluted at a final concentration of 0.5 µg/µL using fresh IPG 
rehydration buffer, and 200 µL of this solution were loaded into a lane in a BioRad 
focusing tray (165-4030) without introducing bubbles. Immobilized pH gradient strips 
(pH 3-10, 11 cm; 163-2014, BioRad) were placed with the gel side down in a IEF tray 
lane making sure the + end of the strip touched the left side of the tray. 1.5mL of mineral 
oil (163-2129) were immediately added to each IEF strip, and the IEF tray was placed in 
a BioRad Protean IEF cell to separate proteins according to their isoelectric point.  
Isoelectric focusing started with a passive rehydration step (5 hr), followed by 12 hr of 
active rehydration (50 V). The protocol continued with a gradual voltage increase, 500 V 
for 1 hr, 1000 V for 1 hr, and 8000 V for 2.5 hrs (all voltage changes occurred in rapid 
mode). Upon separation, the strips were removed from the IEF tray and placed between 
western blot filter papers to remove excess mineral oil. The strips were then transferred 
gel side up into a rehydration/equilibration (165-4035) tray and kept at -80 ºC overnight 
or until ready to proceed with the second dimension.   
5.   SDS-PAGE-Second Dimension 
Frozen strips were thawed and equilibrated first with 1.6 mL of DTT/equilibration 
buffer (10mg DTT/mL, 375 mM tris pH 8.8, 6 M urea, 30% glycerol, 2% SDS, 0.002% 
bromophenol blue, Appendix A.3.c) followed by1.6 ml of iodoacetamide/equilibration 
buffer (25mg/mL. Equilibration was done at room temperature for 15 min each on a 
bidirectional Max/rotator (4361, Barnstead Int., IA, USA), and the equilibration buffer 
was removed from the strips by decantation. 12.5% polyacrylamide gels were prepared 
according to Appendix A.4, using BioRad Criterion cassettes, IPG +1 well 1.0 mm (345-
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9906). The strips were loaded onto the polymerized gels after a quick immersion in 1X 
running buffer (see Appendix A.3.d), making sure the (-) side was placed on right side of 
the gel.  An IEF electrode wick (165-4071) containing low range molecular weight 
standard (161-0304, see Appendix A.3.e) was placed in the far left side of the gel, which 
was covered with melted 0.8% agarose containing Laemmeli SDS electrophoresis buffer 
(25 mmol/L tris-base, 192 mmol/L glycine, 0.1% SDS, Appendix A.3.f). Once the 
agarose was solidified, the cassettes were placed inside a BioRad Criterion Dodeca cell 
and filled with 1x buffer. The dodeca box was connected to a cooling system (HAAKE 
K10, Thermo Scientific, IA, USA) set at 10 ºC, and slow stirring was initiated. The unit 
was connected into a BioRad Power Pac HC and set at 200V constant current for 
approximately 55 min, or until the blue loading dye reached the bottom of the gel.  
6.   Sensitive Stepwise Colloidal Staining 
An adapted protocol described by Westermeier (2006) was utilized for visualization 
(Westermeier, 2006). The gels were washed three times in nanopure water for five min to 
remove any remaining detergent followed by overnight fixing in a 50% ethanol/3% 
phosphoric acid solution. Upon incubation, the gels were washed three times for 20 
minutes with nanopure water and pre-incubated for hour in staining solution (34% (v/v) 
CH3OH /3% (v/v), H3PO4 /17% (w/v) (NH4)2SO4, see Appendix A.5). Then, Coomassie 
brilliant blue G-250 powder (BP-100, Fisher Biotech) was added at a final concentration 
of 350 mg per liter of staining solution. The gels were stained for 5 days on a rotator 
shaker at room temperature. Upon staining, the gels were washed three times with 
nanopure water for 20 min. Images were captured with an Epson scanner (Epson 
Expression 1680) in conjunction with Epson Scan Software in professional mode. 
  
94 
7.   Fluorescent Staining-Sypro-Ruby 
The gels were washed three times in nanopure water for five min to remove any 
remaining detergent followed by overnight fixing in 10% methanol/7% acetic acid, v/v, 
(100mL per gel) in a clean plastic staining tray. Incubation was performed over a 
rotational shaker at room temperature, making sure the gels were protected from light 
during the staining protocol. Upon incubation, the fixing solution was replaced with 
diluted SYPRO Ruby (170-3127, Biorad, 1:5 with nanopure water) solution. After 
overnight incubation at room temperature, the gels were transferred into a new clean 
container to minimize the deposition of stain speckles and washed three times with 10% 
methanol/ 7% acetic acid, v/v, for 30 min each at room temperature and rotation at 40 
rpm. After washing, the gels were transferred into a large volume of nanopure water to 
remove methanol and rotated for 10 min.  
The gels were scanned with Typhoon Trio+ variable mode imager (98115, Amersham 
Biosciences). The Typhoon was allowed to warm up for 20 minutes, and the following 
scanning parameters were selected: fluorescence acquisition mode; 610 BP30 deep-
purple, SYPRO Ruby, EtBr emission filter; 575 PMT; blue 532 nm laser; normal 
sensitivity; 200 microns pixels; platen focal plane, and ImageQuant analysis.  The glass 
surface was washed with 70% ethanol followed with dH2O, and the gels were placed face 
down, removing bubbles and blotting puddles around edges with Kimwipe. Once 
scanning was complete, the file was saved and reopened in ImageQuant 5.2 (Amersham 
Biosciences) to save them as “tif” files. 
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8.   2-DE Gel Image & Statistical Analysis 
Digitized two-dimensional gel images were analyzed using Delta 2D (version 4.0.8 
final 06, Decodon, Greifswald, Germany). The images were imported and connected 
through match vectors using Group Warping Strategy. Then, all the images were fused to 
a composite image (proteome map, which represents average volume for each spot) by 
using Union as fusion type, which adjusts the common regions and eliminates 
background. After background subtraction, protein spot volumes were normalized against 
total spot volume of all proteins in a gel image.  
Normalized spot volumes were analyzed using an analysis of variance (two-factor 
ANOVA) for all the treatment. A second statistical analysis was done with all the 
treatments except UHT because this heat process caused many changes in protein levels, 
making difficult to overlap gel images. In addition, a two-way ANOVA was performed 
between Fresh milk and each treatment for a total of seven statistical analyses. For all the 
analyses, a null distribution was generated using 1000 permutations, and a p-value of < 
0.01 was used to limit the number of false positives. To construct a hierarchical 
clustering, Pearson correlation, and average linking within the statistical tool suite within 
Delta2D was used. 
9.   Protein Excision & Digestion from SDS-PAGE  
The reagents were of LC/MS grade and kept at room temperature unless otherwise 
indicated. Eppendorf Safe-Lock microcentrifuge tubes and tips were used to avoid plastic 
contamination, and glassware was washed with appropriate solvents before use. Proteins 
with different expression levels were excised from SDS-PAGE gels using a manual tissue 
arrager puncher (MP15-1.5 mm diameter, Beecher Instruments, Prairie, WI, USA). The 
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gels were placed over a gel sheet (165-7018, BioRad) during excision. The gel plugs 
were stored at -20 ºC. 
  The gel plugs were thawed, and 200 µL of destaining buffer (25mM NH4HCO3/50% 
acetonitrile, see Appendix A.6.a) were added to each tube. Vials were incubated on 
shaker at room temperature for 30 min. Upon incubation, the liquid was pipetted out and 
discarded carefully without discarding the gel plug. If Coomassie stain was still 
noticeable, an additional destaining step was performed. To dehydrate the plugs, 200 µL 
of 100% acetonitrile was added to each vial and incubated at room temperature for 10 
min. This step was repeated if the gel was not dehydrated, as seen by semi-clear gel 
plugs. The acetonitrile was discarded, and the samples were allowed to dry completely 
under the hood for a few minutes with the tube open. To digest the proteins, 15µL of 
prepared trypsin solution in a 40mM NH4HCO3/10% acetonitrile was added to the bottom 
of vials at a final concentration of 11µg/µL (see Appendix A.6.c ); vials were incubated at 
37˚C overnight. Upon incubation, the liquid containing the digested protein was 
transferred into a fresh Eppendorf tube (0.6ml), and 25 µl of analyte solution (0.1% TFA/ 
acetonitrile 2:1 v/v, see Appendix A.6.b) was added to each sample to elute the remaining 
peptides out of the gel. Samples were incubated for 30 min at room temperature, and 
peptide elution was repeated after removing the liquid and consolidating into the 
collection tube. The consolidated sample (~65 µL) was concentrated in a SpeedVac 
(Eppendorf Vacufuge TM AG 22331, USA) at 45˚C for 50-60 min. Once the samples 
were dry, six and 12 µL of freshly prepared matrix solution (HCCA, α -
hydroxycyanocinnamic acid, see Appendix A.6.e) were added to each sample and peptide 
calibration standard (see Appendix A.6.d), respectively. On an AnchorchipTM Target 
(MTP Anchorchip 600/384 targus, Bruker DaltonicsPlate), one µL of this matrix/analyte 
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sample was plated in duplicates onto the 600 µm anchors. Samples were allowed to dry 
under the hood. One replicate of standards and samples was rinsed gently with 10µL of 
wash buffer (1.15 NH4H2PO4 mg/mL 0.1% TFA, see Appendix A.6.f) by pipetting up and 
down twice without touching the sample on the target. After drying, the matrix was 
recrystalized by adding one µL of recrystalization buffer (see Appendix A.6.g) directly to 
each spot on the target.  Spots were allowed to dry before placing in the M/S analysis. 
10.   Mass Spectrometry- Protein Identification with MALDI-TOF 
Peptide mass fingerprints (PMGs) were obtained by using a matrix-assisted laser 
desorption ionization (MALDI) mass spectrometer (Ultraflex II, Bruker Daltonics Inc., 
Billerica, MA, USA). Twelve peptides were chosen to conduct tandem mass 
spectrometry (time of flight, TOF) in order to obtain formation about the b- and y-ions of 
the peptide sequence. Peptide spectra were analyzed with FlexAnalysis (version 3.0, 
Bruker Daltonics, Inc.) and applied the TopHat algorithm for baseline subtraction, the 
Savitzky-Golay analysis (with 0.2 m/z; number of cycles =1) for smoothing and the 
SNAP algorithm to detect peaks (signal-to-noise ratio: 6 for MS and 1.5 for MS/MS).  
The charge state of the peptides was assumed to be +1, and porcine trypsin was used as 
an internal standard.  
Proteins were identified using Mascot (version 3.1, Matrix Science inc., MA, USA) 
and combined PMFs and tandem mass spectra in a search against NCBI database for Bos 
taurus. Oxidation of methionine and carbamidomethylation of cysteine were selected as 
variable modifications, and one missed cleavage during trypsin digestion was allowed. 
The precursor-ion mass tolerance was set to 0.6 Da for tandem mass spectrometry, and 
two matched peptides was the lower limit for a significant hit that indicates a positive 
identification. Most identifications were to bovine sequences although some matches to 
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other mammals were accepted if there was not a corresponding bovine sequence in the 
database. Theoretical pI and molecular weight were predicted using Compute pI/Mw in 
monoisotopic mode at www.expasy.ch.  
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IV. RESULTS 
A. Microbial Reduction in Milk 
The efficiency of UV pulsed light to kill aerobic microorganisms was compared to 
batch, HTST, and UHT pasteurization as seen in Figure 15.  In non-transparent fluids, 
such as milk, the depth of the sample is critical in determining the penetration of 
irradiation, thus, milk was treated with different pulse times (seconds, s) at different 
volumes. While conventional methods were able to achieve a log reduction, UV light 
treatment only reduced 44% of the initial microbial population present in raw milk. 
Nevertheless, a decrease in microbial growth is seen as the volume of the sample is 
reduced.  
 
Figure 15. Aerobic bacterial counts in pasteurized and UV pulsed light treated milk.  The 
volume is shown in ml, and the irradiation time is in seconds (s).  Each second 
delivers three Joules/cm2. Counts after 48 hrs of incubation at 37 °C. 
The microbial reduction of coliforms was also determined with UV irradiation 
(Figure 16).  No coliforms were seen in milk after treatment with the conventional 
methods. On the other hand, a different pattern was observed in the microbial reduction 
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with UV pulsed light. The highest reduction was seen in the 7mL/9sec milk sample with 
a 22% decrease in microbial population.  
 
Figure 16. Coliform counts in pasteurized and UV pulsed light treated milk.  The volume is 
shown in ml, and the irradiation time is in seconds (s).  Each second delivers three 
Joules/cm2. A 22% reduction is observed in the 7ml/9sec UV pulsed treated sample. 
Counts after 24 hrs of incubation at 37 °C. 
To determine the best parameters that allow processing a high volume of samples and 
decreasing the microbial population, a second study was performed with different sample 
volumes and irradiation times. As seen in Figure 17, a 7mL-sample with UV energy of 15 
Joules/cm2 resulted in the highest microbial reduction among the treated samples. This 
treatment was significantly different from the raw material (p <0.0001), with a 70% 
decrease in microbial population. 
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Figure 17.  Microbial reduction in aerobic bacteria in UV pulsed treated milk. The volume is 
shown in ml, and the irradiation time is in seconds (s).  Each second delivers three 
Joules/cm2. Counts after 48 hrs of incubation at 37 °C. Statistically significant 
difference in samples is denoted by  (p < 0.0001) 
With regard to coliforms, the highest reduction, 53%, is seen in a 5mL sample with 
15 Joules/cm2 of energy followed by the 7mL/5sec sample with a 44% decrease in 
microbial population as depicted in Figure 18.  If the volume is held constant, higher 
irradiation times are more efficient in killing coliforms and aerobic bacteria; however, 
higher energy intensities results in more bacterial counts. In fact, in both aerobic and 
coliforms, 21 Joules/cm2 (7s) of energy is the turning point to observe more CFU. 
Experiments in our laboratory have demonstrated that higher energy intensities result in 
spore germination (data not shown). This may explain the higher CFU counts observed in 
samples that received more energy. There is not a linear relationship that explains this 
observation, but it can be expected that higher energy intensities at a constant volume 
may result in similar outcomes. 
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Figure 18. Microbial reduction in coliforms in UV pulsed treated milk. The volume is shown 
in ml, and the irradiation time is in seconds (s).  Each second delivers three 
Joules/cm2. Counts after 24 hrs of incubation at 37 °C. 
B. Fat Globule Size Distribution in Milk Processing 
The dispersion of MFG size in processed whole milk, cream, and skim milk was 
analyzed with five parameters: the volume-weighted average diameter (d4,3), the volume–
surface average diameter (d3,2), the mode, the specific surface area (SSA), and the size 
distribution width (Span). To eliminate an apparent increase in the average globule 
diameter, a chelating agent, EDTA, was used to sequester Ca+2 and dissolve casein 
micelles, which range between 130 and 206 µm (Gassi et al., 2008). Disintegration of 
casein micelles diminishes fat globule aggregation formation through casein interaction. 
Figure 19 illustrates the percent volume of whole milk fat globules (MFG) as a function 
of particle diameter (µm) in milk for the six treatments. The plot resembles a Gaussian 
distribution, which is in accordance with previous studies with milk (Mènard et al., 2010; 
Garcia-Amezquita et al., 2009). The fat globules range from 0.4 µm to 10 µm, and similar 
distributions were observed among the trials. 
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Figure 19. Milk fat globule (MFG) size distribution (volume %) in milk as a function of 
particle diameter (µm). Data for Trial II. Similar results were observed with the 
other trials (I, III, and IV). Values are average of tree measurements. 
A visual analysis does not indicate a vast change, but statistical analysis of the five 
parameters determined a significant difference in the volume–surface average diameter, 
d3,2, which is sensitive to smaller particles (p < 0.001), and consequently in the specific 
surface area (SSA) (p < 0.001) of milk (Table 8). The Fresh sample has the highest d3,2 
and smallest specific surface area indicating a difference in the active surface of the fat 
globules.  
Table 8. Parameters that describe the fat globule size distribution in milk. 
 
Treatment 
D(3,2) 
µm 
Mode 
µm 
SSA 
cm
2/mL 
D(4,3) 
µm 
SPAN 
Fresh 3.02a 4.05 19890b 3.89 1.33 
4C 2.90b 3.93 20700a 3.83 1.39 
Batch 2.91b 3.93 20590a 3.83 1.38 
HTST 2.91b 3.93 20600a 3.89 1.40 
UHT 2.92b 3.93 20543a 3.86 1.41 
UV 2.88b 3.93 20838a 3.85 1.41 
s/•N 0.01 0.05 103 0.03 0.02 
s/•N, standard error of mean among treatments. N, sample size, three trials 
(d4,3), volume-weighted average diameter; (d3,2), volume–surface average;  
SSA, specific surface area; SPAN, size distribution width. 
Means with different subscripts within a column are statistically different (p < 0.05). 
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Despite the variation observed in whole milk, no significant difference (p < 0.05) was 
described in the particle size distribution of isolated creams, which ranges from 0.4 µm to 
200 µm depending on the treatment (Figure 20). Three peaks are visible in the fat 
globules distribution that center at 4 µm, 35 µm, and at about 70 µm. The first peak 
belongs to the regular fat globules diameters (Lopez et al., 2010b) while the other two 
peaks are expected to be medium and large fat globule aggregates. The third peak 
distribution is very prominent in milk that underwent heat pasteurization, especially in 
HTST and batch milks with a center at about 90 µm and 100 µm, respectively. UHT milk 
follows a similar pattern, but the large fat aggregates peak at 60 µm. The samples that did 
not undergo heat treatment have a higher percent volume in the normal size fat globule 
range. In fact, the Fresh and UV samples depict fewer fat aggregates at the 35 µm and 70 
µm peaks whereas the 4 º C sample shows a higher percent volume in the 100 µm fat 
globule diameter region. Unfortunately, no trials were performed with 1% SDS to 
measure individual fat globule diameter. SDS dissociates fat globule aggregates by 
providing a net negative charge on the surface of globules that inhibits agglomeration. In 
addition, the samples that underwent heat treatment present smaller fat globules (< 0.5 
µm), which may correspond to vesicles formed by MFGM fragments composed of 
phospholipids and proteins.  
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Figure 20. Fat globule (FG) size distribution of 40% cream as a function of particle diameter 
(µm). Data are shown for Trial IV. Similar results observed for other trials. 
As previously observed with whole milk, similar fat globule size distribution patterns 
were obtained with cream among the trials (Appendix E). The Fresh sample has smallest 
volume-weighted average diameter (d43), volume–surface average diameter (d3,2), mode, 
and size distribution width (SPAN), but these results are not significantly different from 
the other treatments (Table 9).  
Table 9. Parameters that describe the fat globule size distribution in 40% cream. 
 
Treatment 
D(3,2) 
µm 
Mode 
µm 
SSA 
cm
2/mL 
D(4,3) 
µm 
SPAN 
Fresh 3.23 3.63 18657 6.19 3.32 
4C 4.17 21.89 15429 18.80 5.52 
Batch 4.16 28.88 15308 19.26 3.57 
HTST 4.13 50.07 15383 21.59 4.34 
UHT 4.27 39.19 15150 23.44 3.35 
UV 4.21 27.85 15264 16.72 4.69 
s/•N 0.34 13.94 1058 3.86 0.94 
s/•N, standard error of mean among treatments. N, sample size. 
(d4,3), volume-weighted average diameter; (d3,2), volume–surface average;  
SSA, specific surface area; SPAN, size distribution width. 
 
A change in the simulated Gaussian plot distribution of fat globules indicates a 
change in globule size (Evers, 2004b). Statistically, there is not significant difference, 
Aggregates of  
fat globules 
Individual 
fat globules 
Coalescence 
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probably due to the way the data is analyzed; the measured parameters only indicate a 
central tendency that does not take into account different regions. Figure 20 clearly shows 
a defined pattern in cream, so with a novel analysis by Garcia-Amezquita et al. (2009) a 
difference may be seen. They analyzed MFG size distribution by dividing the plot into 
four areas: smallest globules (0.1-1 µm), medium size globules (2-4 µm), large globules 
(5-11 µm), and out of range globules (20-70 µm). For this data set, four distinct areas are 
seen: small globules (0.4 -1.0 µm), mid-large globules (1.5-10 µm), out of range (20-60 
µm), and aggregated globules (70-200 µm).   
The centrifugation of milk, which was performed at 7,000g to concentrate fat 
globules, left residual fat globules with normal particle diameter (0.4 to 10 µm) and 
globules with bigger diameter (40 to 250 µm, fat globules aggregates) in the skim milk as 
seen in Figure 21.  
 
Figure 21. Fat globule (FG) size distribution in skim milk showing residual fat globules 
aggregates and normal size fat globules. 
Table 10 presents the calculated parameters that describe the size distribution in skim 
milk. Even though the data is not statistically different (p > 0.05), the modal diameter is 
Fat globules 
aggregates 
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lower in UHT milk compared to other treatments. In regard to surface-volume, smaller 
values are observed for cooling temperature as well as UHT treatment. 
Table 10.  Parameters calculated from the size distributions of fat globules in skim milk. 
 
Treatment 
D(3,2) 
µm 
Mode 
µm 
SSA 
cm
2/mL 
D(4,3) 
µm 
SPAN 
Fresh 50.83 146.95 2297 122.47 0.86 
4C 18.77 140.93 3629 115.38 0.88 
Batch 66.32 143.29 1412 130.33 0.70 
HTST 62.12 144.81 2013 127.12 0.83 
UHT 24.23 95.21 2556 79.03 1.55 
UV 48.61 149.53 2771 124.76 0.92 
s/•N 25.48 2.77 1148 18.01 0.32 
s/•N, standard error of mean among treatments. N, sample size. 
(d4,3), volume-weighted average diameter; (d3,2), volume–surface average;  
SSA, specific surface area; SPAN, size distribution width. 
 
C. Chemical Composition of Milk during Milk Processing 
1.   Milk Composition by FTIR Analysis 
The fat, lactose, total solid, and protein content of milk were measured using a FTIR 
instrument. No significant difference was seen in the above parameters among the 
samples, as indicated in Table 11. On the other hand, FTIR artifact of β-lactoglobulin and 
casein complexes results in a lower casein content for the ultra high temperature (UHT) 
milk (p =0.05). Citric acid content also shows a marginal difference (p =0.05), especially 
in UHT milk, but such observations are attributed to detection limits of FTIR, as it has 
been shown that citric acid does not change with heating (Sommer and Hart, 1918). In 
addition, the urea content is high in UHT milk (p < 0.0001) probably due to induced 
protein catabolism at 121 °C and 15 psi, as urea naturally decomposes into ammonia and 
carbon dioxide (Metwalli et al., 1996; Metwalli and van Boekel, 1998). With regard to 
free fatty acids (FFA), a significant lower content is observed in Fresh and UHT 
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compared to the other treatments (p< 0.0001). Similar findings were described in 
previous studies (Burton, 1988; Kintner and Day, 1965). 
Table 11.  Fat, lactose, total solid, and protein content of milk during milk processing. 
g/100 mL milk  
Sample Fat Prot Cas Citric Lac TS SNF 
Acidity 
°TH 
Urea 
mg/dL 
Density 
SG 
FPD 
mC 
FFA 
mEkv/l 
Fresh 3.82 3.34 2.46a,b 0.17a,b 4.78 12.94 8.88 16.29 365b 1028.41 515.94 0.294b 
4-C 3.91 3.34 2.43a,b 0.17a,b 4.76 13.04 8.99 15.86 320c 1028.41 513.56 0.450a 
Batch 3.95 3.40 2.54a,b 0.18a,b 4.86 13.22 9.13 15.63 347b,c 1029.26 522.44 0.517a 
HTST 3.88 3.25 2.35b 0.17b 4.64 12.78 8.76 15.68 327b,c 1027.51 495.56 0.438a 
UHT 3.94 3.39 2.65a 0.19a 4.75 13.10 9.00 15.83 437a 1028.85 521.06 0.324b 
UV 3.90 3.36 2.48a,b 0.17a,b 4.78 13.04 9.01 15.71 332b,c 1028.72 513.00 0.535a 
S/•(N) 0.17 0.04 0.05 0.00 0.05 0.22 0.09 0.18 7.19 0.35 6.75 0.02 
Prot, protein; Cas, casein; Citric, citric acid; Lac, lactose; TS, total solid; SNF, solid nonfat;  
FPD, freezing point depression; FFA, free fatty acid;  
°TH, Thorner degrees; SG, specific gravity; mEkv/l, milliequivalents/l 
S/•(N), standard deviation of the mean, which was calculated from three independent trials 
Subscripts within a column indicate statistically significant values (p< 0.05) 
 
2.   Isolation of Milk Fat Globule Membrane 
The isolated MFGM material was not in accordance with previous reports mainly due 
to the extraction procedure, which did not include washes (Kitchen, 1977; Sánchez-
Juanes et al., 2009); however, the MFGM isolates in this project differed depending on 
the sample’s temperature, as observed by Kim and Jiménez (1995). They described that 
higher temperatures resulted in less membrane and more insoluble product. In fact, there 
was a clear reduction in the isolated MFGM pellet as the pasteurization temperature 
increased. Figure 22 illustrates and compares the extracted MFGM where the UHT 
isolate is significantly different from the other treatments (p < 0.0001). As pasteurization 
temperatures increased, the final MFGM material decreased. Samples without heat 
treatment, such as Fresh, 4 °C, and cold pasteurization UV, had higher membrane 
material than those where heat was applied.  
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Figure 22. MFGM isolates of samples collected during milk processing. Values represent the 
mean weight of dry membrane material of four independent experiments, expressed 
as mg of MFGM (pellet upon ultracentrifugation) per liter of milk.  Samples with 
different subscript are statistically significant different (p <0.0001). 
A discoloration was also observed in samples that underwent heat treatment, 
especially UHT (Figure 23). Corredig and Dalgleish (1998) also reported similar results 
in heated samples. According to their findings, the color of the MFGM material changed 
from brown-red in unheated isolates to white-yellow in samples derived from high heat 
treatments. They attributed the discoloration to the loss of iron content in the MFGM and 
hypothesized that heat induces the release of iron from xanthine oxidase, a metalloflavo 
protein, which has four residues holding iron molecules. Structural changes due to XO 
denaturation liberate iron as a function of heating temperatures since a decrease in iron is 
seen in temperatures as low as 62 °C. It also exposes the sulfhydryl bonds for chemical 
interchange and further denaturation. Unfortunately in this project, the iron content was 
not measured to correlate such observations. Discoloration was more intense in UHT 
followed by HTST samples. 
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Figure 23. Final MFGM material isolated from milk following a modified protocol by Patton 
et al. (1986). From left to right: Fresh, UHT, and UV MFGM pellets. 
 
3.   Changes in the Amount of Protein in the Milk Fat Globule Membrane  
The extracted MFGM material was collected as pellet, and the amount of protein was 
measured using a colorimetric assay. Figure 24 illustrates the amount of protein present 
in each isolate where HTST had the highest amount of protein per 100 mg of MFGM 
pellet (p < 0.0001) and Fresh the lowest amount. 
 
Figure 24. Effect of milk processing on the amount of protein in the milk fat globule 
membrane. Values represent the mean of three independent experiments, expressed 
as mg of protein per 100 mg of MFGM pellet. Samples with different subscript are 
statistically significant different (p <0.0001; n = 3 experiments;, n =3 measurement). 
4.   Changes in the Phospholipid of the Milk Fat Globule Membrane 
The major five phospholipids in the MFGM were separated and quantified by HPLC 
in accordance to a protocol described by Rombaut et al. (2005). Figure 25 depicts a 
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typical chromatogram of the phospholipid standards where distinct peaks are seen for 
each PL. Sphingomyelin from bovine brain had three peaks, which are caused by the 
absence or presence of an extra hydroxyl group (Rombaut et al., 2006c). These peaks are 
present in higher intensities compared to the first peak as reported in previous studies 
(Rombaut et al., 2006c; Fong et al., 2007). Sphingomyelin derived from eggs has only 
two peaks, peak 2 and 3 (Data not shown). 
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Figure 25. Normal-phase high performance liquid chromatography (HPLC) coupled with 
charged aerosol detector (CAD) chromatogram of phospholipid standards to 
quantify the PL from the MFGM, phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylcholine (PC) and 
sphingomyelin (SM) with three peaks. 
Calibration curves were constructed from the standards to determine PL concentration 
in each milk sample. The area under each PL peak was calculated with ShimadzuLC 
software and correlated to individual PL concentration. Since the CAD response is 
approximately linear over a narrow range, a linear equation was applied to the standard 
curves, and the resulting formulas are presented in Table 12. All the R2 values are higher 
or equal to 0.99, indicating a linear relationship between PL area and PL concentration. 
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Table 12. Linear equations of phospholipid standards and respective retention time (TR).  
PLs TR  (min) Equation* R2 
PE 7.35 PE
con
 = (3.8722 x10-5) x Area - 20.3624 0.99 
PI 8.42 PI
con
 = (1.9307 x10-5) x Area  - 1.0866 0.99 
PS 8.99 PS
con
 = (2.1852 x10-5) x Area + 0.0872 1.00 
PC 9.91 PC
con
 = (2.5123 x10-5) x Area - 13.6201 1.00 
SM 11.28 SM
con
 = (3.3228 x10-5) x Area - 5.1631 0.99 
           * Concentration was graphed as a function of PL area, 
 
The actual sample chromatograms were a little different from the standards as seen in 
Figure 26. Even after SPE concentration and purification, the samples still had some 
neutral lipids (NL) and other unidentified peaks, which some of them have previously 
been identified as lactosylceramide, phophatidic acid, or as oxidative products of PL. In 
addition, each PL class is composed of a complex mixture of fatty acids with different 
acyl chain length (Lopez et al., 2008; Sánchez-Juanes et al., 2009). In the chromatograms 
of samples, the PC peak is composed of four individual peaks as reported by Mènard et 
al. (2010).  
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Figure 26. Normal-phase liquid chromatography (LC) coupled with charged aerosol detector 
(CAD) chromatograms of (Black) PL standards and (Blue) 4 °C sample. PE, 
phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; PC, 
phosphatidylcholine; SM, sphingomyelin; NL, neutral lipids; PA, phosphatidic acid. 
The reported effects of heating on the phospholipids of the milk fat globules are 
contradictory (Evers, 2004a). It is well established that milk lipids differ with lactation 
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(Bitman and Wood, 1990), diet (Lopez et al., 2008) as well as with cow’s breed among 
other factors; therefore, in this study, the same line of milk was used during the 
processing to discard variations from these factors. Statistical differences (p < 0.05) were 
observed among each trial (II, III, and IV), which can be attributed to physiological 
factors such as stage of lactation, time of the year, and sample preparation. The latter 
encourages lipid oxidation and promotes changes in total phospholipid content. In fact, 
higher PL concentrations are seen in trial IV compared to trial II (Appendix F).  
After accounting for these variations by using blocks and trials as random effects in 
Minitab, no statistical difference was observed among the six samples (Figure 27).  
Phospholipids present in lower concentrations such as PI and PS are seen in Figure 28. 
The concentration of polar lipids that constitute part of the outer bilayer membrane, PC 
and SM, was very constant throughout milk processing as well as in the innermembrane 
PI and PS phospholipids. PE, which is located inside the membrane, illustrates a pattern 
that indicates a change in PE concentration as a function of thermal treatment, but more 
trials are needed to confirm such observations. These results add to the pool of 
uncertainty about the fluctuation of phospholipids during processing.  
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Figure 27. Polar lipid concentration (mg of PL per g of total lipids) in the milk fat globules. 
The PL means of two independent experiments are presented with the standard 
error of mean (s/•N). 
 
Figure 28. Concentration of PI and PS (mg of PL per g of total lipid) in the milk fat globules. 
These PLs are found in lower amounts in the MFGM. The means of two 
independent experiments are presented with the standard error of mean (s/•N). 
The reported polar lipid content in the MFGM is less than 1%, and in this study, the 
PL content is in the range of the data in literature (Rombaut et al., 2006c; Sánchez-Juanes 
et al., 2009; Jensen, 2002). In their review, Rombaut and Dewettinck (2006c) reported 
0.35 to 0.53 g of polar lipids per 100 g of total lipid in isolated creams whereas Ménard et 
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al. (2010) reported 3.64 mg of polar lipid per g fat in milk. The amount of polar lipids in 
cream was 0.57 g of polar lipid per 100 of total lipids while the PLs in milk ranged from 
7.7 to 20.5 mg of polar lipid per 100 g of milk. 
The content of each polar lipid was analyzed as a percentage of the total five polar 
lipids present in the fat globules as mainly reported in most literature (Table 13). The last 
trial (IV) was included because the percentage of PLs were within the same range as the 
previous trials.  
Table 13. Phospholipid content in fat globules 
Phospholipid g per 100 g polar lipid  
PL PE PI PS PC SM 
Fresh 18.70 3.96 1.66 31.20 44.49 
4C 12.34 3.18 0.30 37.83 46.35 
Batch 14.64 3.58 0.25 36.79 44.74 
HTST 17.07 2.39 0.44 35.29 44.81 
UHT 18.42 2.78 0.23 36.88 41.69 
UV 11.50 4.23 0.77 36.99 46.52 
Mean percentages of three independent studies 
 
 
No statistical difference was observed in the analysis of PL percentages; however, the 
individual PL percentages are in accordance with previous reports (Astaire et al., 2003; 
Rombaut et al., 2006a). Among the PLs, SM was present in the highest concentration in 
all the samples (44.5-46.5%) followed by PC (31.2-37.0%) and PE (11.5-18.7%). PI and 
PS were present in lower concentrations, (2.4-4.2%) and (0.2-1.7%), respectively. Figure 
29 shows a graphical representation of the mean of three trials (II, III, IV).  
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Figure 29. Phospholipid content of milk fat globules presented as percentage of the total 
phospholipids. The PL means of three independent experimentsis presented with 
standard error of mean (s/•N). 
The experimental design did not allow for an evaluation of the phospholipid variation 
during processing, but a pattern may be observed in the mg/g fat data set. In fact, Figure 
30 shows a global representation of the PL content in fat globules and illustrates that with 
a larger sample size a difference in polar lipid may be observed. The exact quantification 
of phospholipid is complicated by the different fatty acid moieties present on the acyl 
chains, which depend on different factors such as ruminants’ diet. 
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Figure 30. Global representation of phospholipids in treated samples for three independent 
trials (II, III, and IV). PL content is presented as mean of three HPLC 
measurements (mg PL per g of fat). 
5.   Changes in the Sulfhydryl (SH) & Disulfide SS Groups 
Thermal treatment induced SH/S-S exchange reactions and led to an increase in S-S 
groups. Figure 31 denotes a reduced in SH group level and an increased in SS group level 
as a function of thermal treatment. Disulfide bonds stabilize the folded conformation of 
proteins and decreases the conformational entropy leading to more SS group levels as 
heat treatment was increased. In fact, UHT milk had the lowest free SH groups and the 
highest SS groups. 
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Figure 31. Effect of milk processing on the free and total sulfhydryl (SH) and disulfide (SS) 
groups of milk fat globule membrane protein 
D. Protein Profile from One Dimensional Gels Coupled with LC/MS 
1.   Milk Fat Globule Membrane Protein Profile 
When milk is heated above 70 °C, whey protein denatures and deposits on the surface 
of the milk fat globules interacting with MFGM proteins. These protein interactions are 
important because they determine the physicochemical and functional properties of 
MFGM isolates. Figure 32 depicts a representative pattern of MFGM proteins resolved in 
4-12% bis-tris NuPAGE gel after Coomassie staining. The protein profile displays 
several major bands identified in previous studies by molecular weight (Mather and 
Keenan, 1975; Evers, 2004a). Butyrophilin ran at apparent molecular weight of 60 kDa 
when its literature value is 67kDa, probably due to post-translational modifications such 
as phosphorylation that may affect its electrophoretic mobility. Some glycosylated 
proteins of the MFGM are not seen because a more sensitive staining technique is needed 
to identify their location by molecular weight. 
  
119 
 
Figure 32. Sodium dodecyl sulfate-PAGE pattern (4-12% gradient Bis-Tris NuPAGE gel) of 
milk fat globule membrane material isolated from different fractions of milk 
processing. 1&8) Novex Sharp Standards, 2) Fresh, 3) 4 °C, 4) Batch, 5) HTST, 6) 
UHT, and 7) UV. 
Heat treatment resulted in high incorporation of β-lactoglobulin (β-LG, 18 kDa) in 
the MFGM isolates (lanes 4, 5, 6) as denoted by the staining intensity in the gel. The 
UHT treatment, in particular was enriched in caseins and β-LG. Even with a reducing 
gel, some high-molecular bands are observed in this sample (lane 6), indicating formation 
of protein complex as a function of time. According to Ye 2004, xanthine oxidase (XO) 
and butyrophilin (BTN) form complexes above 60 ºC, which may be present in these 
bands. In fact, the bands that identify these two proteins are less intense in the UHT 
sample compared to the other treatments, confirming XO-BTN complex formation. In 
addition, fluctuations in other MFGM proteins are observed by changes in band intensity; 
however, these proteins were identified by comparing molecular weights were performed. 
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2.   MFGM Protein Quantification by SDS-PAGE Densitometry 
Table 14. Relative abundance of MFGM proteins during milk processing. 
Relative Protein Abundance  
MFGM Proteins 
MW 
(kDa) 
Obs. 
MW F 4 °C B H U UV 
Mucin 1 (MUC1)* 160-500 252 1.9 1.0 1.4 1.8   
BRCA1 and BRCA2 210 217 1.9 1.1 1.1 1.0 6.4 3.8 
  181 1.0 1.2 1.1 1.3 1.6 1.0 
  174 1.0 1.2    1.9 
Xanthine oxidase (XO)+ 150-155 151 4.6a 4.7a 4.2a 4.3a 1.0b 4.3a 
  140 1.7 1.7 1.0 1.3 1.2 1.3 
  131 2.9 1.6 1.0 1.5  1.9 
  124     1.0  
  120 1.4 1.3 1.0 1.5  1.2 
  110   1.1   1.0 
  106   1.0    
Mucin 15 (MUC 15 or PAS III)* 94-100 101 1.2 1.0 1.3 1.0  1.5 
Cluster of Differentiation (CD36 
or PAS IV) 
88 89-87 6.1 2.2 10.5 5.3 3.3 1.0 
  80 1.1 1.0    1.3 
Lactoferrin 78 76-77  2.2 1.7 1.0 1.5 1.5 
Serum Albumin 69 70 8.9a 11.5a 11.7a 9.7a 1.0b 10.4a 
  63 1.0 1.3 1.4 1.3  1.3 
Butyrophilin (BTN) 59 59 2.1a 2.3a 2.0a 2.2a 1.0b 2.0a 
  55-56 5.5 4.4 3.8 1.8 1.0 2.4 
  53 1.3 1.0 1.8 2.8 3.5 1.0 
Adipopholin (ADFP) 52 51-52 5.1a 6.7a 5.8a 6.5a 1.0b 5.8a 
Lactadherin (PAS 6/7)++ 
MFG-E8 
43-59 49-50 6.7a 9.1a 7.0a 8.9a 1.0b 8.0a 
Monocyte differentiation antigen 
(CD14) 
40 41-43 1.0 2.9 2.0 1.7  4.6 
Annexin 39 39 3.1a 3.4a 1.0b 1.1b 3.1a 1.9a,b 
Mucin 15 36 38 3.6a 2.9b 1.0c 1.1c  2.3b 
  33-34 1.3 1.2 1.0 1.1 1.5 1.1 
  31 1.0 1.2 2.0 1.2  1.0 
  29   1.3 1.0   
α-(s2)- casein 24 25-26 1.0c 1.6b,c 2.8b 1.4c 6.3a 1.3c 
α-(s1)- casein 23 21-22 5.6a 4.8a,b 2.1b,c 2.5a,b,c 1.0c 4.7a,b 
κ-casein 19 20 1.4 1.0 1.2 1.1  1.1 
β-lactoglobulin 18 18 1.8c 1.2c 10.3b 10.2b 20.5a 1.0c 
α-lactalbumin 14.4 13 1.6b,c 1.7b,c 2.4b 2.0b,c 3.8a 1.0c 
* Usually identified by PASS staining (Riccio, 2004) 
++ Also known as MFG-E8 
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In order to assess the change in MFGM proteins upon milk processing, protein bands 
were identified and quantified by densitometry using the band trace tool (intensity peak x 
mm) in BioRad Quantity One software. The program was automated with the same 
settings for NuPAGE gels, and the relative abundance of proteins was calculated (Raw 
data, Appendix G. Table 14 shows the relative abundance of MFGM proteins among 
samples. Proteins were identified according to their molecular weight in literature, and 
those bands without a molecular weight match are expected to be unidentified proteins, 
polypeptides, or complexes of proteins. High-molecular weight proteins were more 
intense and detectable in Fresh sample (308 kDa and 284 kDa) as well as in the 4 ºC 
sample (284 kDa). They may correspond to fatty acid synthase (275 kDa) and acetyl-CoA 
carboxylase (265 kDa). A 104 kDa band is also seen in UHT.  
3.   MFGM Protein Identification through LC/MS 
SDS-PAGE is an excellent technique to visualize proteins; however, identification of 
proteins is limited by protein resolution; therefore, to assess the effect of milk processing 
into more depth, liquid chromatography connected with tandem mass spectrometry (LC-
MS/MS) was used to detect more proteins from 1DE gel. Results were in accordance to 
previous studies where more than 120 proteins were identified in bovine MFGM 
(Reinhardt and Lippolis, 2006). In this study, 117 proteins were identified, which 
fluctuated depending on the milk processing treatment, especially when heat was applied. 
Among these proteins, 15 of them are still uncharacterized bovine proteins. Table 15 
presents the probabilities of proteins that were identified according to the threshold 
parameters designated in Scaffold. The false discovery rate (FDR) for peptide 
identification was determined by Scaffold as 0.1%; thus, yielding high confidence in the 
identified proteins.  
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Table 15. MFGM proteins identified by LC-MS/MS upon milk processing. 
Protein Probability (Identification) Accession Number MW 
(kDa) 
Identified Proteins+ 
Fresh 4°C Batch HTST UHT UV 
 
Lipid transport/metabolism 
 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member 
A1  
100 100 100 100 100 100 
PLIN2_BOVIN 49 Perilipin-2 (ADFP) 100 100 100 100 100 100 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase  100 100 100 100 100 100 
FABPH_BOVIN 15 Fatty acid-binding protein, heart  100 100 100 100 100 100 
CD36_BOVIN 53 Platelet glycoprotein 4  100 100 100 100 100 100 
Q0VCZ8_BOVIN 78 Acyl-CoA synthetase long-chain 
family member 1  
100 100 100 100 100 100 
ACACA_BOVIN 265 Acetyl-CoA carboxylase 1  100 100 100 100 100 100 
FAS_BOVIN 275 Fatty acid synthase  100 100 100 100 98 98 
A4FUX1_BOVIN 25 CIDEA protein  100 100 100 100 16 100 
Q3SX32_BOVIN 48 Mannose 6 phosphate receptor 
binding protein 1  
100 100 83 100  100 
Q9TSF1_BOVIN 14 Butyrophilin (Fragment)  42 98 97 100   
Q3ZC65_BOVIN 46 Ancient ubiquitous protein 1  30   99   
ERG7_BOVIN 83 Lanosterol synthase  58  74 100 100  
A9XTK4_BOVIN 38 17-beta hydroxysteroid 
dehydrogenase 
100 99  100  41 
NSDHL_BOVIN 40 Sterol-4-alpha-carboxylate 3-
dehydrogenase, decarboxylating 
73   100 58 100 
A6H7G0_BOVIN 34 CYB5R3 protein   83 83 100 100 74 
A6H7D4_BOVIN 52 Lysophosphatidic acid 
acyltransferase, zeta 
  83 100 40 71 
A7YWR0_BOVIN 36 Apolipoprotein E   83 100  53 
LIPL_BOVIN 53 Lipoprotein lipase    100 21  
FABP7_BOVIN 15 Fatty acid-binding protein, brain   100    
 
Immunity & defense 
 
Q3T0K7_BOVIN 48 MFGE8 protein  100 100 100 100 100 100 
PIGR_BOVIN 82 Polymeric immunoglobulin 
receptor  
100 100 100 100 100 100 
Q3T101_BOVIN 25 IGL@ protein  100 100 100 100 100 100 
A7E340_BOVIN 36 Mucin 15, cell surface associated  58 71 79 99 98 51 
CTHL1_BOVIN 18 Cathelicidin-1  100 100 100 100  100 
MUC1_BOVIN 58 Mucin-1  100 100 71 50  100 
Q3SYR8_BOVIN 18 Immunoglobulin J chain  100 100 100 71  74 
ANXA1_BOVIN 39 Annexin A1 73   50  100 
B0JYP6_BOVIN 26 IGK protein  100 100 100   100 
GLCM1_BOVIN 17 Glycosylation-dependent cell 
adhesion molecule 1 
 100 100 100 80  
A6QNL0_BOVIN 40 CD14   63 100 100 98  
Q1RMN8_BOVIN 25 Immunoglobulin light chain, λ 
gene cluster  
 100 100  75  
  
123 
Protein Probability (Identification) Accession Number MW 
(kDa) 
Identified Proteins+ 
Fresh 4°C Batch HTST UHT UV 
PERL_BOVIN 81 Lactoperoxidase   63  50 99  
B5T263_9CETA 90 Toll-like receptor 2     97   
 
Membrane/protein trafficking 
 
RAB18_BOVIN 23 Ras-related protein Rab-18  100 100 100 100 100 100 
RB11A_BOVIN 24 Ras-related protein Rab-11A  100 99 100 100 70 100 
Q2T9M8_BOVIN 23 Synaptosomal-associated protein 
23 isoform SNAP23A 
100 100 99 100  100 
SAR1A_BOVIN 22 GTP-binding protein SAR1a  100 100 98 100  100 
RAB7A_BOVIN 24 Ras-related protein Rab-7a  100 100 100 100  74 
YKT6_BOVIN 22 Synaptobrevin homolog YKT6 35 100  71  100 
ARF1_BOVIN 21 ADP-ribosylation factor 1  100 73    74 
A6QLH3_BOVIN 33 STX3 protein  100 51  50  71 
RAB13_BOVIN 23 Ras-related protein Rab-13 73   100   
Q2TBH2_BOVIN 24 Related RAS viral (R-ras) 
oncogene homolog 
100 99    100 
RAB5C_BOVIN 23 Ras-related protein Rab-5C  73 100     
A5D7E0_BOVIN 23 RAB35 protein   100  71 39 74 
RAB8A_BOVIN 24 Ras-related protein Rab-8A 99      
 
G-protein mediated cell signaling 
 
A1L528_BOVIN 23 RAB1A, member RAS oncogene 
family  
100 100 100 100 100 100 
GBB2_BOVIN 37 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  
100 100 100 100 100 100 
GBB1_BOVIN 37 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1  
100 83 83 100 100 99 
GNAS2_BOVIN 46 Guanine nucleotide-binding protein 
G(s) subunit alpha isoforms short  
100 73 83 100 32  
RAC1_BOVIN 21 Ras-related C3 botulinum toxin 
substrate 1  
100 73 73 100  99 
RAP1A_BOVIN 21 Ras-related protein Rap-1A  100 100 73 99  98 
ARL15_BOVIN 23 ADP-ribosylation factor-like 
protein 15 
98 97  100  74 
B6VAP7_BOVIN 21 CDC42 protein 100 100  99   
A5D7R9_BOVIN 21 NRAS protein   97   100 
RHOC_BOVIN 22 Rho-related GTP-binding protein 
RhoC  
73   100   
GNAI1_BOVIN 40 Guanine nucleotide-binding protein 
G(i) subunit alpha-1 
99    31  
 
Protein synthesis, binding and/or folding 
 
Q861V9_BOVIN 16 Similar to peptidylprolyl isomerase 
A (Cyclophilin A) (Fragment)  
100 100 100 100 43 100 
SEP15_BOVIN 18 15 kDa selenoprotein  73 73 99 100  74 
B0JYL8_BOVIN  19 Cofilin 1 73 100 73 71  100 
HSP7C_BOVIN 71 Heat shock cognate 71 kDa protein  100   50   
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Protein Probability (Identification) Accession Number MW 
(kDa) 
Identified Proteins+ 
Fresh 4°C Batch HTST UHT UV 
Q99BK3_9ALPH 88 Ribonucleotide reductase large 
subunit  
61 100 79    
A5D7N2_BOVIN 14 HIST2H2BE protein  99    98 
A2VDV1_BOVIN 22 Ankyrin repeat domain 22  73  99  74 
EF1A1_BOVIN 50 Elongation factor 1-alpha 1  100     28 
A5D792_BOVIN 18 DCK protein           100 
 
Homeostatic regulator 
 
D5HSX1_BOVIN 87 cGMP-dependant type II protein 
kinase  
100 64  100  66 
Q6QRN7_BOVIN 34 PP1201 protein 73 100  71  100 
Q2KIS4_BOVIN 34 Dehydrogenase/reductase (SDR 
family) member 1  
97   100   
B3VTM3_BOVIN 78 Lactoferrin    100 100 100  
ANXA5_BOVIN 36 Annexin A5    38 100   
ALBU_BOVIN 69 Serum albumin     100 100  
ACOC_BOVIN 98 Cytoplasmic aconitate hydratase  100      
 
General Transporter 
  
ABCG2_BOVIN 73 ATP-binding cassette sub-family G 
member 2  
100 100 100 100 100 100 
A8E4P3_BOVIN 31 STOM protein  100 100 100 100 50 100 
NPT2B_BOVIN 76 Sodium-dependent phosphate 
transport protein 2B  
100 100 100 100 100  
Q8MKB7_BOVIN 73 Na+/glucose cotransporter 73 83   100 51 
5NTD_BOVIN 63 5'-nucleotidase 19 71  100 100  
CHP1_BOVIN 22 Calcium-binding protein p22 73 100    100 
 
Cell Structure 
 
A6QNZ7_BOVIN 55 Keratin 10  100 100 71 100 100 98 
A4FV94_BOVIN 61 KRT6A protein  73 100 79 100 100 74 
A5D7M6_BOVIN  63 KRT5 protein  99 100  99 100 20 
ACTB_BOVIN 42 Actin, cytoplasmic 1 100 100 100 100 58 100 
Q17QL7_BOVIN 49 KRT15 protein 73 100   50  
GIPC2_BOVIN 35 PDZ domain-containing protein 
GIPC2  
100   100   
 
Cell surface receptor mediated signal transduction 
 
A5PKG9_BOVIN 59 FGR protein  73   100   
ANXA2_BOVIN 39 Annexin A2  73 83  99 45  
D4QGC1_BOVIN 59 Tyrosine-protein kinase Lyn    100   
 
Milk proteins 
 
CASA1_BOVIN 25 Alpha-S1-casein  100 100 100 100 100 100 
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Protein Probability (Identification) Accession Number MW 
(kDa) 
Identified Proteins+ 
Fresh 4°C Batch HTST UHT UV 
CASK_BOVIN 21 Kappa-casein 98 100 100 100 100 100 
CASA2_BOVIN 26 Alpha-S2-casein  73 100 100 100 100 100 
 
Whey proteins 
 
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin 73 100 100 100 100 100 
LACB_BOVIN 20 β-lactoglobulin   73 100 100  
Q28049_BOVIN 14 α-lactalbumin (Fragment)    100 100  
Q9TRB9_BOVIN 2 Enterotoxin-binding glycoprotein 
PP20K (Fragment) 
  28 100 100  
 
Unknown function 
 
ENPP3_BOVIN 100 Ectonucleotide pyrophosphatase/ 
phosphodiesterase family member3  
100 100 100 100 100 100 
Q0IIA4_BOVIN 59 Glycoprotein 2 100 100 100 100  100 
PPBT_BOVIN 57 Alkaline phosphatase    99   
A4FUH8_BOVIN 21 Chromosome 1 open reading frame 
93 ortholog 
   99   
HTST, high temperature short time; UHT, ultra high temperature; UV, UV pulsed light treatment 
 
 
It is well known that heat induces protein interactions and protein displacement as 
well as protein adsorption on the milk fat globule membrane (Singh, 2006; Evers, 2004a). 
LCMS identified these proteins and permitted the graphical representation of the number 
of proteins identified in each treatment (Figure 33). HTST milk had the highest protein 
identification, 83%, from the 102 total identified proteins. Tyrosine-protein kinase Lyn, 
alkaline phosphatase, chromosome 1 open reading frame 93 ortholog, and most 
importantly toll-like receptor 2 were four proteins exclusively found in HTST, indicating 
that heating may have contributed to fix these proteins to the MFGM. The Fresh and 4 °C 
treatments had almost the same number of proteins identified, 76 and 71, respectively, 
and UHT had the least number of identified proteins. 
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Figure 33. Percentage of identified proteins in each milk treatment from the 102 total 
characterized proteins identified by LC-MS . 
The deoxycytidine kinase (DCK) enzyme was exclusively present in the UV pulsed 
treatment, and the ras-related protein Rab-8A and the cytoplasmic aconitase hydratase 
proteins were only present in the Fresh treatment. The elongation factor 1-alpha-1 was 
also present only in Fresh and with a low probability in the UV treatment. Appendix J 
shows the protein probability, identified peptide, and peptide coverage for each protein 
according to every treatment.  
For MFGM, one of the greatest obstacles is identifying low abundance proteins due to 
the high abundance of some proteins such as butyrophilin, which results in fewer proteins 
being identified with high confidence; therefore, in order to minimize the high dynamic 
range in protein abundance that complicates proteomic analysis, 1DE gels were cut into 
molecular weight regions (I, II, III, and IV) for protein identification. Tables 16 through 
19 depict the proteins present at specific intervals in the 1DE gels and possible 
interactions among MFGM proteins. 
Table 16.  Proteins identified in region I ( higher than 150 kDa) of  MFGM isolates through 
LC/MS.  
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Protein Probability Accession 
Number 
MW 
(kDa) 
Identified Proteins in  
>150 kDa Region (I)* F 4°C B H U UV 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member A1  100 100 100 100 100 100 
PLIN2_BOVIN 49 Isoform 2 of Perilipin-2 100 100 100 100 100 100 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase  100 100 100 100 100 100 
ACACA_BOVIN 265 Acetyl-CoA carboxylase 1 100 100 100 100 100 100 
ABCG2_BOVIN 73 
ATP-binding cassette sub-family G 
member 2 100 100 100 100 100 100 
ENPP3_BOVIN 100 
Ectonucleotide pyrophosphatase/ 
phosphodiesterase family member 3 100 100 100 100 100 100 
FAS_BOVIN 275 Fatty acid synthase 100 100 100 100 99 99 
CD36_BOVIN 53 Platelet glycoprotein 4 100 100 100 100 100 100 
Q3T0K7_BOVIN 48 MFGE8 protein 100 100 68 100 100 100 
A6QNZ7_BOVIN 55 Keratin 10 100 100 68 100 100 98 
K2C7_BOVIN 52 Keratin, type II cytoskeletal 7 100 100 68 99 50 58 
Q0VCZ8_BOVIN 78 
Acyl-CoA synthetase long-chain 
family member 1  100 100  100 100 100 
A4FV94_BOVIN 61 KRT6A protein 100 100 68  100 99 
MUC1_BOVIN 58 Mucin-1 100 100 68 50  100 
NPT2B_BOVIN 76 
Sodium-dependent phosphate transport 
protein 2B 100 100  100 100  
GBB2_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T)  
subunit beta-2  53 55   100 30 
K2C71_BOVIN 57 Keratin, type II cytoskeletal 71 97 55   29 98 
A7E340_BOVIN 36 Mucin 15, cell surface associated 30     17 
RAB18_BOVIN 23 Ras-related protein Rab-18  99   49 50 58 
Q17QL7_BOVIN 49 KRT15 protein  53    50  
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin   68 100 100 100 
PIGR_BOVIN 59 
Isoform Short of Polymeric 
immunoglobulin receptor    100 100 100  
FABPH_BOVIN 15 Fatty acid-binding protein, heart    100 50  
ALBU_BOVIN 69 Serum albumin    100 100  
Q9TRB9_BOVIN 2 
Enterotoxin-binding glycoprotein 
PP20K (Fragment)    50 22  
PERL_BOVIN 81 Lactoperoxidase    98 100  
CASB_BOVIN 25 Beta-casein     50 58 
PTCD2_BOVIN 44 
Pentatricopeptide repeat-containing 
protein 2      96  
A4FUX1_BOVIN 25 CIDEA protein   98   22 100 
D5HSX1_BOVIN 87 
cGMP-dependant type II protein 
kinase  99    58 
GLCM1_BOVIN 17 
Glycosylation-dependent cell adhesion 
molecule 1  22  50 50  
A6QQR3_BOVIN 36 APOL3 protein 98      
CASA1_BOVIN 25 Alpha-S1-casein 30      
HSP7C_BOVIN 71 Heat shock cognate 71 kDa protein 53      
Q2T9M8_BOVIN 23 Synaptosomal-associated protein   26     
A1L528_BOVIN 23 
RAB1A, member RAS oncogene 
family   55     
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Protein Probability Accession 
Number 
MW 
(kDa) 
Identified Proteins in  
>150 kDa Region (I)* F 4°C B H U UV 
ANXA2_BOVIN 39 Annexin A2   68    
Q8MKB7_BOVIN 73 Na+/glucose cotransporter     100  
5NTD_BOVIN 63 5'-nucleotidase     50  
A8E4P3_BOVIN 31 STOM protein      50  
GBB1_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1     45  
A6QLW3_BOVIN 37 RPRD1B protein     99  
B3VTM3_BOVIN 78 Lactoferrin     100  
LACB_BOVIN 20 Beta-lactoglobulin     100  
Q28049_BOVIN 14 Alpha lactalbumin (Fragment)     100  
CASK_BOVIN 21 Kappa-casein     100  
ANXA1_BOVIN 39 Annexin A2      58 
F, Fresh; B, Batch; H, HTST; U, UHT; UV 
A total of 48 proteins were identified. 
 
Table 17. Proteins identified in region II (higher than 55 and less than 150 kDa) of  MFGM 
isolates through LC/MS.  
Protein Probability Accession  
Number 
MW  
(kDa) 
Identified Proteins in  
>55<150 kDa Region (II)* F 4 °C B H U UV 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member A1  100 100 100 100 100 100 
PLIN2_BOVIN 49 Isoform 2 of Perilipin-2 100 100 100 100 100 100 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase 100 100 100 100 100 100 
Q3T0K7_BOVIN 48 MFGE8 protein 100 100 100 100 100 100 
ABCG2_BOVIN 73 
ATP-binding cassette sub-family G 
member 2 100 100 100 100 100 100 
PIGR_BOVIN 59 
Isoform Short of Polymeric 
immunoglobulin receptor 100 100 100 100 100 100 
CD36_BOVIN 53 Platelet glycoprotein 4  100 100 100 100 100 100 
Q0VCZ8_BOVIN 78 
Acyl-CoA synthetase long-chain 
family member 1  100 100 100 100 100 100 
A7E340_BOVIN 36 Mucin 15, cell surface associated 98 98 73 100 98 64 
Q0IIA4_BOVIN 59 
Glycoprotein 2 (Zymogen granule 
membrane)  100 100 100 100  100 
NPT2B_BOVIN 76 
Sodium-dependent phosphate 
transport protein 2B 100 100 100 100 99  
A4FV94_BOVIN 61 KRT6A protein 100 100 73 100 100  
K2C7_BOVIN 52 Keratin, type II cytoskeletal 7  50 100 73 100 100  
K2C71_BOVIN 57 Keratin, type II cytoskeletal 71   99  50 99  
A6QNZ7_BOVIN 55 Keratin 10 50 100  100 100  
GBB2_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2 98    100  
D5HSX1_BOVIN 87 
cGMP-dependant type II protein 
kinase  100   100   
ERG7_BOVIN 83 Lanosterol synthase  50  59 99 100  
ACHE_BOVIN 55 
Acetylcholine receptor subunit 
epsilon  19   50 96 25 
  
129 
Protein Probability Accession  
Number 
MW  
(kDa) 
Identified Proteins in  
>55<150 kDa Region (II)* F 4 °C B H U UV 
5NTD_BOVIN 63 5'-nucleotidase 25 99  100 100  
Q8MKB7_BOVIN 73 Na+/glucose cotransporter  50 54    64 
Q9TSF1_BOVIN 14 Butyrophilin (Fragment)   19 98 16  62 
CASA1_BOVIN 25 Alpha-S1-casein   100  50 99 64 
GLCM1_BOVIN 17 
Glycosylation-dependent cell 
adhesion molecule 1  100  50   
B3VTM3_BOVIN 78 Lactoferrin   100 100 100  
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin    100 100  
ALBU_BOVIN 69 Serum albumin    100 100  
Q9TRB9_BOVIN 2 
Enterotoxin-binding glycoprotein 
PP20K (Fragment)    13 47  
PERL_BOVIN 81 Lactoperoxidase     12 50  
HSP7C_BOVIN 71 Heat shock cognate 71 kDa protein 100   50   
GBB1_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1  12      
A6QQR3_BOVIN 36 APOL3 protein 100  98    
RAB18_BOVIN 23 Ras-related protein Rab-18 100      
ACOC_BOVIN 98 Cytoplasmic aconitate hydratase 100      
A4FUX1_BOVIN 25 CIDEA protein  37      
FABPH_BOVIN 15 Fatty acid-binding protein, heart  14      
Q08E14_BOVIN 138 Collagen, type III, alpha 1  100     
Q08DZ4_BOVIN 98 Smoothelin   98     
PPBT_BOVIN 57 Alkaline phosphatase    100   
LACB_BOVIN 20 Beta-lactoglobulin     100  
Q28049_BOVIN 14 Alpha lactalbumin (Fragment)     100  
CASK_BOVIN 21 Kappa-casein     100  
A6QNL0_BOVIN 40 CD14 protein     50  
Q17QL7_BOVIN 49 KRT15 protein     50  
A1L528_BOVIN 23 
RAB1A, member RAS oncogene 
family         17   
F, Fresh; B, Batch; H, HTST; U, UHT; UV 
A total of 46 proteins were identified 
 
Table 18. Proteins identified in region III (higher than 35 and less than 55 kDa) of  MFGM 
isolates through LC/MS.  
Protein Probability Accession  
Number 
MW 
(kDa) 
Identified Proteins in 
 >35<55 kDa Region (III)* F 4°C B H U UV 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member A1  100 100 100 100 100 100 
PLIN2_BOVIN 49 Isoform 2 of Perilipin-2 (ADFP) 100 100 100 100 100 100 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase 100 100 100 100 100 100 
Q3T0K7_BOVIN 48 MFGE8 protein 100 100 100 100 100 100 
ABCG2_BOVIN 73 
ATP-binding cassette sub-family G  
Member 2 100 100 100 99 100 100 
GBB2_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  100 100 100 100 100 100 
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Protein Probability Accession  
Number 
MW 
(kDa) 
Identified Proteins in 
 >35<55 kDa Region (III)* F 4°C B H U UV 
K2C7_BOVIN 52 Keratin, type II cytoskeletal 7  100 100 75 51 50 73 
ACTB_BOVIN 42 Actin, cytoplasmic 1  100 100 100 100 50 100 
GBB1_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T)  subunit beta-1 100 80 98 100 100 100 
CASA1_BOVIN 25 Alpha-S1-casein  99 68 75 100 100 100 
A4FV94_BOVIN 61 KRT6A protein 100 100  100 100 73 
A9XTK4_BOVIN 38 17-beta hydroxysteroid dehydrogenase  100 80  100  64 
A6QNZ7_BOVIN 55 Keratin 10  100 100  99 50  
GNA11_BOVIN 42 
Guanine nucleotide-binding protein subunit 
alpha-11  100  36 100 99 73 
GNAS2_BOVIN 44 
Isoform Alpha-S1 of Guanine nucleotide-
binding protein G(s) subunit alpha isoform 100  98 100 45  
Q3SX32_BOVIN 48 
Mannose 6 phosphate receptor binding 
protein 1 100  75 100  100 
NSDHL_BOVIN 40 Sterol-4-alpha-carboxylate 3-dehydrogenase 99   100 98 100 
CD36_BOVIN 53 Platelet glycoprotein 4  99  75  100 73 
A8E4P3_BOVIN 31 STOM protein 99   100  73 
K2C71_BOVIN 57 Keratin, type II cytoskeletal 71 63   90   
Q8MKB7_BOVIN 73 Na+/glucose cotransporter  98 98     
Q17QL7_BOVIN 49 KRT15 protein  63 100     
ANXA2_BOVIN 39 Annexin A2  63 80  100 22  
GIPC2_BOVIN 35 PDZ domain-containing protein GIPC2 100   100   
ANXA1_BOVIN 39 Annexin A1  63   51  100 
A6QLH3_BOVIN 33 STX3 protein  100 57  51  99 
Q2KIS4_BOVIN 34 
Dehydrogenase/reductase (SDR family) 
member 1 98   100   
A5PKG9_BOVIN 59 FGR protein  63   100   
A7MBH9_BOVIN 40 GNAI2 protein  100 60     
Q0VCZ8_BOVIN 78 
Acyl-CoA synthetase long-chain family 
member 1  98    99 
ACHE_BOVIN 55 Acetylcholine receptor subunit epsilon       55 
PIGR_BOVIN 59 
Isoform Short of Polymeric immunoglobulin 
receptor   100 100 100 100 
A7YWR0_BOVIN 36 Apolipoprotein E    98 100  73 
A6H7D4_BOVIN 52 Lysophosphatidic acid acyltransferase, zeta   75 100 47 73 
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin   75 100 100 99 
CASA2_BOVIN 26 Alpha-S2-casein    100 100  
A6H7G0_BOVIN 34 CYB5R3 protein   80 75 100 100  
A6QNL0_BOVIN 40 CD14 protein  66 100 100 99  
ANXA5_BOVIN 36 Annexin A5   51 100   
CASK_BOVIN 21 Kappa-casein    100 100  
ALBU_BOVIN 69 Serum albumin     99 100  
LIPL_BOVIN 53 Lipoprotein lipase     100 97  
EF1A1_BOVIN 50 Elongation factor 1-alpha 1  100     29 
NPT2B_BOVIN 76 Sodium-dependent phosphate transport-2B  100      
HSP7C_BOVIN 71 Heat shock cognate 71 kDa protein  99      
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Protein Probability Accession  
Number 
MW 
(kDa) 
Identified Proteins in 
 >35<55 kDa Region (III)* F 4°C B H U UV 
K1C17_BOVIN 49 Keratin, type I cytoskeletal 17   98     
PIPNA_BOVIN 32 
Phosphatidylinositol transfer protein alpha 
isoform   97     
5NTD_BOVIN 63 5'-nucleotidase        
A1L528_BOVIN 23 RAB1A, member RAS oncogene family    75    
D4QGC1_BOVIN 59 Tyrosine-protein kinase Lyn    100   
RAB18_BOVIN 23 Ras-related protein Rab-18      100  
LACB_BOVIN 20 Beta-lactoglobulin      100  
Q28049_BOVIN 14 Alpha lactalbumin (Fragment)     100  
CASB_BOVIN 25 Beta-casein     98  
Q3T101_BOVIN 25 IGL@ protein     98  
Q0IIA4_BOVIN 59 Glycoprotein 2           100 
F, Fresh; B, Batch; H, HTST; U, UHT; UV 
A total of 58 proteins were identified 
 
Table 19. Proteins identified in region IV (less than 35 kDa) of  MFGM isolates through 
LC/MS.   
Protein Probability Accession  
Number 
MW 
(kDa) 
Identified Proteins in 
 <35 kDa Region (IV)* F 4°C B H U UV 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member A1  100 100 100 100 100 100 
PLIN2_BOVIN 49 Isoform 2 of Perilipin-2 (ADFP) 100 100 100 100 100 100 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase  100 100 100 99 100 100 
Q3T0K7_BOVIN 48 MFGE8 protein   100 100 100 100 78 100 
Q3T101_BOVIN 25 IGL@ protein 100 100 100 100 100 100 
FABPH_BOVIN 15 Fatty acid-binding protein, heart 100 100 100 100 100 100 
RAB18_BOVIN 23 Ras-related protein Rab-18  100 100 100 100 100 100 
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin  72 100 100 100 100 100 
CASA1_BOVIN 25 Alpha-S1-casein  100 100 100 100 100 100 
A4FV94_BOVIN 61 KRT6A protein  72 100 68 100 100 98 
A1L528_BOVIN 23 RAB1A, member RAS oncogene family  100 100 100 100 100 100 
CASA2_BOVIN 26 Alpha-S2-casein  72 100 100 100 100 100 
CASK_BOVIN 21 Kappa-casein  98 100 100 100 100 100 
K2C7_BOVIN 52 Keratin, type II cytoskeletal 7  100 100 98 70 78 70 
RB11A_BOVIN 24 Ras-related protein Rab-11A 100 100 100 100 69 100 
A8E4P3_BOVIN 31 STOM protein 100 100 100 100  100 
Q861V9_BOVIN 16 Peptidyl-prolyl cis-trans isomerase (Frag) 100 100 100 100 62 100 
CASB_BOVIN 25 Beta-casein 100 100  100 78 100 
A4FUX1_BOVIN 25 CIDEA protein 100 100 100 100  100 
Q2T9M8_BOVIN 23 Synaptosomal-associated protein 100 100 100 100  100 
CTHL1_BOVIN 18 Cathelicidin-1 100 100 100 100  100 
Q3SYR8_BOVIN 18 Immunoglobulin J chain 100 100 100 70  70 
RAC1_BOVIN 21 Ras-related C3 botulinum toxin substrate 1 100 73 68 100  97 
SAR1A_BOVIN 22 GTP-binding protein SAR1a  100 100 99 100  100 
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Protein Probability Accession  
Number 
MW 
(kDa) 
Identified Proteins in 
 <35 kDa Region (IV)* F 4°C B H U UV 
RAB7A_BOVIN 24 Ras-related protein Rab-7a 100 100 100 100  70 
RAP1A_BOVIN 21 Ras-related protein Rap-1A 100 100 68 99  98 
B6VAP7_BOVIN 21 CDC42 protein  100 100  100   
SEP15_BOVIN 18 15 kDa selenoprotein  72 73 99 100  70 
B0JYL8_BOVIN 19 Cofilin 1 72 100 68 70  100 
MUC1_BOVIN 58 Mucin-1 100 98 57   27 
B0JYP6_BOVIN 26 IGK protein 100 100 100   100 
ABCG2_BOVIN 73 ATP-binding cassette sub-family G-2  72 100 68   100 
Q0IIA4_BOVIN 59 Glycoprotein 2   98    70 
Q2TBH2_BOVIN 24 
Related RAS viral (R-ras) oncogene 
homolog  100 100    100 
CHP1_BOVIN 22 Calcium-binding protein p22  72 100    100 
ARF1_BOVIN 21 ADP-ribosylation factor 1  100 73    70 
GBB2_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  72 73 47    
YKT6_BOVIN 22 Synaptobrevin homolog YKT6 72 100  70  100 
ARL15_BOVIN 23 ADP-ribosylation factor-like protein 15 99 99  100  70 
Q6QRN7_BOVIN 34 PP1201 protein  72 100  70  100 
A5D7E0_BOVIN 23 RAB35 protein   100  99 64 70 
Q1RMN8_BOVIN 25 Immunoglobulin light chain, λ gene cluster   100 100  70  
A5D7R9_BOVIN 21 NRAS protein   99   100 
PROF1_BOVIN 15 Profilin-1    70  99 
A4FUH8_BOVIN 21 
Chromosome 1 open reading frame 93 
ortholog     100   
A6QQR3_BOVIN 36 APOL3 protein   73 28    
A7YWR0_BOVIN 36 Apolipoprotein E    28   
A6QNZ7_BOVIN 55 Keratin 10  99 34 100 100 98 
GLCM1_BOVIN 17 
Glycosylation-dependent cell adhesion 
molecule 1   100 100 100 98  
Q9TRB9_BOVIN 2 
Enterotoxin-binding glycoprotein PP20K 
(Fragment)   53 31 100 100  
LACB_BOVIN 20 Beta-lactoglobulin   68 100 100  
Q28049_BOVIN 14 Alpha lactalbumin (Fragment)     100 100  
Q0VCZ8_BOVIN 78 
Acyl-CoA synthetase long-chain family 
member 1  44  27  42 
K2C71_BOVIN 57 Keratin, type II cytoskeletal 71   99  66  47 
ACTB_BOVIN 42 Actin, cytoplasmic 1   100    100 
A6H7G0_BOVIN 34 CYB5R3 protein   73    100 
GNAS2_BOVIN 44 
Alpha-S1 of Guanine nucleotide-binding 
protein G(s) subunit alpha isoforms short  73    47 
Q1JQ95_BOVIN 18 
CKLF-like MARVEL transmembrane 
domain containing 7       100 
A5D7N2_BOVIN 14 Histone H2B   99    99 
RAB5C_BOVIN 23 Ras-related protein Rab-5C  72 100     
RAB1B_BOVIN 22 Ras-related protein Rab-1B  95 58  70   
RAB13_BOVIN 23 Ras-related protein Rab-13  72   100   
RHOC_BOVIN 22 Rho-related GTP-binding protein RhoC  72   100   
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Protein Probability Accession  
Number 
MW 
(kDa) 
Identified Proteins in 
 <35 kDa Region (IV)* F 4°C B H U UV 
RAB8A_BOVIN 24 Ras-related protein Rab-8A  99      
Q3SX32_BOVIN 48 
Mannose 6 phosphate receptor binding 
protein 1  100     
1433B_BOVIN 28 Isoform Short of 14-3-3 protein beta/alpha  95     
PERL_BOVIN 81 Lactoperoxidase   73     
Q9TSF1_BOVIN 14 Butyrophilin (Fragment)   96     
FABP7_BOVIN 15 Fatty acid-binding protein, brain   100    
A7E340_BOVIN 36 Mucin 15, cell surface associated      31  
RBM22_BOVIN 47 Pre-mRNA-splicing factor RBM22      98 
A5D792_BOVIN 18 DCK protein      100 
GBB1_BOVIN 37 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T)subunit beta-1      70 
FAS_BOVIN 275 Fatty acid synthase           54 
F, Fresh; B, Batch; H, HTST; U, UHT; UV 
A total of 74 proteins were identified 
 
E. MFGM Protein Profile from 2-Dimensional Gel Coupled with MALDI-TOF 
1.   Visualization of MFGM Proteins with Fluorescent Dye 
SyproRuby is one of the most sensitive stains in the market, capable of detecting as 
little as 0.5-1 ng of protein per mm2 (Candiano et al., 2004). In this research, this 
fluorescent dye was utilized in preliminary studies to determine the MFGM protein 
pattern. Studies have shown that the sensitivity of SyproRuby is superior to colloidal 
Coomassie brilliant blue (Berggren et al., 2000). It specifically binds to proteins by non-
covalent interactions, avoiding impurities in samples such as lipids. As observed in 
Figure 34, SyproRuby resulted in similar 2-DE maps as the ones analyzed in the research. 
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Figure 34. Representative 2-DE map of Batch (left) and high temperature short time (HTST) 
pasteurization treatments dyed with fluorescent dye, Sypro-Ruby.  A total of 100 µg 
of protein was loaded and stained with a 1:5 dilution of the dye. 
2.   Visualization of MFGM Protein with Coomassie Blue 
For a better understanding of the changes in the MFGM proteins during milk 
processing, 2DE gels were performed on the six treatments. Different concentrations 
were tested to optimize the protocol and obtain good resolution as well as sensitivity. The 
use of sensitive colloidal stain, which utilizes Coomassie Blue (Westermeier, 2006), 
permitted loading only 100 µg of protein. Figure 35 depicts the 2DE pattern for each 
treatment.  
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Figure 35. Representative 2-DE map of MFGM proteins during milk processing. A 12.5% 
SDS-PAGE stained w sensitive colloidal. A) Fresh, B) 4 °C, C) Batch, D) HTST,      
E) UHT, and F) UV. 
 
All the treatments had good resolution with the exception of UHT, which resulted in 
streaks and spotting, probably due to the presence of complexes (Figure 35.E).  
3.   MFGM Protein Variation during Milk Processing 
With the help of Delta2D, the 2-D gels were compared in a two-way ANOVA using 
the Fresh sample as a control to determine protein fluctuation (p < 0.01). Figure 36 shows 
a graphical representation of the percent protein change between each treatment and the 
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control, Fresh milk. As expected, UHT had the highest percent change among the 
comparisons followed by the batch treatment. The complete ANOVA-2 results are shown 
in Appendix K. 
 
Figure 36. Protein expression change during milk processing. 2DE gels were compared using 
a statistical program. Each treatment was compared against the Fresh sample, and 
the change in protein expression is indicated as a percentage (Delta2D, p <0.01). 
The global change during the entire milk processing, including the cold treatment, can 
be visualized in Figure 37 (p < 0.01). An increase in temperature induced a 86% change 
in MFGM proteins; however, almost 20% of this fluctuation was due to UHT. Batch 
pasteurization also produced a high protein change, probably due to the prolonged time 
during the treatment. Cold pasteurization resulted in a protein fluctuation similar to 4 °C. 
Analysis of the treatments without heat (Fresh, 4 °C, and UV) resulted in a 52% change 
(Figure 37).  
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Figure 37. Protein expression change during milk processing. 2DE gels were compared using 
a statistical program. All the treatments were compared against the Fresh sample (6 
Treat), without UHT (5 Treat), and no heat application (Fresh, 4 °C, UV). The 
change in protein expression is indicated as a percentage. 
This data indicates that protein variation during milk processing can be visualized 
with 2DE gels and analyzed with Delta2D; but the latter is a tool that can be further used 
to help us interpret results.  
4. Identification of MFGM Proteins during Milk Processing 
Milk fat globule membrane proteins that are altered during milk processing were 
detected using Peptide Mass Fingerprinting (PMF).  More than 300 spots were detected 
on the 2-dimensional gels with a pI range of 3 to 7 that differed significantly (p < 0.01) as 
a function of temperature. Region with high variation were chosen for further 
identification; however, only 65% of the these spots were successfully identified via 
MALDI-TOF. Limitations such as incompleteness of bovine protein databases and 
relatively high threshold parameters used to define a positive identification may have 
reduced the number of hits obtained. In addition, some proteins may have been 
irreversibly denatured and not rehydrated during the 2D sample preparation step, which 
avoided their final detection. 
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Among the identified proteins that vary during cold storage (4 °C), many isoforms of 
the major MFGM proteins were observed in accordance to previous studies (Fong et al., 
2007). Butyrophilin was detected in different areas of the composite gel image (proteome 
map) of the Fresh/4 °C set (Figure 35). These results corroborate previous observations 
that BTN is present in multiple forms. Indeed, Vanderghem, et al. (2008) identified three 
groups, 67 kDa, 62 kDA, and a third group at 80 kDa. The BTN present in this study has 
molecular weight of approximately 52 kDa. 
 
Figure 38. Proteome map (Delta 2D) depicting 104 spots from the 4 ºC milk sample versus 
the Fresh milk sample (control). The proteome map represents average pixel 
volumes for each protein spot.  Labeled spots showed changes in abundance in 
response to cold storage temperature (two-way ANOVA , p < 0.01, total spots 305).  
 
Lactadherin also varied in abundance during the storage conditions of milk, and it 
was observed as a train of spots at a molecular weight of approximately 90 kDa. Previous 
studies described two groups of lactadherin, with 60 kDa and 80 kDa (Vanderghem et al., 
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2008). Other molecules that were altered in concentration during cold condition were 
adipophilin and perilipins. Mather (2000) reported two adipophilin with different 
isoelectric points (pI), 7.5 and 7.8. In another study, five isoelectric variants were found 
in 2DE gels. In this research, adipophilin with a predicted pI of 5.85 was observed, and 
the lower pI is probably due to phosphorylation (Table 20). The constant region of 
immunoglobulin heavy chain was identified indicating that immunoglobulins are altered 
and even denatured during cold temperatures. Fong et al. (2007) also identified this 
protein in the MFGM. For a positive identification, a minimum of two peptides was 
required along with a Mascot score of 50. 
Table 20. Identified proteins in the proteome map from 4 °C milk sample versus the Fresh 
milk sample that vary during milk processing. 
Spot  
ID 
 
Protein ID 
MW  
(kDa) 
 
pI 
GenBank 
 ID 
Mascot 
Score 
 
Pep 
Seq. 
(%) 
5 Butyrophilin 59.21 5.11 gi|2266432 283 6 25 
2 Polymeric immunoglobulin  
receptor precursor 
82.47 7.68 gi|296479365 69 2 9 
6 Perilipin-2 49.31 8.72 gi|296484843 276 7 30 
9 rho-related GTP-binding protein ThoC-
like 
21.93 6.20 gi|327271431 246 2 23 
10 Perilipin-2 49.31 8.72 gi|296484843 472 8 36 
11 Perilipin-2 49.31 8.72 gi|296484843 414 9 36 
12 ADFP protein 49.04 5.85 gi|74354901 82 3 11 
13 ADFP protein 49.04 5.85 gi|74354901 49 4 17 
16 ADFP protein 49.04 5.85 gi|74354901 115 4 15 
17 ADFP protein 49.04 5.85 gi|74354901 114 4 13 
20 rab GDP dissociation inhibitor beta 50.46 5.94 gi|76253900 47 2 11 
22B Perilipin-2 49.31 8.72 gi|296484843 204 6 27 
24 ADFP protein 49.31 5.85 gi|74354901 122 5 13 
26 Perilipin-2 49.31 8.72 gi|296484843 94 4 19 
27 Perilipin-2 49.31 8.72 gi|296484843 357 9 36 
28 Butyrophilin-Fragment * 14.13 4.99 gi|40388469 44 1 2 
29 Butyrophilin 59.21 5.11 gi|2266432 285 5 21 
30 Butyrophilin subfamily 1 member 
 A1 precursor † 
59.22 5.10 gi|27806233] 194 5 32 
32 Protein phosphatase 1J 87.05 8.94 gi|296208863 204 3 26 
35A Fatty acid-binding protein, heart 14.77 6.73 gi|27805809 280 5 28 
35B Fatty acid-binding protein, heart 14.77 6.73 gi|27805809 316 5 28 
36 CDC42 protein 21.23 5.5 gi|210062862 173 3 21 
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Spot  
ID 
 
Protein ID 
MW  
(kDa) 
 
pI 
GenBank 
 ID 
Mascot 
Score 
 
Pep 
Seq. 
(%) 
38 immunoglobulin heavy chain 
constant region § 
49.91 5.09 gi|34538498 86 3 25 
39 immunoglobulin heavy chain § 49.91 5.09 gi|34538498 122 3 25 
40 immunoglobulin heavy chain § 49.91 5.09 gi|34538498 74 2 30 
41 Butyrophilin 59.21 5.11 gi|2266432 248 4 26 
42 Butyrophilin 59.21 5.11 gi|2266432 281 5 21 
43 Butyrophilin 59.21 5.11 gi|2266432 176 5 21 
44 Butyrophilin 59.21 5.11 gi|2266432 260 4 26 
45 Butyrophilin 59.21 5.11 gi|2266432 149 4 27 
47 Butyrophilin 59.21 5.11 gi|2266432 159 3 20 
48 Butyrophilin 59.21 5.11 gi|2266432 377 6 39 
49 Butyrophilin 59.21 5.11 gi|2266432 276 5 34 
50 Butyrophilin 59.21 5.11 gi|2266432 322 6 34 
53 Alpha S1 casein*     gi|159793193 68 1 8 
54 Butyrophilin subfamily 1 member † 59.22 5.10 gi|27806233 71 2 11 
55 Butyrophilin subfamily 1 member † 59.22 5.10 gi|27806233 143 4 21 
56 Butyrophilin subfamily 1 member † 59.22 5.10 gi|27806233 165 5 27 
59A Butyrophilin subfamily 1 member † 59.22 5.10 gi|27806233 148 5 27 
59B Butyrophilin subfamily 1 member † 59.22 5.10 gi|27806233 179 5 27 
60 Butyrophilin subfamily 1 member † 59.22 5.10 gi|27806233 108 4 22 
63 Lactadherin 47.82 6.80 gi|296475529 385 8 28 
63 Lactadherin 47.82 6.80 gi|296475529 423 8 28 
65 Lacadherin 47.82 6.80 gi|296475529 536 10 35 
68 ADFP protein 49.04 5.85 gi|74354901 143 5 13 
74 Perilipin-2 49.31 8.72 gi|296484843 185 7 34 
78 Perilipin-2* 49.31 8.72 gi|296484843 49 1 13 
91 Butyrophilin 59.21 5.11 gi|2266432 173 5 21 
* Marginal identification  
† Butyrophilin subfamily 1 member A1 precursor; § Immunoglobulin heavy chain constant region 
Pep. match, Peptide matches; Seq. (%), sequence coverage (%); MW, molecular weight. 
 
 
After milking, milk goes into cold storage where it remains from hours to days before 
pasteurization. In this research, three types of pasteurization were performed on the milk 
after storage. Batch pasteurization (65 °C, 30 m) resulted in dramatic protein alterations. 
In fact, 344 spots were detected, from which 175 were significantly different (p < 0.01) as 
shown in Figure 39. The main proteins that change in concentration during batch 
treatment are alpha casein, CSN2, CSN3, β-lactoglobulin, and α-lactalbumin. The results 
from the 1D-LC/MS analysis highlighted the same findings (Figure 36). 
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Figure 39. Proteome map (Delta 2D) depicting 175 spots from Batch milk sample versus the 
Fresh milk sample (control). The proteome map represents average pixel volumes 
for each protein spot.  Labeled spots showed changes in abundance in response to 
thermal treatment  (65 °C, 30 m; two-way ANOVA , p < 0.01, total spots 344). 
 
As in the 4 °C sample, butyrophilin, ADFP, and perilipins were also altered. A 
change in lactoferrin was specific to this thermal treatment as well as in the folate 
receptor 1-like protein (Table 21). A train of spots in the 90 kDa region was identified as 
polymeric immunoglogulin receptor (PIGR), which was in an area close to the 
lactadherin protein, which also fluctuated during this treatment. 
Table 21. Identified proteins in the proteome map from Batch milk sample versus the Fresh 
milk sample that vary during milk processing. 
Spot  
ID 
 
Protein ID 
MW  
(kDA) 
 
pI 
GenBank 
 ID 
Mascot 
Score 
 
Pep 
Seq. 
(%) 
15 CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 128 4 24 
16 CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 81 2 16 
18 Peptidyl-prolyl cis-trans isomerase A † 17.86 8.34 gi|47523764 139 3 23 
23 Peptidyl-prolyl cis-trans isomerase A† 17.86 8.34 gi|47523764 55 2 17 
25 Perilipin-2 49.31 8.72 gi|296484843 522 9 38 
26 Perilipin-2 49.31 8.72 gi|296484843 443 9 38 
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Spot  
ID 
 
Protein ID 
MW  
(kDA) 
 
pI 
GenBank 
 ID 
Mascot 
Score 
 
Pep 
Seq. 
(%) 
29 Folate receptor 1-like 52.81 8.09 gi|297460991 311 7 32 
38 Lactoferrin 78.03 8.73 gi|9650974 179 6 27 
40 Lactoferrin 78.03 8.73 gi|9650974 139 5 27 
65 Folate receptor 1-like 52.81 8.09 gi|297460991 253 5 26 
78 Butyrophilin 59.21 5.11 gi|2266432 151 5 27 
86 Alpha S1 casein 18.67 5.23 gi|159793193 375 6 28 
87A CSN1S2 protein-alpha-S2-casein 26.07 8.55 gi|92097520 125 3 17 
87B CSN1S2 protein-alpha-S2-casein 26.07 8.55 gi|92097520 150 4 22 
88 Alpha S1 casein 18.67 5.23 gi|159793193 343 6 28 
90A CSN1S2 protein-alpha-S2-casein 26.07 8.55 gi|92097520 125 4 22 
91 CSN2 protein-beta casein 25.20 5.53 gi|83406093 49 2 16 
94 CSN2 protein-beta casein 25.20 5.53 gi|83406093 127 3 16 
95 CSN2 protein-beta casein 25.20 5.53 gi|83406093 96 3 16 
100 Beta lactoglobulin 17.16 4.75 gi|162748 283 6 31 
101 Beta lactoglobulin 17.16 4.75 gi|162748 309 6 35 
103A Beta lactoglobulin 17.16 4.75 gi|162748 283 6 31 
103B Alpha lactalbumin 16.21 4.92 gi|7542833 76 2 10 
104A Keratin, Type 1 cytoskeletal- Bovine 54.50 4.97 gi|296476308 126 3 12 
104B Fatty acid-binding protein, heart 14.77 6.73 gi|27805809 324 6 28 
105 CSN3- kappa casein 21.22 6.83 gi|36988716 115 4 24 
106 CSN3- kappa casein 21.22 6.83 gi|36988716 140 4 24 
107 CSN3- kappa casein 21.22 6.83 gi|36988716 96 3 24 
108 CSN3- kappa casein 21.22 6.83 gi|36988716 117 3 24 
111 Actin, beta cytoplasmic 41.68 5.29 gi|148744172 90 2 16 
115 Butyrophilin 59.21 5.11 gi|2266432 98 3 16 
118 PIGR 82.46 7.08 gi|151555693 98 3 18 
119 PIGR 82.46 7.08 gi|151555693 142 7 11 
120 PIGR 82.46 7.08 gi|151555693 144 4 25 
121 PIGR 82.46 7.08 gi|151555693 143 2 9 
122 PIGR 82.46 7.08 gi|151555693 129 3 18 
124 PIGR 82.46 7.08 gi|151555693 68 2 9 
127 5'-nucleotidase † 62.84 6.22 gi|194035289 90 3 13 
128 5'-nucleotidase † 62.84 6.22 gi|194035289 99 2 10 
129 Lactadherin 47.82 6.80 gi|296475529 133 4 12 
133 IgG1 Heavy Chain constant region 35.83 6.09 gi|7547266 120 2 22 
143 ADFP protein 49.04 5.85 gi|74354901 43 2 17 
147 Lactadherin 47.82 6.80 gi|296475529 42 2 14 
154 PIGR 82.46 7.08 gi|151555693 140 7 7 
155 PIGR 82.46 7.08 gi|151555693 115 4 6 
161 ALB-serum albumin 69.19 5.88 gi|74267962 56 3 18 
163 Serotransferrin precursor 77.69 6.75 gi|114326282 104 3 14 
164 Perilipin-2 49.31 8.72 gi|296484843 384 8 31 
167 Butyrophilin 59.21 5.11 gi|2266432 42 1 6 
Pep. match, Peptide matches; Seq. (%), sequence coverage (%); MW, molecular weight. 
† Sus scrofa 
 
In the high temperature short time (HTST) pasteurization treatment, 350 spots were 
identified, and 128 spots were temperature significant (p < 0.01) (Figure 40).  The 
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proteome map is similar to the 4 °C sample, but with other alterations as in the batch 
milk. Lactoferrin also fluctuated during this treatment. 
 
Figure 40. Proteome map (Delta 2D) depicting 128 spots from high temperature short time 
(HTST) milk sample versus the Fresh milk sample (control). The proteome map 
represents average pixel volumes for each protein spot.  Labeled spots showed 
changes in abundance in response to thermal treatment (72 °C, 16 s; two-way 
ANOVA , p < 0.01, total spots 350). 
The main proteins that change in concentration during HTST are β-lactoglobulin and 
α-lactalbumin but in a smaller degree compared to batch treatment. A GTP-binding 
protein SAR1a varied during this treatment (Table 22). GTP-binding proteins play a role 
in regulating exocytosis.   
Table 22. Identified proteins in the proteome map from HTST milk sample versus the Fresh 
milk sample that vary during milk processing. 
Spot  
ID 
 
Protein ID 
MW  
(kDA) 
 
pI 
GenBank 
 ID 
Mascot 
Score 
 
Pep 
Seq. 
 (%) 
2 GTP-binding protein SAR1a 22.39 6.22 gi|72535188 124 2 12 
9 Butyrophilin 59.21 5.11 gi|2266432 182 3 20 
Pep. match, Peptide matches; Seq. (%), sequence coverage (%); MW, molecular weight. 
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Ultra high temperature (UHT) pasteurization resulted in 186 spots that were 
temperature significant (p<0.01). The casein profile underwent a new pattern in the 
proteome map compared to batch and HTST pasteurization (Figure 41).  
 
Figure 41.  Proteome map (Delta 2D) depicting 186 spots from ultra high temperature 
(UHT) milk sample versus the Fresh milk sample (control). The proteome map 
represents average pixel volumes for each protein spot.  Labeled spots showed 
changes in abundance in response to high thermal treatment (121 °C, 3 m; two-way 
ANOVA , p < 0.01, total spots 277). 
 
Streaking diminished the number of identified proteins due to the complexity in 
matching spots between the UHT samples and Fresh milk. Nevertheless, the proteome 
map depicts clear changes in the casein, β-lactoglobulin, and α-lactalbumin proteins. The 
major milk allergen, β-lactoglobulin fragment, was identified in this thermal treatment 
(Table 23).  
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Table 23. Identified proteins in the proteome map from UHT milk sample versus the Fresh 
milk sample that vary during milk processing. 
Spot  
ID 
 
Protein ID 
MW  
(kDa) 
 
pI 
GenBank 
 ID 
Mascot 
Score 
 
Pep 
Seq. 
 (%) 
1A CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 62 2 15 
1B CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 150 3 24 
2A CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 88 4 24 
2B CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 115 3 23 
3A CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 156 4 24 
3B CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 87 4 22 
4A CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 118 4 24 
4B CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 56 2 16 
10 Major Allergen Beta-lactoglobulin 19.96 4.85 gi|195957138 71 3 21 
11 CSN3 protein- Kappa casein 21.22 6.83 gi|36988716 104 4 24 
158A Major Allergen Beta-lactoglobulin 19.96 4.85 gi|195957138 211 4 23 
158B Major Allergen Beta-lactoglobulin 19.96 4.85 gi|195957138 157 4 17 
160B Beta lactoglobulin 17.16 4.75 gi|162748 186 5 22 
165 Alpha lactalbumin 16.21 4.92 gi|7542833 146 3 20 
166 Alpha lactalbumin 16.21 4.92 gi|7542833 74 1 8 
Pep. match, Peptide matches; Seq. (%), sequence coverage (%); MW, molecular weight. 
 
The last variant in this study was cold pasteurization via pulse ultraviolet treatment 
(UV). The proteome map permitted the detection of 344 spots from which 116 were 
temperature significant (p <0.01, Figure 42). The percent protein change (37%) in the UV 
treatment versus Fresh milk is in the same range as cold storage and HTST thermal 
treatment; however, visually the proteome map looks more like the 4 °C sample.  
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Figure 42.  Proteome map (Delta 2D) depicting 116 spots from cold pasteurization (pulsed 
ultraviolet, UV) milk sample versus the Fresh milk sample (control). The proteome 
map represents average pixel volumes for each protein spot.  Labeled spots showed 
changes in abundance in response to thermal treatment (1.0 Joules/cm2/pulse; two-
way ANOVA , p < 0.01, total spots 344). 
 Proteins with high carbohydrate content were not identified as altered proteins during 
milk processing, probably due to inhibitory action from the carbohydrate moieties, which 
may inhibit trypsin digestion and/or impair ionization of glycopeptides during mass 
spectrometry analyses.  
V. DISCUSSION 
A. Effects of Milk Processing on the Physical Properties of the MFGM 
The particle size distribution in milk was between 0.4 to 10 µm in diameter in 
accordance to literature (Gassi et al., 2008; Fong et al., 2007; Mènard et al., 2010). The 
Fresh milk has the highest volume-surface diameter (d3,2), indicating the presence of small 
fat globules with larger surface area in unprocessed milk (Table ). Cooling, thermal 
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treatment, and cold pasteurization did not have a pronounced influence on the particle 
size of milk; however, the fat globule size distribution width (Span) in these samples is 
wider, implying the presence of smaller vesicles and larger fat globules. Milk processing 
might induce the formation of smaller vesicles, which were first described by Waninge et 
al. (2004) utilizing cryogenic transmission electron microscopy (Cryo-TEM). They 
proposed that milk procedures such as cooling and homogenization lead to phospholipid 
release from the membrane and gives birth to phospholipid vesicles. These vesicles could 
also originate from milk fat globule coalescence and consist of lost membrane material 
(Waninge et al., 2004). Walstra (1969) highlighted the presence of small fat globules (< 
200 nm) even in milk after milking (Walstra, 1969); however, Michalski et al. (2002) 
later concluded that small fat droplets (<500 nm) start to appear in early processing 
stages but not right after milking. Using confocal microscopy, Gallier et al. confirmed 
variation in fat globule size in milk upon milk processing (Gallier et al., 2010a).   
With respect to the fat globules in cream, there is more variation in the size 
distribution, which ranges from 0.4 µm to 200 µm. Four peak areas are visible, which 
correspond to small globules (0.4 -1.0 µm), mid-large globules (1.5-10 µm), out of range 
(20-60 µm), and aggregated globules (70-200 µm). Gassi et al. (2008) observed fat 
globules from 0.02 µm to 200 µm with three peaks centering at 0.5 µm, 4 µm, and 45 µm. 
The large fat globules (>20 µm) were more pronounced in cream with medium and high 
heat treatments, and the results were ascribed to the fusion of smaller globules to form 
larger ones due to coalescence. Addition of SDS decreased the third peak (45 µm) 
indicating that it corresponds to aggregates of fat globules. In this study, it is expected 
that the third and four distributions represent fat globule aggregates of large globules 
since large fat globules are more predisposed to coalescence and lipolysis during milking 
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operations such as pumping and agitation (Wiking et al., 2004). In fact, these areas are 
very prominent in milk that underwent heat pasteurization, especially in HTST, Batch, 
and UHT, whereas the samples that did not undergo heat treatment exhibit a higher 
percent volume in the normal size fat globule range. Prolonged and higher temperature 
treatments, such as in Batch and UHT, may have deactivated lipases and contributed to 
the stability of fat globules and therefore to less coalescence as compared to the HTST 
milk. Lipases are not always completely inactivated during regular pasteurization 
temperatures, so lipid breakdown continues during the milk’s lifespan after heat treatment 
as well as of free fatty acid production. Furthermore, thermal treatment resulted in 
smaller fat globules (< 0.5 µm), which may correspond to vesicles formed by MFGM 
fragments composed of phospholipids and proteins as previously discussed.  
B. Effects of Milk Processing on the Chemical Composition of the MFGM 
1.   Changes in Milk Composition 
No significant difference was seen in the fat, lactose, total solid, and protein content 
of milk (p >0.05). However, the casein content was marginally higher for UHT milk (p 
=0.05). Complexes between β-lactoglobulin and casein may explain this observation. In 
buttermilk, higher casein content has been attributed to thermal treatment since whey 
proteins are titrated with the casein fraction, making casein value higher (Gassi et al.). 
The citric acid content also is higher in UHT milk compared to the other milk treatments 
(p =0.05).  Such findings were ascribed to the detection limits of FTIR as research 
indicates that citric acid does not vary with heating (Sommer and Hart, 1918). The urea 
content in UHT milk was higher (p < 0.0001) probably due to induced protein catabolism 
at 121 °C at 15 psi as urea naturally decomposes into ammonia and carbon dioxide 
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(Metwalli et al., 1996; Metwalli and van Boekel, 1998). This may also explain the higher 
urea content in the Fresh sample that gradually decreases in concentration in milk. The 
Fresh and UHT milk also exhibit a lower free fatty acid (FFA) content (p< 0.0001) in 
accordance to literature (Burton, 1988; Kintner and Day, 1965). Kintner and Day (1965) 
found that as the intensity of thermal treatment increases, the amount of FFA decreased. 
Higher FFA content in milk has been accredited to the survival of heat-resistant lipases of 
natural milk origins or produced by psychrotrophic bacteria during cold storage (Burton, 
1988). The higher FFA content in 4 ºC, Batch, HTST, and UV indicate instability of fat 
globules probably due to lipase activity from microbiological or natural origins or from 
fat globule damage during milk processing. In fact, lipoprotein lipase reaches optimal 
binding to MFGM after four hours of milking, and thereby, contributed to the high FFA 
in these samples (Dickow et al., 2011; Wiking et al., 2005). 
2.   Effects on MFGM Isolates & Protein  
The MFGM isolates obtained, ranging from 171 to 315 mg of dry weight (pellet) per 
liter of milk, were higher than that previously described in literature, which correspond to 
approximately 95 mg dry weight per liter of fresh milk (Sánchez-Juanes et al., 2009). 
These high values may have resulted from omission of cream washes that contribute to 
more material in the final product. Furthermore, the amount of MFGM isolate decreased 
as a function of thermal treatment as observed in previous research (Kim and Jiménez-
Flores, 1995). According to their findings, higher temperatures resulted in less membrane 
and more insoluble product. The insolubility of the MFGM was not measured, but it was 
noticed that MFGM material from UHT sample had a difficult time going into solution. 
In addition, the isolated MFGM pellet in pasteurized samples was lower in protein 
content than those samples without thermal treatment (p < 0.0001). The amount of 
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protein in these isolates was lower than those previously reported, 48.7 mg of protein per 
100 mg of MFGM (Sánchez-Juanes et al., 2009). In this research, the protein in the 
isolates varies from 13.3 to 17.7 mg of protein per 100 mg of MFGM isolates, explaining 
the high amount of MFGM in the final pellets, which may contain other milk 
components. Thermal treatment resulted in higher protein content in the isolates 
compared to Fresh milk, indicating interactions between MFGM proteins and milk 
components, especially proteins, as temperature increased. 
Discoloration was also observed in MFGM isolates as thermal treatment increased in 
accordance to other authors (Morin et al., 2007b; Corredig and Dalgleish, 1998). Milk 
without thermal treatment such as Fresh and UV were reddish-brown compared to 
yellow-white from HTST milk.  This result is believed to be caused by a decrease in the 
amount of iron in the MFGM. Corredig and Dalgleish actually measured the iron content 
by atomic absorption in samples that underwent heat treatment, concluding that the 
amount of iron in the MFGM decreased as a function of heating temperature even in 
temperatures as low as 62 ºC. They hypothesized that heat induces the release of iron 
from xanthine oxidase, which has four residues holding an iron molecule. Iron release 
coupled with structural changes in XO make the protein available for disulfide exchange 
with other cyteine-containing proteins causing permanent denaturation and iron loss. 
Morin et al. (2007b) supported this hypothesis with a pronounced lower ash content in 
pasteurized cream compared to raw cream. We hypothesized that other iron-containing 
proteins such as lactoferrin denaturation may contribute to the discoloration, which 
becomes more prominent in ultra high temperature milk. 
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3.   Effects on the Phospholipid Profile of the MFG 
Separation and quantification of milk polar lipids were in accordance to literature 
(Rombaut et al., 2005). The five major entities were isolated as single peaks with the 
exception of sphingomyelin (SM), which depicted three peaks. Peak 2 and 3 have been 
interpreted as derivatives of SM with extra hydroxyl groups (Rombaut et al., 2006a). In 
other studies, three peaks were reported corresponding to different sphingoloid bases and 
fatty acids (Lopez et al., 2008; Fong et al., 2007). Phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC) containing different acyl groups were separated resulting in 
elution of phospholipids with longest to shortest acyl chain (18:0, 12:0, and 6:0) (Fagan 
and Wijesundera, 2004). With this evidence, it is suspected that the three peaks of SM 
correspond to derivatives with varying acyl chain length. PC also depicted different 
peaks, but the effect was not as pronounced as SM. These peaks have previously been 
correlated to changes in the fatty acid composition of polar lipids due to cow diet (Lopez 
et al., 2008). 
The amount of total polar lipids isolated in this study is in accordance with previous 
studies where PLs in milk range from 9.4 to 35.5 mg per 100 g of product (Christie et al., 
1987; Fong et al., 2007). In this research, 7.7 to 20.5 mg of polar lipid were detected per 
100 g of milk, which equals to 0.21 to 0.57 g of polar lipid per 100 of total lipids. The 
individual concentrations of polar lipids was not significantly differently (p > 0.05), 
implying that milk processing such as cooling and thermal treatment does not influence 
the concentration of PLs. In literature, conflicting results on the effect of temperature on 
polar lipids from whole milk fat globules have been reported. According to Rombaut et 
al. (2006), variations in polar lipids can be ascribed to differences in the methodology 
used in the analysis. The Mojonnier procedure may not extract all the individual polar 
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lipids, including lecithins, and cephalins (Morin et al., 2007b), which contribute to the 
polar lipid variation. In fact, the lower concentrations of PI and PS observed in the 
samples are probably due to the use of ammonium to dissociate the MFGM matrix, as 
indicated in previous studies (Avalli and Contarini, 2005). Their acidic characteristics 
might have solubilized them in the aqueous phase.  
With the experimental design utilized in this research, it was difficult to discern how 
milk processing affects the concentration of individual polar lipids in the milk fat globule 
membrane. The literature reported for this topic is also inconsistent. According to 
Houlihan et al. (1992), heating alone had little or no effect on polar lipids whereas 
Christie et al. (1987) did not detect PLs in UHT powders, attributing such observations to 
the effect of heat during processing, especially oxidation of polyunsaturated fatty acids 
(PUFA). Buttermilk produced from pasteurized cream resulted in lower phospholipid 
concentration, especially PE, PS, and PI (Morin et al., 2007b). The authors hypothesized 
that during cream churning the inner membrane of the fat globules is exposed to milk 
serum, inducing possible interactions as well as dislocation of the MFGM. Gassi et al. 
(2008) found no variation in total PL content of creams that underwent different heat 
treatments while the PL content increased in their respective buttermilk by a factor of 
seven. During cream churning, more PE and less SM are observed in skim milk 
predicting that loosely bound polar lipids appear in skim milk due to high shear forces 
that destroy the surface of fat globules (Morin et al., 2008).  
Migration of lipids from MFGM to serum only occurs in the presence of serum 
components (Houlihan et al., 1992). Residual MFGM material is found in skim milk, and 
since SM and PC are located in the outer leaflet, they are more likely to migrate into the 
milk serum upon centrifugation (Anderson and Brooker, 1974). Gallier et al. (2010a) 
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confirmed these observations in her PL quantification where SM and PC were less 
abundant in cream than in raw milk (Christie et al., 1987). PE was three times less 
abundant in buttermilk and more concentrated in cream. Since PE is more hydrophobic 
than PC and SM, it might partition into the butter phase during butter manufacture and 
MFGM preparation. 
Larger fat globules are more prone to coalescence due to changes in the MFGM 
(Mulder and Walstra, 1974) while small fat globules are more stable at high 
temperatures, enriching high-heat buttermilk in PL content (Gassi et al., 2008). Studies 
indicate that proteins and glycoproteins play a role in stabilization of fat globules by 
interrupting clustering (Shimizu et al., 1980). Removal of phopholipids’ polar heads 
diminished the stability of cream by coalescence of fat globules and promoting oiling-off. 
Shimizu et al. (1980) concluded that PLs interrupt coalesce by repulsive forces derived 
from the ionogenic groups of the phospholipids. According to Lopez et al. (2010a), 
glycolipids and glycoproteins are heterogeneously present in the MFGM among 
glycerophospholipids, contributing to the stabilization of globules. The liquid-ordered 
domains, lipid rafts, are devoid of carbohydrate–containing molecules and enriched in 
SM and cholesterol. Only the outer layer of the bilayer allows lateral plane movement 
(Lopez et al., 2010b) where SM may disengage from the MFGM throughout milk 
processing. On the other hand, similar phospholipid organization was seen in processed 
cream and native globules, indicating membrane component reorganization after drastic 
processing (Gallier et al., 2010a).  
The lower amounts of polar lipids in the first trials denote autooxidation of the 
polyunsaturated fatty acids during sample preparation or storage. The appearance of a 
polar peak, expected to be phosphatidyl acid (after the elution of SM) suggests 
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phospholipid degradation. LysoPC was not quantified in this research but in the literature 
more lysoPC is indicative of PC degradation during milk processing (Gallier et al., 
2010a). Moreover, Fong et al. (2007) reported levels of lyso-PE and lyso-PC even when 
lipids were stored at -80 ºC.  Gallier et al. (2010) concluded that milk processing leads to 
difference in phospholipid composition (Gallier et al., 2010a); however, her samples did 
not originate from the same milk line. Since polar lipids change as a function of the fat 
content, season, stage of lactation, feeding, and breed (Jensen, 2002; Bitman and Wood, 
1990), the absence of statistical differences in phospholipid concentration during milk 
processing might be a result of the effects discussed previously as well as the contribution 
of PL oxidation in our samples. 
4.   Changes in the Sulfhydryl (SH) and Disulfide (SS) Groups 
Thermal treatment is indirectly proportional to the amount of free sulfhydryl (SH) 
groups and directly proportional to the amount of disulfide (SS) groups. This study 
indicates that heat treatments such in UHT result in lower free sulfhydryl groups and 
therefore more disulfide-bonding indicative of protein interactions and denaturation. Cold 
pasteurization on the contrary has similar values to the ones observed in Fresh milk. An 
interesting finding is the higher amount of free SH and SS in 4 °C compared to Fresh 
milk. Cooling may promote the association between milk and whey proteins via other 
interactions besides covalent bonding, which may explain the higher free sulfhydryl 
groups present in storage milk. These interactions were strong enough to maintain protein 
association during MFGM extraction, especially in centrifugation for cream collection. 
During storage, milk is contantly agitated to prevent creaming, so this process introduced 
air bubbles in the milk, and thereby, promoted the formation of disulfide bonds from the 
oxidation of free sulfhydryl groups or from thiol-disulfide exchange reactions. It must be 
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emphasized that these observations are only preliminary studies with regard to SH and SS 
quantification. 
C. Effects of Milk Processing on the MFGM Proteins from 1DE Perspectives 
1.   Quantification of Protein Variation during Milk Processing 
The proteins of the milk fat globule fluctuate during milk processing; however, the 
introduction of milk and whey proteins is more pronounced. Thermal treatment resulted 
in the absorption of β-lactoglobulin as a function of heat intensity, as previously seen in 
literature (Fong et al., 2007). The amount of β-casein and α-lactalbumin in MFGM 
isolates also increased in heat-treated samples, especially in UHT milk. In the contrary, 
the amount of α-casein decreased in thermally treated milks, probably due to interactions 
with other proteins. Figure 43 illustrates the relative abundance of these proteins in the 
MFGM from SDS-PAGE densitometry (p < 0.0001). 
 
Figure 43. Fluctuation of milk and whey proteins in the MFGM during milk processing. 
Results obtained from SDS-PAGE densitometry (p < 0.0001, three independent 
trials, and three replicates). 
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Thermal treatment of milk can induce desorption of protein and lipids from the 
MFGM. The complex formed by β-lactoglobulin and κ-casein during heat treatment may 
displace the proteins from the MFGM (Houlihan et al., 1992). In fact, xanthine oxidase, 
butyrophilin, and ADFP are less abundant in UHT milk compared to the other treatments 
(Figure 44). These three proteins are the main MFGM proteins involved in fat globule 
excretion and are located within the trilayer, indicating complete disruption of the 
membrane during UHT pasteurization.  
 
Figure 44. Fluctuation of the main MFGM proteins during milk processing. Results obtained 
from SDS-PAGE densitometry (p < 0.0001, three independent trials, and three 
replicates). 
Other MFGM proteins such as MFG-E8, Mucin 15, annexin, and another protein with 
an apparent molecular weight of 69 kDa (denoted as X, Figure 45) fluctuate highly under 
intensive heat treatments. At this molecular weight, proteins such as serum albumin and 
heat shock cognate 71 kDa may be present; nevertheless, this band could encompass 
other proteins with similar weight. UHT causes the disappearance of Mucin 15, monocyte 
differentiaton antigen (CD14), and κ-casein in their apparent MW region while high 
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molecular weight bands are observed even in reducing conditions (Figure 32). Also, UHT 
milk depicted more streaking, which originates from polypeptides resulting from protein 
denaturation. 
 
Figure 45. Fluctuation of MFGM proteins during milk processing. Results obtained from 
SDS-PAGE densitometry. X unidentified protein band (p < 0.0001, three 
independent trials, and three replicates). 
2.   Identification of Proteins that Change in Milk Processing 
a)   Proteins in Globlal Composition 
Heat induces protein interactions and displacement as well as adsorption on the milk 
fat globule membrane (Singh, 2006; Evers, 2004a). LC/MS identified changes in the 
MFGM protein profile in each treatment and permitted the functional classification of 
these. From this work, the 100 identified proteins were categorized into 13 groups, with 
the lipid transport/metabolism as the highest section followed by the immunity & defense 
section (Figure 46). 
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Figure 46. Functional category assignments for identified proteins. A total of 13 categories 
were assigned based on information in Uniprot and NCBI. 
To better understand the changes that milk undergoes during regular milk processing, 
the frequency of proteins in eacth treatment was compared in each category. The 
following spider graphs represent a treatment for each angle, and only the proteins that 
showed variation are graphed. The protein probability is given as a percentage; this is a 
straightforward means to evaluate the relative abundance change of each protein for each 
processing treatment. The following graphs depict each group of proteins by function, 
and its variation given the processing steps. The categories for function are: 
• Lipid transport / metabolism (Figure 47) 
• Immunity / Defense (Figure 48) 
• Membrane / Protein trafficking (Figure 49) 
• G-protein mediated signaling (Figure 50) 
• Protein synthesis, binding and/or folding (Figure 51) 
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• Homeostatic regulators (Figure 52) 
General transporters, Cell Structure, Cell surface receptor mediated signal 
transduction, Milk proteins, Whey proteins, and Unknown function proteins are better 
understood in a table (Table 15). 
 
Figure 47. Variation of proteins involved in lipid tranport/metabolism during milk 
processing. BTN (Frag), Butyrophilin (Fragment); AUP-1, Ancient ubiquitous 
protein 1; LS, Lanosterol synthase; 17-b HSDH, 17-beta hydroxysteroid 
dehydrogenase; S-4-a-C-3-D, Sterol-4-alpha-carboxylate 3-dehydrogenase, 
decarboxylating; CYB5R3, CYB5R3 protein; LPAAT, Lysophosphatidic acid 
acyltransferase, zeta; AP E, Apolipoprotein E; LPL, Lipoprotein lipase; FABP 
(brain),  Fatty acid-binding protein, brain 
A total of 20 proteins involving lipid transport/metabolism were identified, but nine 
of them are present in all the samples with high probabilities including the two main 
MFGM proteins, XO and BTN. Mannose-6- phosphate receptor binding protein 1 was 
absent from UHT milk while CDEA protein, which plays a role in fat accumulation, had 
a low probability (16%) in the same sample. CIDEA also inhibits triglyceride hydrolysis 
and promotes lipid storage (Christianson et al., 2010). The remaining nine proteins 
fluctuated as indicated in Figure 47. More proteins are observed as thermal treatment 
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increases, indicating association of lipid transport/metabolism proteins during heating and 
explaining the higher levels of SH and SS groups observed in 4 ºC milk, which gradually 
decreases as heat intensity augments. 
Fourteen proteins associated with immunity and defense were identified, of which 
four are constantly present throughout milk processing such as MFG-E8 (lacthaderin), 
immunoglobulin receptor, and mucin 15. Cathelicidin-1, mucin-1, and immunoglobulin J 
chain disappeared in UHT milk. Six proteins varied among the treatments (Figure 48), 
including Annexin A1, a calcium-dependent membrane aggregatin protein that mediates 
inflammation (Perretti and D'Acquisto, 2009). The toll-like receptor 2, implicated in 
pathogen recognition, was uniquely present in HTST.  
 
Figure 48. Variation of proteins involved in immunity & defense during milk processing. 
ANX-A1, Annexin A1; IGK , IGK protein; GDCA, Glycosylation-dependent cell 
adhesion molecule 1; CD14, Monocyte differentiation antigen CD14; Ig ( λ ), 
Immunoglobulin light chain, lambda gene cluster; LPO, Lactoperoxidase. 
Proteins involved in membrane/protein trafficking were also a major group in the 
MFGM isolates. A total of 13 proteins were identified, including two Ras-related proteins 
(Rab-18 and Rab 11A) persistently observed in all the samples whereas three proteins 
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implicated in vesicular transport (SNAP23A and SAR1a) and late endocytic tranport 
(Rab-7a) were missing exclusively in the UHT milk. Seven proteins seem to fade in the 
thermal treatment, Batch and UHT (Figure 49). Ras-related protein Rab-8A was observed 
solely in Fresh milk. 
 
Figure 49. Variation of proteins involved in membrane protein trafficking during milk 
processing. YKT6, Synaptobrevin homolog YKT6; ADP-RF, ADP-ribosylation 
factor 1; STX3, STX3 protein; Rab-13, Ras-related protein Rab-13; R-ras, Related 
RAS viral (R-ras) oncogene homolog; Rab-5C, Ras-related protein Rab-5C; RAB35, 
RAB35 protein; Rab-8A, Ras-related protein Rab-8A. 
In the G-protein mediated cell signaling group, 11 proteins were identified including 
two subunits of the guanine nucleotide-binding protein G(I)/G(S)/G(T) constantly 
identified throughout milk processing and seven proteins that varied highly in all the 
samples with the exception of UHT milk where they were completely absent (Figure 50). 
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Figure 50. Variation in proteins involved in G-mediated cell signaling during milk 
processing. Ras-related C3, Ras-related C3 botulinum toxin substrate 1; Rap-1A, 
Ras-related protein Rap-1A; ADP-RF15, ADP-ribosylation factor-like protein 15; 
CDC42, CDC42 protein; NRAS, NRAS protein; RhoC, Rho-related GTP-binding 
protein RhoC; GNB G(i) a-1, Guanine nucleotide-binding protein G(i) subunit 
alpha-1. 
Nine proteins implicated in protein synthesis, binding, and/or folding were 
recognized, from which a fragment of a protein similar to peptidylprolyl isomerase A 
(cyclophilin A) was picked in all the samples. As in previous groups, UHT was depleted 
of many proteins observed in the other milk treatments (Figure 51). This data in 
conjuction with other analysis are indicative of protein denaturation and exclusion in the 
UHT MFGM isolate. The elongation factor 1-alpha1 was present almost exclusively in 
Fresh, but a low-probability is also seen in UV milk. The latter was also the host of DCK 
protein, which is a core component of nucleosome.  
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Figure 51. Variation of proteins involved in protein synthesis, binding, and/ or folding 
during milk processing. 15 kDa SP, 15 kDa selenoprotein; Cofilin 1, Cofilin 1 (Non-
muscle); HSC, 71 kDa, Heat shock cognate 71 kDa protein; RRL, Ribonucleotide 
reductase large subunit; HIST2H2BE, HIST2H2BE protein; Ankyrin, Ankyrin 
repeat domain 22; EF 1-a 1, Elongation factor 1-alpha 1; DCK , DCK protein. 
Homeostatic regulators were also identified in the MFGM isolates with high variation 
throughout milk processing (Figure 52). A total of seven proteins were detected. One of 
them, cytoplasmic aconitate hydratase, an iron sensor, was solely identified in Fresh milk. 
This group of proteins was more abundant in thermal treated samples.  
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Figure 52. Variation in proteins involved in homeostatic regulation during milk processing. 
cGMP II PK, cGMP-dependant type II protein kinase; PP1201, PP1201 protein; 
SDR-1, Dehydrogenase/reductase (SDR family) member 1; ANX A5, Annexin A5; 
SA, Serum albumin. 
The general transporter and cell structure groups are not illustrated in spider graphs, 
but less variation was observed in these proteins (Table 15). Only three proteins were 
associated with cell surface receptor mediated signal transduction, which are mainly 
present in Fresh and HTST milk. The milk proteins α-S1-casein, α-S2-casein, and κ-
casein were adsorbed onto the MFGM throughout milk processing. On the other hand, 
whey proteins, α-lactalbumin and β-lactoglobulin, were more abundant in intense 
thermal treatments such as HTST and UHT. Four proteins with unknown or unspecified 
roles were detected whereas Reinhard and Lipolis (2010) identified more than 20 proteins 
in this category, including MUC proteins, which in this research have been classified in 
the Immunity & Defense group. The fragment of β-lactoglobulin, enterotoxin-binding 
glycoprotein PP20K, was seen in thermally treated samples, and it has been shown that 
this protein binds to MFGM during heating (Shida et al., 1994). 
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b)  Proteins Identification in Molecular Weight Regions 
Four regions were analyzed in 1-DE gels that encompass a higher than 150 kDa 
(Region I), higher than 55 and less than 150 kDa (Region II), higher than 35 and less than 
55 kDa (Region III), and less than 35 kDa (Region IV).  In region I (Table 16), only three 
proteins with high molecular weight were observed, including XO (155 kDa), acetyl-CoA 
carboxylase 1 (265 kDa), and fatty acid synthase (275 kDa).  
 
Figure 53. Protein identified in region I (> 150 kDa). Molecular weight is shown in 
parenthesis. cGMP-PK (87), cGMP-dependant type II protein kinase; LP (81), 
Lactoperoxidase; Acyl-CoA Syn (78), Acyl-CoA synthetase long-chain family 
member 1; Na-DPTP, Sodium-dependent phosphate transport protein 2B; SA (69), 
Serum albumin; MA-b-LG (20), Major allergen beta-lactoglobulin; GDCAM-1 (17), 
Glycosylation-dependent cell adhesion molecule 1; FABP (15), Fatty acid-binding 
protein. 
The other 45 proteins have lower molecular weights than the expected region, 
indicating complex formations among them. Therefore, HTST and especially UHT 
produce more low-molecular weight proteins such as FABP, SA, PP20K extrinsic 
protein, and β-casein. UHT was exclusively enriched in lactoferrin, β-lactoglobulin, α-
lactalbumin in this region. Figure 53 illustrates some of proteins with high variation in 
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this region, embracing the homeostatic regular serum albumin and lactoperoxidase, an 
antimicrobial agent believed to protect cow’s udder from infection. 
In region II (Table 17), a total of 46 proteins were identified of which 22 proteins had 
a lower-molecular weight outside the range for this region. Figure 54 denotes some of the 
region two proteins that fluctuated during milk processing. The toll-like receptor 2 (TLR-
2) and alkaline phosphatase, an enzyme utilized to verify pasteurization, were identified 
specifically in this region in the HTST sample whereas cytoplasmic aconitate hydratase, 
an iron sensor, was exclusive to Fresh milk. As observed before, whey proteins were 
adsorbed onto UHT MFGM isolates.  
 
Figure 54. Protein identified in region II (>55 and < 150 kDa). Molecular weight is shown in 
parenthesis. GNBP-2 (37), Guanine nucleotide-binding protein G(I)/G(S)/G(T) 
 subunit beta-2; cGMP-KP (87), cGMP-dependant type II protein kinase; LS (83), 
Lanosterol synthase; ACR (55), Acetylcholine receptor subunit epsilon; 5'-Nase (63), 
5'-nucleotidase; Na+/Glu T (73), Na+/glucose cotransporter; BTN (F, 14), 
Butyrophilin (Fragment). 
Region III (Table 18) resulted in the recognition of 60 proteins, including nine and 
twelve outside the upper limit and lower limits, respectively. Seven proteins varied highly 
among the treatments and are shown in Figure 55. Phosphatidylinositol transfer protein 
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alpha form (32 kDa) was identified in this region in the 4 °C milk but was not picked in 
the global identification. CD14 was observed in thermally treated samples including 4 °C 
but not in Fresh and UV milks. 
 
Figure 55. Proteins identified in region III (> 35 and < 55 kDa). Molecular weight is shown in 
parenthesis. GNBP-11 (42), Guanine nucleotide-binding protein subunit alpha-11; 
S-4-a-CD (40), Sterol-4-alpha-carboxylate 3-dehydrogenase; GNAI2 (40), GNAI2 
protein; CD14 (40), CD14 protein; ANX- A2 (39), Annexin A2; ANX- A1 (39), 
Annexin A1; 17-b-HSD (38), 17-beta hydroxysteroid dehydrogenase; CYB5R3 , 
CYB5R3 protein; STX3, STX3 protein. 
Region IV (Table 19) resulted in 74 proteins mainly from protein denaturation and 
the recognition of polypeptides in this section. A total of 58 proteins were identified in 
the proper molecular weight.  
D. Effects of Milk Processing on the MFGM Proteins from 2DE Perspectives 
From the time milk leaves the cow udder, it undergoes changes in temperature as well 
as mechanical processing such as agitation and thermal treatment, causing interactions 
among MFGM, milk, and whey proteins. Using 2-DE gels coupled with MALDI-TOF, 
protein variation was observed along milk processing.  
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As the majority of the milk proteins have pI in the range of 4 to 7, a linear pH 3 to 10 
was expected to resolve more protein from the MFGM. Cooling is the least invasive 
process that influences the association of α- and β-casein to MFGM proteins as well as 
changes in butyrophilin and adipophilin. Cryatallization of the fat causes volume changes 
in the fat globules and thus renders the MFGM to the adsorption of other proteins as 
shown in Figure 56 (Dickow et al., 2011). BTN seems to be damaged more readily than 
other MFGM because it is exposed on the surface of fat globules due to its glycosylated 
nature (Dewettinck et al., 2008). Adipophilin on the other hand locates specifically 
within inner phospholipid layer of the MFGM, and variation can be ascribed to exposed 
monolayer regions as well as damaged bilayer (Robenek et al., 2006a). XO is embedded 
between the inner and bilayers, which may preclude denaturation due to milk processing. 
It cannot be ruled out that the protocol used in this analysis prevented the identification of 
XO. 
VI. CONCLUSIONS & LIMITATIONS 
In milk processing, the most abrupt thermal treatment can be considered UHT 
pasteurization since the intensity of the heat disturbs the native structure of fat globules 
and MFGM constituents. In fact, Christie et al. (1987) did not detect PLs in UHT 
powders, attributing such findings to autoxidation and the harsh treatment. Also, thermal 
treatment promotes fat globule aggregates as observed in previous studies (Gassi et al., 
2008). In this research, fewer aggregates were observed in non-thermal processes such as 
Fresh, 4 °C, and UV. Among these, Fresh resulted in the smallest globules, and thereby, 
was expected to be enriched in more polar lipids. The latter molecules remained 
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unaffected during milk processing, but these findings add to the plethora of conflicting 
PL research that attempted to characterize the effect of thermal treatment on polar lipids. 
 
Figure 56. Milk processing effects on milk fat globules and milk fat globule membrane 
proteins. Globules are smaller in Fresh milk, and as processing proceeds, some 
triacylglycerides are released in cooling as well MFGM membrane. Thermal 
treatment enhances rearrangements between proteins and lipids of the membrane 
and promotes aggregation of globules and vesicle formation. Casein micelles and 
whey proteins are the main proteins that are adsorbed to the globule surface. 
Even though the procedure utilized in this research was not the exact UHT protocol, 
the environment was simulated enough to observe reactions. In real UHT milk, 
mechanical stress also plays a role in milk processing and probably adds to the effect of 
heat treatment. In general, it can be stated that as the intensity of heat increases, more 
milk and whey proteins absorbed onto the milk fat globule membrane and augmented 
MFGM proteins displacement. In addition, a decrease in the amount of free sulfhydryl 
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(SH) and an increase in disulfide bonds (SS) in the line production of milk correlates with 
protein interactions. Even cooling promoted the association of proteins, probably through 
hydrophobic bonding, contributing to the amount of SH and SS levels. Figure 56 
represents the main effects of milk processing on the milk fat globule membrane as milk 
proceeds in the dairy industry from the dairy unit, cooling, and thermal treatment. 
In summary, pulsed UV light is clearly effective in inactivating microorganisms in 
vitro, but its potential in real foods and efficacy still need research despite the minimal 
effects observed in this study. Further research to separate MFGM from milk sources is 
also necessary (Singh, 2006); however, this task will not be easy as MFGM is sensitive to 
processing and handling. Nevertheless, with our findings it can be concluded that HTST 
milk is an optimal source of MFGM to supplement formulated foods that attempt to 
satisfy consumer’s expectation of health-oriented and nutritious food products. 
VII. DIRECTIONS FOR FUTURE RESEARCH 
The interaction between polar lipids and proteins are important aspects of the MFGM 
that deserve more research in order to help us understand their functions (Gubbens et al., 
2009). Characterizing the alterations of these molecules during the regular path that milk 
takes from the dairy unit to our table is even more important to help us establish 
parameters that will preserve the integrity of polar lipids and proteins that have been 
ascribed with health-promoting effects. Another process to consider in milk production is 
spray-drying, as milk powder is the most common source of milk in developing 
countries, and so, the need to preserve the MFGM is also required. As Fong et al. (2007) 
suggested, some MFGM proteins may be used as alternates to synthetic anti-bacterial and 
anti-viral agents on top of their use as supplements; however, further work is required on 
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the optimization of food-grade downstream production processes for MFGM isolates that 
results in products similar to native state (El-Loly, 2011) and thereby allowing us to 
benefit from the effects that neonates received in milk. 
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IX. APPENDIX 
A. Protocols for Buffers 
All the reagents were of analytical grade and kept at room temperature unless 
otherwise stated. With regard to 2D protein analysis, reagents were of electrophoresis 
purity grade. Nanopure water of 18MΩ/cm2 was utilized to make solutions. 
1.   10X Phosphate Buffer Saline (PBS) 
To make a 10X stock solution, 87 g of NaCl, 18.2 g of K2HPO4, and 2.3 g of KH2PO4 
were placed into a one-liter bottle and filled with deionized water up to 900 mL.  The 
solutes were dissolved completely, and the pH was adjusted with 1N NaOH to 7.2. Then, 
the final volume was adjusted to one liter using a graduated cylinder.  
2.   Formic Acid Buffer 
A 1M formic acid (06440, Fluka) buffer was made and neutralized with triethylamine 
(TEA) (HPLC grade, 04884, Fisher Scientific) to a final pH of 3. In a small beaker, 80% 
of the final buffer volume was placed with nanopure water. The 1M formic acid was 
made by adding the equivalent concentrated formic acid (Vi= (CfxVf)/Ci   i=initial, f=final) 
followed by dropwise addition of TEA. Neutralization point was checked with litmus 
paper, and for the final pH, a small volume was measured with a pH meter to avoid 
introducing contamination. The buffer could be used for one week.  
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3.   2-DE-gel Buffers 
a)   Homogenization Buffer 
This was a 7M urea, 2M thiourea, 1% ASB-14, 40mM Tris base, 0.001% 
bromophenol blue, 0.5% ampholyte and 40mM DTT.  Reagents were purchased from 
BioRad unless indicated. In a 250 mL beaker, 42g of urea (161-0731), 15.2g of thiourea 
(T8656, Sigma-Aldrich, MO), 0.484g of Tris base (161-0719), 1 g of amidosulfobetaine-
14 (ASB-14) (182750, Calbichem), and 1 mL of 0.1% bromophenol blue were combined.  
The solution’s volume was brought up to 100 mL with nanopure water and stored at 4ºC.  
Immediately before use, 6mg dithiothreitol (DTT, 161-0611) and 5µl immobilized pH 
gradient (IPG) buffer pH 3-10 (17-6000-87, GE Healthcare, NJ) were added per mL of 
working homogenization buffer. ASB-14, bromophenol blue, DTT, and IPG buffer were 
kept at 4ºC. 
b)   Immobilized pH Gradient (IPG) Rehydration Buffer 
This was a 7M urea, 2M thiourea, 2% CHAPS, 2% NP-40, 0.002% bromophenol 
blue, 0.5% ampholyte and 100mM DTE.  In a 200 mL beaker, 42.4g of urea, 15.2g 
thiourea, 2 mL 100% nonidet P-40 (Fluka), 2.0g CHAPS (C3023, Sigma-Aldrich, MO), 
0.5 mL 0.1% Bromophenol Blue. The volume was brought up to 100mL with nanopure 
water, and the solution was filtered with a 0.2 micron filter. The final solution was stored 
at 4ºC, and before use, 20mg dithioerythritol (DTE, D8255, Sigma-Aldrich, MO) and 
6.25ul IPG buffer pH 3-10 were added per 1.25 mL of rehydration buffer. DTE was kept 
at -20 ºC. 
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c)   Equilibration Buffer 
This was a 375mM Tris pH 8.8, 6M urea, 30% glycerol, 2% SDS, 0.002% 
bromophenol blue. In a 400 mL beaker, 50 mL of 1.5M Tris-HCl, pH8.8 (161-0798), 72 
g urea, 60 mL 99% glycerol (BP229, Fisher Scientific), 20 mL 20% SDS (161-0418), and 
400 µL 0.1% bromophenol blue were combined. The volume was brought up to 200mL 
with nanopure water, and the solution was stored at 4 ºC. To make working equilibration 
buffer, the solution was brought to room temperature, and 250 mg of DTT and 625 mg of 
iodoacetamide (163-2109) were added to 25 mL of equilibration buffer in separate tubes. 
d)  10X SDS-PAGE Running Buffer 
In 1L bottle, 50mL of 20% SDS, 30g of Tris-base, and 144g of glycine were mixed 
and dissolved with nanopure water to fill one liter. The solution was stored at 4ºC. 
e)   Molecular Weight Standards for 2-D gels 
All the reagents were molecular grade from BioRad and kept at 4 ºC unless otherwise 
stated. An aliquot of 950 µL of Laemmli sample buffer (161-0737), 50 µL of beta-
mercaptoethanol, and 27 µL of SDS-PAGE molecular weight standards low range (161-
0304, stored at -20ºC) were combined. Aliquots of 40µL were kept in microcentrifuge 
tube and stored at -20ºC. To load gels, an aliquot was heated at 100ºC for 3 min, and 5 µL 
of standard solution was pipetted onto a Biorad IEF electrode wick square (165-4071) 
placed over parafilm. The wicks were dried completely before placing in cassettes. 
f)   Agarose (0.8%)  
This was a 25 mmol/L Tris-base, 192 mmol/L glycine, 0.1% SDS. In a 250mL 
Erlenmeyer flask, 0.8g of low melt agarose (161-3111), 100 mL of 1x running buffer, and 
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300 µL of 0.1% bromophenol blue were mixed and heated in a microwave. Once the 
agarose melted, it was stored at -20ºC. The agarose was reheated for gel electrophoresis 
and allowed to cool to 40-50ºC before loading over the IPG strips. 
g)   10% TCA/Acetone 
In a beaker, 20 g of trichloroacetic acid (TCA, BP555, Fisher Scientific) was placed 
into 100 ml of 100% acetone and dissolved completely. The volume was then adjusted 
with a graduated cylinder up to 200 ml with more 100% acetone and stored at -20 °C. 
h)   Bromophenol Blue (0.1%) 
In a 250 mL Erlenmeyer flask, 0.61g of Tris base was added to 100ml nanopure water 
and mixed with a stir bar until dissolved. Then 0.1g of bromophenol blue was added and 
stirred until completely solubilized. Solution was kept at 4 °C. 
4.   SDS-PAGE Gel Preparation 
All the reagents were of electrophoresis purity grade from BioRad and stored at room 
temperature unless indicated. To make 12 gels at 12.5% acrylamide, 120mL of milliQ 
H2O, 58.5mL of 1.5M Tris-HCl pH 8.8, 75mL of 40% acrylamide/bisacrylimide solution 
(161-0148, stored at 4 ºC), and 1.463 mL of 20% SDS were combined in a 500 mL 
Erlenmeyer vacuum flask. This solution was de-gassed for about 15 min with a vacuum 
pump.  A solution of 10% ammonium persulfate (APS) (161-0700) was prepared by 
dissolving 0.10g of APS into 1.00mL of MilliQ water. Once degassed, 675µl of the 10% 
APS solution, the catalyst, and 292.5µL of tetramethylethylenediamine (TEMED, 161-
0801, kept at 4 ºC) were added to polymerize the gels. To remove bubbles and smooth 
the surface, 95% isopropanol was added to the top of the gels with a glass Pasteur pipette. 
Gels were set on a leveled surface for 30 min, and the ethanol was decanted off top. The 
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gels were then rinsed with nanopure water and dried before placing the equilibrated IPG 
strips. 
5.   Sensitive Colloidal Staining Solution 
This was a 34% (v/v) methanol, 3% (v/v) phosphoric acid, 17% (w/v) ammonium 
sulfate. In a 1L bottle, 400 mL of water and 30 mL of 85% H3PO4 were mixed. Then, 170 
g of (NH4)2SO4  were added to the solution slowly. If (NH4)2SO4  is added too quickly, it 
becomes granulated and hard to dissolve. Once all the (NH4)2SO4 was dissolved, 340 mL 
of methanol were added slowly to prevent localized precipitation of (NH4)2SO4. Once the 
solution was homogenous, the volume was adjusted to one liter.  
6.   Protein Extraction Buffers for MALDI-TOF 
Reagents were of LC/MS grade and kept at room temperature.  Glassware was used 
Small beakers cleaned well and rinsed with the appropriate solvent. 
a)   Destaining Buffer (25mM NH4HCO3/50% acetonitrile)  
In a 50ml beaker, 0.059 g of NH4HCO3 was added to 15mL of 100% acetonitrile. The 
volume was adjusted to 30mL by adding 15mL HPLC grade water. 
b)   Analyte Solution (0.1% TFA/ Acetonitrile 2:1) 
First a 0.1% TFA solution was prepared by adding 20µL of TFA (kept at -20 C) to 20 
mL of HPLC Grade Water (W5-4, Fisher Scientific). Then, the analyte solution was 
prepared by adding 10 mL of 0.1%TFA and 5 mL of acetonitrile. The solution was mixed 
in a glass beaker rinsed with acetonitrile. 
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c)   Promega Mass Spectrometry Grade Porcine Trypsin Gold 
Aliquots of Promega V5280 trypsin (100ug/vial) were prepared and stored at -70ºC.  
First, 50 mM acetic acid was made by diluting 29 µL of concentrated acetic acid to 10 
mL with HPLC grade water in a graduated cylinder. Then, 100 µL of this solution was 
added to the vial containing the powdered trypsin. Then, the trypsin solution was mixed 
and put in 5 µL aliquots. To prepare working trypsin solution, a 40 mM NH4HCO3/10% 
acetonitrile solution was prepared by dissolving 31.6 mg of NH4HCO3 into 9 mL of 
HPLC Grade water in a graduated cylinder followed by the addition of one mL of 
acetonitrile. Before digestion, an aliquot was thawed, and 450 µL of 40mM 
NH4HCO3/10% acetonitrile were added for a final 165µg/15µL trypsin concentration per 
well. 
d)   Mass Spectrometry Peptide Standard 
Aliquots of Peptide Calibration Standard (206195, Bruker Corp.) were prepared by 
adding 0.1%TFA/water. First, 2mL of HPLC grade water was measured in a graduated 
cylinder, and 2 µL of TFA were added. The peptide mixture was dissolved completely in 
125 µL of 0.1%TFA/water, and 5µL aliquots were stored at -70ºC.  
e)   Matrix Solution (0.2mg HCCA/mL 0.1%TFA/ Acetonitrile) 
In a 1.5mL Eppendorf tube, 0.2mg of α -hydroxycyanocinnamic acid (HCCA, 201344 
mass-spectrometry grade, Bruker Corp., stored at -20ºC) was measured, or enough 
powder was put in the tube to fill up to the bottom line. To acidify HCCA, 50 µL of 0.1% 
TFA was added and mixed. Then, 950 µL of LC/MS grade acetonitrile was added and 
vortexed until HCCA was in solution. 
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f)   Wash Buffer (10mM Ammonium Phosphate in 0.1%TFA) 
In a 50mL beaker, 20 µL of TFA (kept at – 20°C was added to 20 mL of HPLC water. 
Then, 5.75mg of NH4H2PO4 was added to 5 mL of 0.1% TFA. The beaker was rinsed 
with HPLC water.   
g)   Recrystalization Buffer (Ethanol/acetone/0.1% TFA, 6:3:1 v/v/v)  
This buffer must be prepared right before use (at the most five min). In a 50ml glass 
beaker rinsed with ethanol, 6mL of ethanol, 3mL of acetone, and 1mL of 0.1%TFA were 
combined. 
h)   Tris-glycine buffer 
This was a 91.9 mM glycine, 4 mM EDTA. In a 1L bottle, the Tris-glycine buffer was 
prepared by adding 10.4 g of Tris (hydroxymethyl) aminomethane and 1.2 g of EDTA in 
nanopure water. The pH was adjusted to 8, and the final volume to one liter. 
i)   Tris-glycine/8M urea/ 17mM SDS buffer 
This was a 91.9 mM glycine, 4 mM EDTA, 8M urea, 17mM. To a liter of Tris-
glycine buffer, 480.5 g of urea was added and allowed to dissolve completely before 
adding 5 g of SDS.  
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B. Microbial Reduction 
Table 24. Microbial reduction in heat and cold pasteurization. Aerobic and coliforms 
petrifilms were incubated for 48 and 24 hrs respectively. 
  CFU/mL % Reduction 
Process Aerobic  Coliform Aerobic  Coliform 
Raw 7.43E+04 174 0 0 
5ml,2s 4.15E+04 153 44 12 
7ml,2s 4.80E+04 151 35 13 
7ml,3s 5.30E+04 148 29 15 
7ml,5s 5.25E+04 140 29 20 
7ml,7s 5.15E+04 140 31 20 
7ml,9s 5.35E+04 135 28 22 
10ml,5s 6.85E+04 146 8 16 
Batch 2.65E+02 0 100 100 
HTST 1.05E+02 0 100 100 
UHT 0 0 100 100 
 
Table 25. Microbial reduction in UV pulsed light treatment. Aerobic and coliform petrifilms 
were incubated for 48 and 24 hrs respectively. 
 CFU/mL % Reduction 
Process Aerobic Coliform Aerobic Coliform 
Raw 6.40E+05 565 0 0 
5ml,5s 4.25E+05 270 34 52 
7ml,2s 4.95E+05 330 23 42 
7ml,3s 3.65E+05 330 43 42 
7ml,5s 1.95E+05 320 70 43 
7ml,7s 4.15E+05 390 35 31 
7ml,9s 3.25E+05 380 49 33 
10ml,5s 5.55E+05 380 13 33 
 
C. MFGM Extraction 
Table 26. MFGM material (pellet) from samples. 
MFGM Trials, pellet mg per liter of milk  
Treat I II III IV Mean 
Fresh 350 325 322 261 315a 
4C 328 343 273 257 300a 
Batch 262 311 208 229 252a,b 
HTST 194 223 184 275 219b,c 
UHT 160 208 167 150 171c 
UV 338 329 274 239 295a 
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D. MFGM Protein Quantification 
Table 27. Effect of milk processing on MFGM proteins. 
Protein Trials, mg per 100 mg of MFGM pellet   
Treat II III IV Mean ± STD 
Fresh 13.28 11.56 15.18 13.34 ± 1.81 
 4 °C 13.04 14.64 14.68 14.12 ± 0.93  
Batch 17.90 17.08 15.86 16.95 ± 1.03 
HTST 17.89 17.83 17.27 17.66 ± 0.34 
UHT 16.35 19.83 15.45 17.21 ± 2.31 
UV 14.55 14.51 15.93 15.00 ± 0.81 
 
E. Milk Composition 
Table 28. Milk composition for each independent trial. 
g/100 mL milk  
MP 
 
Treat Fat Prot Cas Citric Lac TS SNF 
Acidity 
°TH 
Urea 
mg/dL 
Density 
SG 
FPD 
mC 
FFA 
mEkv/l 
II Fresh 4.29 3.49 2.60 0.18 4.74 13.55 9.11 16.63 385.00 1028.47 516 0.313 
 4-C 4.01 3.33 2.42 0.18 4.79 13.15 9.01 15.83 328.00 1028.33 520 0.403 
 Batch 4.11 3.43 2.59 0.18 4.94 13.49 9.25 15.29 360.67 1029.67 533 0.514 
 HTST 4.00 3.33 2.47 0.18 4.79 13.13 9.01 15.87 346.67 1028.33 518 0.405 
 UHT 4.03 3.39 2.71 0.19 4.81 13.25 9.09 16.14 479.33 1028.80 532 0.261 
 UV 3.98 3.34 2.46 0.18 4.81 13.12 9.03 15.46 354.00 1028.73 517 0.519 
III Fresh 2.99 3.14 2.29 0.19 4.84 11.92 8.49 15.86 338.00 1028.10 512 0.240 
 4-C 4.03 3.30 2.39 0.18 4.71 13.07 8.90 15.72 305.00 1027.90 507 0.386 
 HTST 3.69 3.03 2.06 0.17 4.35 12.05 8.23 14.80 283.50 1025.30 455 0.353 
 Batch 4.05 3.35 2.48 0.19 4.79 13.22 9.03 15.67 328.00 1028.65 515 0.432 
 UHT 4.13 3.39 2.60 0.20 4.74 13.29 9.00 15.51 399.50 1028.90 521 0.292 
 UV 3.99 3.33 2.45 0.18 4.73 13.06 8.93 15.57 317.00 1028.25 507 0.488 
IV Fresh 4.19 3.41 2.50 0.15 4.76 13.35 9.03 16.39 372.50 1028.65 520 0.328 
 4-C 3.70 3.41 2.49 0.16 4.79 12.90 9.05 16.04 329.50 1029.00 514 0.562 
 Batch 3.69 3.43 2.55 0.16 4.85 12.95 9.13 15.93 352.00 1029.45 519 0.606 
 HTST 3.95 3.40 2.53 0.16 4.77 13.15 9.04 16.39 352.00 1028.90 514 0.558 
 UHT 3.67 3.40 2.65 0.17 4.69 12.75 8.92 15.85 432.50 1028.85 511 0.420 
 UV 3.73 3.42 2.55 0.16 4.79 12.94 9.06 16.10 325.00 1029.18 515 0.597 
MP, milk processing (trial); Prot, protein; Cas, casein; Citric, citric acid; Lac, lactose; 
 TS, total solid; SNF, solid nonfat; FPD, freezing point depression; FFA, free fatty acid;  
°TH, Thorner degrees; SG, specific gravity; mEkv/l, milliequivalents/l 
S/•(N), standard deviation of the mean, which was calculated from three independent trials 
Subscripts within a column indicate statistically significant values (p< 0.05) 
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F. Phospholipids in the MFGM  
Table 29. Phospholipid content+ indicated as mg of phospholipid per gram of milk 
Treatment, mg PL per gram of milk  
Trial 
 
PL Fresh 4C Batch HTST UHT UV 
II PE 3.04 ± 0.06 1.83 ± 0.04 3.14 ± 0.04 2.68 ± 0.06  3.55 ± 0.07  2.38 ± 0.04 
 PI 0.47 ± 0.02 0.41 ± 0.02 0.62 ± 0.01 0.34 ± 0.02 0.48 ± 0.01 0.80 ± 0.09 
 PS 0.04 ± 0.01  0.02 ± 0.01 0.03 ± 0.02 0.04 ± 0.01 0.02 ± 0.01 0.11 ± 0.09 
 PC 5.49 ± 0.04  5.59 ± 0.18 6.18 ± 0.06 5.80 ± 0.05 6.52 ± 0.17 6.91 ± 0.41 
 SM 6.96 ± 0.16 6.47 ± 0.12 7.65 ± 0.36 7.75 ± 0.15 7.30 ± 0.21 8.71 ± 0.36 
        
III PE 3.01 ± 0.07  2.15 ± 0.11 2.06 ± 0.06 3.39 ± 0.14 3.43 ± 0.04 1.90 ± 0.13 
 PI 0.82 ± 0.05 0.63 ± 0.01 0.65 ± 0.05 0.51 ± 0.10 0.58 ± 0.10 0.77 ± 0.10 
 PS 0.50 ± 0.03 0.08 ± 0.00 0.06 ± 0.0 0.12 ± 0.05 0.07 ± 0.0 0.17 ± 0.01 
 PC 4.59 ± 0.15 6.64 ± 0.09 6.92 ± 0.28 6.70 ± 0.21 7.52 ± 0.07 6.82 ± 0.25 
 SM 7.44 ± 0.17 8.61 ± 0.22 8.27 ± 0.25 8.07 ± 0.14 8.59 ± 0.09 8.57 ± 0.22 
        
IV PE 4.61 ± 0.31 2.69 ± 0.04 2.99 ± 0.02 2.89 ± 0.03 2.05 ± 0.03 0.72 ± 0.02 
 PI 0.42 ± 0.0  0.41 ± 0.01 0.39 ± 0.01 0.46 ± 0.01 0.47 ± 0.00 0.41 ± 0.01 
 PS 0.02 ± 0.01 0.28 ± 0.02 0.26 ± 0.01 0.18 ± 0.01 0.12 ± 0.01 0.05 ± 0.0 
 PC 5.09 ± 0.52 3.13 ± 0.04 2.83 ± 0.10 3.49 ± 0.00 3.60 ± 0.03 2.94 ± 0.01 
 SM 5.48 ± 0.38 3.86 ± 0.06 3.62 ± 0.04 4.33 ± 0.07 4.74 ± 0.02 3.63 ± 0.03 
+ Mean and standard deviation of three HPLC measurements 
 
 
 
Table 30. Polar lipids quantification in milk during processing (trials II & III).                           
Polar lipids, mg per 100 g of milk  
Treat PE PI PS PC SM Total 
Fresh 3.02 0.64 0.27 5.04 7.20 16.18 
4°C 1.99 0.52 0.05 6.12 7.54 16.22 
Batch 2.60 0.64 0.05 6.55 7.96 17.79 
HTST 3.03 0.43 0.08 6.25 7.91 17.70 
UHT 3.49 0.53 0.05 7.02 7.95 19.04 
UV 2.14 0.79 0.14 6.87 8.64 18.58 
S/SR(N) 0.31 0.07 0.08 0.39 0.41 0.83 
S/•(N), standard deviation of the mean, which was calculated from two independent trials 
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Table 31. Polar lipid quantification in milk during processing (trials II, III, and IV). 
Polar lipids, mg per 100 g of milk  
Treat PE PI PS PC SM Total 
Fresh 3.55 0.57 0.19 5.06 6.62 15.99 
4°C 2.22 0.48 0.13 5.12 6.32 14.27 
Batch 2.73 0.55 0.12 5.31 6.51 15.22 
HTST 2.99 0.44 0.11 5.33 6.72 15.58 
UHT 3.01 0.51 0.07 5.88 6.88 16.35 
UV 1.67 0.66 0.11 5.56 6.97 14.97 
S/SR(N) 0.44 0.06 0.08 0.54 0.44 1.23 
S/•(N), standard deviation of the mean, which was calculated from three independent trials 
 
 
 
Table 32. Phospholipids in total lipids (mg/100 g total lipids). 
Treatments mg PL per 100 gram total lipids  
Trial 
 
PL Fresh 4C Batch HTST UHT UV 
II PE 71.97 44.72 74.87 66.46 87.01 59.45 
  PI 11.08 10.11 14.76 8.48 11.89 20.04 
  PS 0.92 0.58 0.82 1.08 0.41 2.78 
  PC 129.88 136.33 147.31 144.00 160.06 172.53 
  SM 164.64 158.01 182.55 192.34 179.00 217.40 
  Total 378.49 349.75 420.31 412.35 438.38 472.20 
III PE 104.28 53.66 51.16 90.82 83.69 47.85 
 PI 28.34 15.65 16.24 13.69 14.07 19.37 
 PS 17.48 1.95 1.40 3.11 1.81 4.39 
 PC 159.35 165.57 171.83 179.60 183.45 172.11 
 SM 258.08 214.47 205.36 216.44 209.54 216.05 
 Total 567.52 451.30 445.99 503.65 492.56 459.76 
IV PE 113.71 74.73 83.08 74.63 57.01 19.89 
 PI 10.38 11.31 10.80 11.75 13.02 11.29 
 PS 0.57 7.89 7.26 4.53 3.42 1.41 
 PC 125.52 87.06 78.60 89.98 99.86 81.59 
 SM 135.04 107.48 100.36 111.76 131.43 100.79 
 Total 385.23 288.47 280.09 292.66 304.74 214.96 
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 Table 33. Polar lipids quantification in cream during processing (trials II & III).                           
Polar lipids, mg per 100 g of total lipids  
Treat PE PI PS PC SM Total 
Fresh 88.13 19.71 9.20 144.61 211.36 224.91 
4C 49.19 12.88 1.26 150.95 186.24 128.41 
Batch 63.02 15.50 1.11 159.57 193.95 96.16 
HTST 78.64 11.08 2.09 161.80 204.39 93.36 
UHT 85.35 12.98 1.11 171.76 194.27 97.55 
UV 53.65 19.70 3.58 172.32 216.73 101.58 
S/•(N), standard deviation of the mean, which was calculated from two independent trials 
 
 
G. SH & SS Quantification 
Table 34. Effect of heat treatment on the amounts of free and total sulfhdryl (SH) and 
disulfide (SS) groups in the milk fat globule membrane. 
µmol per gram of protein  
Sample FreeSH TotalSH SS 
Fresh 52.94b 153.78b 50.42c 
4 °C 71.40a 298.98a 113.79a 
Batch 37.73c 206.92b 84.60b 
HTST 31.86c 159.14b 63.64b 
UHT 19.04d 280.98a 130.97a 
UV 53.39b 179.16b 62.88b,c 
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H. Particle Size Analysis 
 
Figure 57. Fat globule (FG) size distribution of 40% cream as a function of particle diameter 
(µm). Data for Trial III. 
 
 
Figure 58. Fat globule (FG) size distribution of 40% cream as a function of particle diameter 
(µm). Data for Trial II.  
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I. SDS-PAGE Quantification 
Table 35. Quantification of MFGM proteins by SDS-PAGE densitometry.  
Relative Concentration (Intensity x mm )+  
Band # Fresh 4°C Batch HTST UHT UV STD 
308 2707       
284 4743 4834      
252 10796 5580 7794 9813   1690 
217 10506 6181 5999 5540 35239 21148  
181 10370 12283 11782 13813 16848 10837 1228 
174 9340 10978    18197  
151 89227a 92421a 82725a 84773a 19588b 84899a 3413 
140 14169 13844 8301 10534 10270 11204 1471 
131 9620 5167 3313 4826  6327 1199 
124     6532   
120 6508 6327 4703 6827 ND 5590 859 
110   3025   2817  
106   2162     
101 1636 1392 1802 1335  1975 200 
89-87 7530 2729 12864 6481 4066 1226 1360 
80 13363 12493    15980 2947 
76-77  19139 14721 8896 12925 12913 4095 
70 45472a 58776a 60092a 49616a 5132b 53127a 4085 
63 12984 17455 18158 17058 ND 16307 5114 
59 107741a 116856a 104980a 113828a 51726b 104538a 4420 
55-56 21114 16874 14302 6929 3810 9062 3455 
53 6296 4979 8867 13673 16791 4846 2968 
51-52 38187a 49789a 43582a 48326a 7457b 43408a 3220 
49-50 19506a 26504a 20307a 25785a 2900b 23182a 1734 
41-43 2905 8350 5819 4957  13441 2256 
39+ 20923a 22870a 6745b 7225b 20640a 13094ab 2149 
38 21746a 17659b 6059c 6834c  14004b 605 
33-34 6650 6445 5267 6044 7977 5623 579 
31 3057 3539 5951 3791  3046 1595 
29   8347 6193    
25-26 9695c 15745bc 26934b 13215c 60784a 12751c 3466 
21-22++ 13307a 11312a,b 4982bc 6010abc 2378c 11182ab 1577 
20 9737 6872 8017 7335  7682 751 
18 7978c 5168c 45421b 44815b 90121a 4391c 6805 
13 17031bc 17935b,c 25333b 21306bc 40186a 10577c 2833 
10 6424 8859 9542 4586 6860 17465 3577 
Relative concentration is the band trace, which is determined by peak intensity and band length 
Band number indicates the MW 
Groups within a row are statistically different, p <0.000. + p <0.001, ++ p<0.004.  
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J. 1DE & Mass Tandem Spectrometry  
LC/MS data from 1DE was analyzed using Scaffold (TM). The Scaffold’s settings were 95% probability, min 2 peptide, and 70% 
peptide coverage. The analysis resulted in 123 identified proteins from which 100 have been identified, and the rest are 
uncharacterized proteins. Tables 38 and 39 show the results as the percent protein probability, peptides recognized, and peptide 
coverage. Table 40 presents the functional classification of MFGM proteins. 
Table 36. LCMS results for Fresh, 4 C, and Batch treatments. 
Fresh 4 ºC Batch Accession Number 
 
MW 
 
Identified Proteins* 
 Pro Pep %C Pro Pep %C Pro Pep %C 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member A1  100 73 72 100 54 65 100 42 53 
PLIN2_BOVIN 49 Perilipin-2  100 66 83 100 55 71 100 50 77 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase  100 84 59 100 80 55 100 67 50 
Q3T0K7_BOVIN 48 MFGE8 protein  100 23 51 100 19 48 100 20 46 
ABCG2_BOVIN 73 ATP-binding cassette sub-family G member 2  100 19 29 100 15 21 100 9 9 
PIGR_BOVIN 82 Polymeric immunoglobulin receptor  100 10 19 100 14 19 100 20 25 
FABPH_BOVIN 15 Fatty acid-binding protein, heart  100 16 86 100 15 75 100 14 68 
CD36_BOVIN 53 Platelet glycoprotein 4  100 9 15 100 7 12 100 6 12 
RAB18_BOVIN 23 Ras-related protein Rab-18  100 12 60 100 11 57 100 11 60 
CASK_BOVIN 21 Kappa-casein 98 1 5 100 4 24 100 5 23 
Q0VCZ8_BOVIN 78 Acyl-CoA synthetase long-chain family member 1  100 10 17 100 11 19 100 3 9 
CASA1_BOVIN 25 Alpha-S1-casein  100 6 31 100 8 37 100 5 29 
A1L528_BOVIN 23 RAB1A, member RAS oncogene family  100 5 31 100 10 63 100 9 55 
Q3T101_BOVIN 25 IGL@ protein  100 5 26 100 8 38 100 7 39 
ACACA_BOVIN (+1) 265 Acetyl-CoA carboxylase 1  100 8 5 100 3 2 100 5 3 
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Fresh 4 ºC Batch Accession Number 
 
MW 
 
Identified Proteins* 
 Pro Pep %C Pro Pep %C Pro Pep %C 
Q861V9_BOVIN 16 Similar to peptidylprolyl isomerase A (Cyclophilin A) (Fragment)  100 6 33 100 7 67 100 2 15 
GBB2_BOVIN 37 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2  100 7 24 100 3 10 100 3 12 
ENPP3_BOVIN 100 Ectonucleotide pyrophosphatase/phosphodiesterase family member 3  100 6 9 100 6 9 100 3 5 
FAS_BOVIN 275 Fatty acid synthase  100 4 3 100 4 2 100 2 1 
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin 73 1 8 100 2 19 100 10 68 
NPT2B_BOVIN 76 Sodium-dependent phosphate transport protein 2B  100 14 17 100 8 13 100 6 10 
A6QNZ7_BOVIN (+1) 55 Keratin 10 (Epidermolytic hyperkeratosis; keratosis palmaris et plantaris) 100 5 9 100 6 8 71 1 2 
A4FV94_BOVIN 61 KRT6A protein  73 1 4 100 2 5.4 79 1 2 
CASA2_BOVIN 26 Alpha-S2-casein  73 1 4 100 2 9 100 2 9 
GBB1_BOVIN (+1) 37 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1  100 4 23 83 1 10 83 1 7 
A5D7M6_BOVIN (+2) 63 KRT5 protein  99 2 4 100 3 6    
A7E340_BOVIN (+2) 36 Mucin 15, cell surface associated  58 1 3 71 1 3 79 1 3 
RB11A_BOVIN (+1) 24 Ras-related protein Rab-11A  100 3 16 99 2 11 100 3 16 
A6H7J7_BOVIN 25 Putative uncharacterized protein 73 1 30 73 1 41 100 2 30 
ACTB_BOVIN (+3) 42 Actin, cytoplasmic 1 100 4 15 100 2 7 100 3 10 
A8E4P3_BOVIN 31 STOM protein  100 9 32 100 7 31 100 4 18 
A4FUX1_BOVIN 25 CIDEA protein  100 3 22 100 5 27 100 3 22 
Q9TSF1_BOVIN 14 Butyrophilin (Fragment)  42 1 62 98 1 31 97 1 45 
GNAS2_BOVIN 46 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short  100 2 5 73 1 3 83 1 3 
Q2T9M8_BOVIN 23 Synaptosomal-associated protein 23 isoform SNAP23A  100 5 34 100 5 34 99 2 18 
Q0IIA4_BOVIN 59 Glycoprotein 2 (Zymogen granule membrane)  100 9 20 100 11 22 100 8 16 
CTHL1_BOVIN 18 Cathelicidin-1  100 3 27 100 7 44 100 2 23 
A5D7Q2_BOVIN 52 Putative uncharacterized protein  100 3 7 98 1 2 100 5 14 
SAR1A_BOVIN 22 GTP-binding protein SAR1a  100 5 36 100 3 30 98 1 13 
RAB7A_BOVIN 24 Ras-related protein Rab-7a  100 3 19 100 3 14 100 3 22 
MUC1_BOVIN 58 Mucin-1  100 3 3 100 4 5 71 2 2 
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Fresh 4 ºC Batch Accession Number 
 
MW 
 
Identified Proteins* 
 Pro Pep %C Pro Pep %C Pro Pep %C 
Q3SYR8_BOVIN 18 Immunoglobulin J chain  100 2 17 100 2 17 100 2 17 
RAC1_BOVIN 21 Ras-related C3 botulinum toxin substrate 1  100 2 13 73 1 5 73 1 5 
Q3SX32_BOVIN 48 Mannose 6 phosphate receptor binding protein 1  100 5 18 100 2 6 83 1 6 
RAP1A_BOVIN (+1) 21 Ras-related protein Rap-1A  100 2 14 100 2 14 73 1 8 
SEP15_BOVIN 18 15 kDa selenoprotein  73 1 10 73 1 10 99 2 15 
B0JYL8_BOVIN (+2) 19 Cofilin 1 (Non-muscle) 73 1 17 100 2 24 73 1 17 
B0JYP6_BOVIN 26 IGK protein  100 2 15 100 3 15 100 5 36 
A9XTK4_BOVIN 38 17-beta hydroxysteroid dehydrogenase 100 5 26 99 2 13    
YKT6_BOVIN 22 Synaptobrevin homolog YKT6 35 1 4 100 2 12    
ARL15_BOVIN 23 ADP-ribosylation factor-like protein 15 98 1 6 97 2 10    
Q8MKB7_BOVIN (+1) 73 Na+/glucose cotransporter 73 1 4 83 1 4    
B6VAP7_BOVIN (+1) 21 CDC42 protein 100 3 22 100 2 17    
Q17QL7_BOVIN 49 KRT15 protein 73 1 7 100 2 11    
5NTD_BOVIN 63 5'-nucleotidase 19 1 2 71 1 3    
NSDHL_BOVIN 40 Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating 73 1 5       
D5HSX1_BOVIN 87 cGMP-dependant type II protein kinase  100 2 3 64 1 2    
Q6QRN7_BOVIN 34 PP1201 protein 73 1 4 100 2 8    
Q2TBH2_BOVIN 24 Related RAS viral (R-ras) oncogene homolog 100 2 11 99 2 11    
CHP1_BOVIN 22 Calcium-binding protein p22 73 1 8 100 2 13    
ARF1_BOVIN (+2) 21 ADP-ribosylation factor 1  100 4 29 73 1 6    
A6QLH3_BOVIN 33 STX3 protein  100 2 15 51 1 3    
ANXA1_BOVIN 39 Annexin A1 73 1 5       
A5PKG9_BOVIN 59 FGR protein  73 1 6       
GIPC2_BOVIN 35 PDZ domain-containing protein GIPC2  100 2 9       
Q2KIS4_BOVIN 34 Dehydrogenase/reductase (SDR family) member 1  97 1 5       
RHOC_BOVIN 22 Rho-related GTP-binding protein RhoC  73 1 6       
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Fresh 4 ºC Batch Accession Number 
 
MW 
 
Identified Proteins* 
 Pro Pep %C Pro Pep %C Pro Pep %C 
HSP7C_BOVIN 71 Heat shock cognate 71 kDa protein  100 4 5       
RAB13_BOVIN 23 Ras-related protein Rab-13 73 1 12       
Q3ZC65_BOVIN (+1) 46 Ancient ubiquitous protein 1  30 1 3       
ERG7_BOVIN 83 Lanosterol synthase  58 1 2    74 1 1.4 
ANXA2_BOVIN 39 Annexin A2  73 1 5 83 1 5    
Q99BK3_9ALPH 88 Ribonucleotide reductase large subunit  61 1 1 100 2 3 79 1 1 
GNAI1_BOVIN 40 Guanine nucleotide-binding protein G(i) subunit alpha-1 99 2 8       
RAB5C_BOVIN 23 Ras-related protein Rab-5C  73 1 7 100 2 13    
A6H7G0_BOVIN (+1) 34 CYB5R3 protein     83 1 6 83 1 6 
A5D7E0_BOVIN 23 RAB35 protein     100 2 21    
GLCM1_BOVIN 17 Glycosylation-dependent cell adhesion molecule 1    100 3 18 100 2 17 
A6QNL0_BOVIN (+2) 40 Monocyte differentiation antigen CD14     63 1 3 100 3 17 
Q1RMN8_BOVIN 25 Immunoglobulin light chain, lambda gene cluster     100 2 41 100 2 30 
A6QM09_BOVIN 25 Putative uncharacterized protein    100 2 38 100 2 26 
PERL_BOVIN 81 Lactoperoxidase     63 1 3    
Q9TRB9_BOVIN 2 Enterotoxin-binding glycoprotein PP20K (Fragment)       28 1 40 
ANXA5_BOVIN 36 Annexin A5        38 1 3 
LACB_BOVIN 20 Beta-lactoglobulin       73 1 78 
B3VTM3_BOVIN (+4) 78 Lactoferrin        100 4 6 
A6H7D4_BOVIN (+1) 52 
1-acylglycerol-3-phosphate O-acyltransferase 6  
(Lysophosphatidic acid acyltransferase, zeta)        83 1 3 
A7YWR0_BOVIN (+2) 36 Apolipoprotein E       83 1 5 
A5D7R9_BOVIN 21 NRAS protein       97 2 12 
A5D7N2_BOVIN (+7) 14 HIST2H2BE protein    99 2 21    
A2VDV1_BOVIN 22 Ankyrin repeat domain 22    73 1 7    
Q28049_BOVIN 14 Alpha lactalbumin (Fragment)          
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Fresh 4 ºC Batch Accession Number 
 
MW 
 
Identified Proteins* 
 Pro Pep %C Pro Pep %C Pro Pep %C 
ALBU_BOVIN 69 Serum albumin           
LIPL_BOVIN 53 Lipoprotein lipase          
RAB8A_BOVIN 24 Ras-related protein Rab-8A 99 2 21       
EF1A1_BOVIN 50 Elongation factor 1-alpha 1  100 2 9       
ACOC_BOVIN 98 Cytoplasmic aconitate hydratase  100 2 3       
FABP7_BOVIN 15 Fatty acid-binding protein, brain       100 2 22 
D4QGC1_BOVIN (+1) 59 Tyrosine-protein kinase Lyn          
PPBT_BOVIN 57 Alkaline phosphatase, tissue-nonspecific isozyme          
A4FUH8_BOVIN (+1) 21 Chromosome 1 open reading frame 93 ortholog          
B5T263_9CETA (+6) 90 Toll-like receptor 2 OS=Bos indicus x Bos taurus GN=TLR2 PE=4 SV=1          
A5D792_BOVIN (+5) 18 DCK protein          
Pro, probability of protein; Pep, peptides identified; %C, percent peptide coverage 
The number of peptides that could be specifically assigned to a single protein using a peptide false discovery rate of 0.1% is indicated. 
 
 
 
 
Table 37.B.  LC/MS results for HTST, UHT, and UV treatment 
HTST UHT UV  
Accession Number 
 
MW 
 
Identified Proteins* 
Pro Pep %C Pro Pep %C Pro Pep %C 
BT1A1_BOVIN 59 Butyrophilin subfamily 1 member A1  100 83 82 100 53 65 100 51 65 
PLIN2_BOVIN 49 Perilipin-2  100 84 88 100 42 77 100 51 76 
XDH_BOVIN 147 Xanthine dehydrogenase/oxidase  100 118 70 100 67 52 100 73 57 
Q3T0K7_BOVIN 48 MFGE8 protein  100 32 53 100 18 35 100 21 44 
ABCG2_BOVIN 73 ATP-binding cassette sub-family G member 2  100 23 29 100 16 23 100 10 10 
PIGR_BOVIN 82 Polymeric immunoglobulin receptor  100 29 43 100 22 24 100 6 13 
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HTST UHT UV  
Accession Number 
 
MW 
 
Identified Proteins* 
Pro Pep %C Pro Pep %C Pro Pep %C 
FABPH_BOVIN 15 Fatty acid-binding protein, heart  100 17 90 100 6 37 100 9 64 
CD36_BOVIN 53 Platelet glycoprotein 4  100 15 26 100 8 13 100 5 9 
RAB18_BOVIN 23 Ras-related protein Rab-18  100 17 79 100 5 19 100 13 64 
CASK_BOVIN 21 Kappa-casein 100 7 33 100 12 56 100 3 24 
Q0VCZ8_BOVIN 78 Acyl-CoA synthetase long-chain family member 1  100 16 28 100 9 12 100 7 8 
CASA1_BOVIN 25 Alpha-S1-casein  100 8 37 100 3 19 100 4 22 
A1L528_BOVIN 23 RAB1A, member RAS oncogene family  100 8 47 100 3 11 100 5 32 
Q3T101_BOVIN 25 IGL@ protein  100 5 20 100 4 20 100 7 37 
ACACA_BOVIN (+1) 265 Acetyl-CoA carboxylase 1  100 18 11 100 3 2 100 3 2 
Q861V9_BOVIN 16 Similar to peptidylprolyl isomerase A (Cyclophilin A)  
(Fragment)  
100 9 69 43 1 7 100 4 24 
GBB2_BOVIN 37 Guanine nucleotide-binding protein G(I)/G(S)/G(T) 
 subunit beta-2  
100 5 20 100 5 19 100 2 8 
ENPP3_BOVIN 100 Ectonucleotide pyrophosphatase/phosphodiesterase  
family member 3  
100 6 9 100 5 7 100 5 8 
FAS_BOVIN 275 Fatty acid synthase  100 5 3 98 1 0.5 98 1 0.3 
B5B0D4_BOVIN 20 Major allergen beta-lactoglobulin 100 32 87 100 39 89 100 4 27 
NPT2B_BOVIN 76 Sodium-dependent phosphate transport protein 2B  100 11 12 100 9 16    
A6QNZ7_BOVIN (+1) 55 Keratin 10 (Epidermolytic hyperkeratosis;  
keratosis palmaris et plantaris) 
100 7 7 100 7 7 98 1 2 
A4FV94_BOVIN 61 KRT6A protein  100 2 5 100 2 5 74 1 4 
CASA2_BOVIN 26 Alpha-S2-casein  100 8 26 100 4 10 100 3 13 
GBB1_BOVIN (+1) 37 Guanine nucleotide-binding protein G(I)/G(S)/G(T)  
subunit beta-1  
100 5 21 100 2 11 99 3 11 
A5D7M6_BOVIN (+2) 63 KRT5 protein  99 2 4 100 2 4 20 1 4 
A7E340_BOVIN (+2) 36 Mucin 15, cell surface associated  99 2 4 98 2 3 51 1 3 
RB11A_BOVIN (+1) 24 Ras-related protein Rab-11A  100 5 31 70 1 6 100 4 20 
A6H7J7_BOVIN 25 Putative uncharacterized protein 71 1 23 58 1 20 74 1 36 
  
220 
HTST UHT UV  
Accession Number 
 
MW 
 
Identified Proteins* 
Pro Pep %C Pro Pep %C Pro Pep %C 
ACTB_BOVIN (+3) 42 Actin, cytoplasmic 1 100 4 15 58 1 3 100 5 12 
A8E4P3_BOVIN 31 STOM protein  100 3 10 50 1 6 100 5 24 
A4FUX1_BOVIN 25 CIDEA protein  100 6 32 16 1 8 100 5 27 
Q9TSF1_BOVIN 14 Butyrophilin (Fragment)  100 3 80       
GNAS2_BOVIN 46 Guanine nucleotide-binding protein G(s) subunit alpha 
 isoforms short  
100 5 19 32 1 4    
Q2T9M8_BOVIN 23 Synaptosomal-associated protein 23 isoform SNAP23A  100 5 42    100 5 32 
Q0IIA4_BOVIN 59 Glycoprotein 2 (Zymogen granule membrane)  100 2 6    100 6 9 
CTHL1_BOVIN 18 Cathelicidin-1  100 2 23    100 5 40 
A5D7Q2_BOVIN 52 Putative uncharacterized protein  100 4 9    100 2 5 
SAR1A_BOVIN 22 GTP-binding protein SAR1a  100 2 19    100 4 30 
RAB7A_BOVIN 24 Ras-related protein Rab-7a  100 3 19    74 1 5 
MUC1_BOVIN 58 Mucin-1  50 1 2    100 4 5 
Q3SYR8_BOVIN 18 Immunoglobulin J chain  71 1 10    74 1 10 
RAC1_BOVIN 21 Ras-related C3 botulinum toxin substrate 1  100 4 33    99 2 9 
Q3SX32_BOVIN 48 Mannose 6 phosphate receptor binding protein 1  100 7 24    100 3 8 
RAP1A_BOVIN (+1) 21 Ras-related protein Rap-1A  99 2 14    98 1 8 
SEP15_BOVIN 18 15 kDa selenoprotein  100 2 17    74 1 10 
B0JYL8_BOVIN (+2) 19 Cofilin 1 (Non-muscle) 71 1 7    100 2 24 
B0JYP6_BOVIN 26 IGK protein        100 2 15 
A9XTK4_BOVIN 38 17-beta hydroxysteroid dehydrogenase 100 5 22    41 1 5 
YKT6_BOVIN 22 Synaptobrevin homolog YKT6 71 1 5    100 3 16 
ARL15_BOVIN 23 ADP-ribosylation factor-like protein 15 100 3 19    74 1 6 
Q8MKB7_BOVIN (+1) 73 Na+/glucose cotransporter    100 2 6 51 1 4 
B6VAP7_BOVIN (+1) 21 CDC42 protein 99 2 16       
Q17QL7_BOVIN 49 KRT15 protein    50 1 7    
  
221 
HTST UHT UV  
Accession Number 
 
MW 
 
Identified Proteins* 
Pro Pep %C Pro Pep %C Pro Pep %C 
5NTD_BOVIN 63 5'-nucleotidase 100 3 10 100 3 10    
NSDHL_BOVIN 40 Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating 100 3 12 58 1 5 100 2 8 
D5HSX1_BOVIN 87 cGMP-dependant type II protein kinase  100 2 3    66 1 2 
Q6QRN7_BOVIN 34 PP1201 protein 71 1 4    100 2 5 
Q2TBH2_BOVIN 24 Related RAS viral (R-ras) oncogene homolog       100 2 17 
CHP1_BOVIN 22 Calcium-binding protein p22       100 2 14 
ARF1_BOVIN (+2) 21 ADP-ribosylation factor 1        74 1 12 
A6QLH3_BOVIN 33 STX3 protein  50 1 5    71 1 5 
ANXA1_BOVIN 39 Annexin A1 50 1 5    100 3 10 
A5PKG9_BOVIN 59 FGR protein  100 3 9       
GIPC2_BOVIN 35 PDZ domain-containing protein GIPC2  100 2 9       
Q2KIS4_BOVIN 34 Dehydrogenase/reductase (SDR family) member 1  100 4 15       
RHOC_BOVIN 22 Rho-related GTP-binding protein RhoC  100 3 23       
HSP7C_BOVIN 71 Heat shock cognate 71 kDa protein  50 1 2       
RAB13_BOVIN 23 Ras-related protein Rab-13 100 2 17       
Q3ZC65_BOVIN (+1) 46 Ancient ubiquitous protein 1  99 2 9       
ERG7_BOVIN 83 Lanosterol synthase  100 2 4 100 3 5    
ANXA2_BOVIN 39 Annexin A2  99 2 8 45 1 5    
Q99BK3_9ALPH 88 Ribonucleotide reductase large subunit           
GNAI1_BOVIN 40 Guanine nucleotide-binding protein G(i) subunit alpha-1    31 1 5    
RAB5C_BOVIN 23 Ras-related protein Rab-5C           
A6H7G0_BOVIN (+1) 34 CYB5R3 protein  100 5 23 100 2 8 74 1 6 
A5D7E0_BOVIN 23 RAB35 protein  71 1 17 39 1 16 74 1 18 
GLCM1_BOVIN 17 Glycosylation-dependent cell adhesion molecule 1 100 6 44 80 1 7    
A6QNL0_BOVIN (+2) 40 Monocyte differentiation antigen CD14  100 6 31 98 1 9    
Q1RMN8_BOVIN 25 Immunoglobulin light chain, lambda gene cluster     75 1 23    
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HTST UHT UV  
Accession Number 
 
MW 
 
Identified Proteins* 
Pro Pep %C Pro Pep %C Pro Pep %C 
A6QM09_BOVIN 25 Putative uncharacterized protein 100 2 19       
PERL_BOVIN 81 Lactoperoxidase  50 2 1.3 99 3 3    
Q9TRB9_BOVIN 2 Enterotoxin-binding glycoprotein PP20K (Fragment) 100 2 70 100 2 70    
ANXA5_BOVIN 36 Annexin A5  100 3 14       
LACB_BOVIN 20 Beta-lactoglobulin 100 6 87 100 5 85    
B3VTM3_BOVIN (+4) 78 Lactoferrin  100 10 19 100 10 13    
A6H7D4_BOVIN (+1) 52 1-acylglycerol-3-phosphate O-acyltransferase 6  
(Lysophosphatidic acid acyltransferase, zeta)  
100 3 9 40 1 3 71 1 3 
A7YWR0_BOVIN (+2) 36 Apolipoprotein E 100 3 14    53 1 3 
A5D7R9_BOVIN 21 NRAS protein       100 2 12 
A5D7N2_BOVIN (+7) 14 HIST2H2BE protein       98 1 12 
A2VDV1_BOVIN 22 Ankyrin repeat domain 22 99 2 13    74 1 6 
Q28049_BOVIN 14 Alpha lactalbumin (Fragment) 100 2 20 100 5 37    
ALBU_BOVIN 69 Serum albumin  100 22 49 100 18 29    
LIPL_BOVIN 53 Lipoprotein lipase 100 2 5 21 1 4    
RAB8A_BOVIN 24 Ras-related protein Rab-8A          
EF1A1_BOVIN 50 Elongation factor 1-alpha 1        28 1 5 
ACOC_BOVIN 98 Cytoplasmic aconitate hydratase           
FABP7_BOVIN 15 Fatty acid-binding protein, brain          
D4QGC1_BOVIN (+1) 59 Tyrosine-protein kinase Lyn 100 2 6       
PPBT_BOVIN 57 Alkaline phosphatase, tissue-nonspecific isozyme 99 2 4       
A4FUH8_BOVIN (+1) 21 Chromosome 1 open reading frame 93 ortholog 99 2 25       
B5T263_9CETA (+6) 90 Toll-like receptor 2 OS=Bos indicus x Bos taurus GN=TLR2 PE=4 SV=1 97 2 5       
A5D792_BOVIN (+5) 18 DCK protein             100 2 12 
Pro, probability of protein; Pep, peptides identified; %C, percent peptide coverage
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Table 38. Functional classification of MFGM proteins  
 
MW 
Accession 
Number 
 
Uniprot 
 
Identified Proteins 
 
Function 
Functional  
Classification 
275 FAS_BOVI
N 
Q71SP7 Fatty acid synthase  A multifunctional protein with 7 catalytic activities. It catalyzes 
the formation of long-chain fatty acids from acetyl-CoA, 
malonyl-CoA and NADPH. 
Lipid 
transport/metabolism 
265 ACACA_BO
VIN 
Q9TTS3 Acetyl-CoA carboxylase 1  Catalyzes the rate-limiting reaction in the biogenesis of long-
chain fatty acids. It also carries out three functions: biotin 
carboxyl carrier protein, biotin carboxylase and 
carboxyltransferase 
Lipid 
transport/metabolism 
147 XDH_BOVI
N 
P80457 Xanthine dehydrogenase/oxidase  Complexes with butyrophilin and adipholipin in fat globule 
secretion. Also, it plays a role in purine degradation, oxidation 
of hypoxanthine to xanthine, oxidation of xanthine to uric acid, 
and contributes to the generation of reactive oxygen species 
Lipid 
transport/metabolism/ 
secretion 
100 ENPP3_BO
VIN 
P15396 Ectonucleotide 
pyrophosphatase/phosphodiesterase 
family member 3  
Hydrolyzes extracellular nucleotide and  cleaves a variety of 
phosphodiester and phosphosulfate bonds including 
deoxynucleotides, nucleotide sugars, and NAD. 
Unknown 
98 ACOC_BOV
IN 
Q0VCU1 Cytoplasmic 9 aconitate hydratase  Iron sensor. It functions as mRNA binding protein that 
regulates uptake, sequestration and utilization of iron when 
cellular iron levels are low.  
Homeostatic regulator 
90 B5T263_9C
ETA  
B5T263 Toll-like receptor 2 (TLR2) Mediates recognition of microbial patterns to eliminate 
pathogens 
Immunity & Defense 
88 Q99BK3_9A
LPH 
Q99BK3 Ribonucleotide reductase large 
subunit  
Catalyzes the biosynthesis of deoxyribonucleotides from the 
corresponding ribonucleotides 
Protein synthesis, 
binding, and/or 
folding 
87 D5HSX1_B
OVIN 
D5HSX1 cGMP-dependant type II protein 
kinase  
Phosphorylates proteins for up or down regulation Homeostatic regulator 
83 ERG7_BOV
IN 
P84466 Lanosterol synthase  Catalyzes the cyclization of (S)-2,3 oxidosqualene to lanosterol, 
a reaction that forms the sterol nucleus. 
Lipid 
transport/metabolism 
82 PIGR_BOVI
N 
P81265 Polymeric immunoglobulin 
receptor  
Binds polymeric IgA and IgM at the basolateral surface of 
epithelial cells. 
Immunity & Defense 
81 PERL_BOVI
N 
P80025 Lactoperoxidase  Antimicrobial agent that might protect cow’s udder from 
infection and promote growth in newborn calves. 
Immunity & Defense 
78 Q0VCZ8_B
OVIN 
Q0VCZ8 Acyl-CoA synthetase long-chain 
family member 1  
Catalytic activity Lipid 
transport/metabolism 
78 B3VTM3_B B3VTM3 Lactoferrin  Maintains cellular iron homeostasis, transports iron, and Homeostatic regulator 
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MW 
Accession 
Number 
 
Uniprot 
 
Identified Proteins 
 
Function 
Functional  
Classification 
OVIN peptidase activity 
76 NPT2B_BO
VIN 
Q27960 Sodium-dependent phosphate 
transport protein 2B  
Involved in actively transporting phosphate into cells via Na+ 
cotransport 
General transporter 
73 ABCG2_BO
VIN 
Q4GZT4 ATP-binding cassette sub-family G 
member 2  
Plays an important role in the exclusion of xenobiotics from the 
brain. May be involved in brain-to-blood efflux 
General transporter 
73 Q8MKB7_B
OVIN 
Q8MKB7 Na+/glucose cotransporter Transport sodium ion/glucose membrane General transporter 
71 HSP7C_BO
VIN 
P19120 Heat shock cognate 71 kDa protein  Acts as a repressor of transcriptional activation and as a 
chaperone 
Protein synthesis, 
binding, and/or 
folding 
69 ALBU_BOV
IN 
P02769 Serum albumin  The main protein of plasma, also present in milk, with a good 
binding capacity for water, Ca2+, Na+, K+, fatty acids, hormones, 
bilirubin and drugs.  
Homeostatic regulator 
 
63 A5D7M6_B
OVIN 
A5D7M6 KRT5 protein  Structure molecule activity Cell structure 
63 5NTD_BOV
IN 
Q05927 5'-nucleotidase Hydrolyzes extracellular nucleotides into membrane permeable 
nucleosides. 
General transporter 
61 A4FV94_BO
VIN 
A4FV94 KRT6A protein  Intermediate filament provides structure molecule activity Cell Structure 
59 BT1A1_BO
VIN 
A4FV94 Butyrophilin subfamily 1 member 
A1  
Complexes with xanthine oxidase for fat globule secretion & 
MFGM function 
Lipid 
transport/metabolism 
59 Q0IIA4_BO
VIN 
Q0IIA4 Glycoprotein 2 (Zymogen granule 
membrane)  
A major membrane protein in the pancreatic zymogen granule, 
which is cleaved and released into the pancreatic duct along 
with exocrine secretions. Its function is unknown (Dittie and 
Kern, 1992). 
Unknown/secretion 
59 A5PKG9_B
OVIN 
A5PKG9 FGR protein  Also known as Gardner-Rasheed feline sarcoma viral (v-fgr) 
oncogene homolog. It is involved in protein phosphorylation, 
defense response to Gram (+) bacteria, nucleotide binding, 
protein kinase activity, ATP binding; transferase activity; 
transferring phosphorous-containing groups 
Cell surface receptor 
mediated signal 
transduction 
59 D4QGC1_B
OVIN 
D4QGC1 Tyrosine-protein kinase Lyn Protein phosphorylation; response to DNA damage stimulus; + 
regulation of cell proliferation; response to hormone stimulus; 
phosphorylation; erythrocyte differentiation; intracellular signal 
transduction;  
Cell surface receptor 
mediated signal 
transduction 
58 MUC1_BOV
IN 
Q8WML4 Mucin-1  Provides a protective layer on epithelial cells against bacterial. Immunity & Defense 
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MW 
Accession 
Number 
 
Uniprot 
 
Identified Proteins 
 
Function 
Functional  
Classification 
57 PPBT_BOVI
N 
P09487 Alkaline phosphatase, tissue-
nonspecific isozyme 
Catalytic activity: A phosphate monoester + H2O = an alcohol + 
phosphate. 
Unknown/indicator 
55 A6QNZ7_B
OVIN  
A6QNZ7 Keratin 10 (Epidermolytic 
hyperkeratosis; keratosis palmaris 
et plantaris) 
Intermediate filament, provides structural activity Cell structure 
53 CD36_BOVI
N 
P26201 Platelet glycoprotein 4  Binds to collagen, thrombospondin, anionic phospholipids and 
oxidized LDL. Binds long chain fatty acids and may function in 
the transport and/or as a regulator of fatty acid transport. 
Lipid 
transport/metabolism 
53 LIPL_BOVI
N 
P11151 Lipoprotein lipase Hydrolyzes  triglycerides of circulating chylomicrons and very 
low density lipoproteins (VLDL).  
Lipid 
transport/metabolism 
52 A6H7D4_B
OVIN 
A6H7D4 1-acylglycerol-3-phosphate O-
acyltransferase 6 (Lysophosphatidic 
acid acyltransferase, zeta) 
Involved in actyl-CoA metabolic process,  lipid biosynthetic 
process, regulation of multicelular organism growth, and 
transferase activity 
Lipid 
transport/metabolism 
50 EF1A1_BO
VIN 
P68103 Elongation factor 1-alpha 1  Promotes the GTP-dependent binding of aminoacyl-tRNA to 
the A-site of ribosomes during protein biosynthesis. 
Protein synthesis, 
binding, and/or 
folding 
49 PLIN2_BOV
IN 
Q9TUM6 Perilipin-2  May be involved in development and maintenance of adipose 
tissue 
Lipid 
transport/metabolism 
49 Q17QL7_B
OVIN 
Q17QL7 KRT15 protein Intermediate filament  Cell structure 
48 Q3T0K7_B
OVIN 
Q3T0K7 MFGE8 protein  Involved in cell adhesion, phagocytosis, engulfment, integrin 
binding, and phosphatidylethanolamine binding.  
Immunity & Defense 
48 Q3SX32_BO
VIN 
Q3SX32 Mannose 6 phosphate receptor 
binding protein 1  
Coat protein for lipid droplets. Shares homology with perilipin 
and adipophilin 
Lipid 
transport/metabolism 
46 GNAS2_BO
VIN 
P04896 Guanine nucleotide-binding protein 
G(s) subunit alpha isoforms short  
Involved as modulators or transducers in various 
transmembrane signaling systems. The G(s) protein is involved 
in hormonal regulation of adenylate cyclase: it activates the 
cyclase in response to beta-adrenergic stimuli. 
G-protein mediated 
cell signaling 
46 Q3ZC65_BO
VIN 
Q3ZC65 Ancient ubiquitous protein 1  Involved in acyltransferase activity and metabolic process Lipid 
transport/metabolism 
42 ACTB_BOV
IN 
P60712 Actin, cytoplasmic 1 Involved in various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 
Cell structure 
40 NSDHL_BO
VIN 
Q3ZBE9 Sterol-4-alpha-carboxylate 3-
dehydrogenase, decarboxylating 
Catalyzes following reaction: 3-beta-hydroxy-4-beta-methyl-5-
alpha-cholest-7-ene-4-alpha-carboxylate + NAD(P)+ = 4-alpha-
methyl-5-alpha-cholest-7-en-3-one + CO2 + NAD(P)H. 
Lipid 
transport/metabolism 
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MW 
Accession 
Number 
 
Uniprot 
 
Identified Proteins 
 
Function 
Functional  
Classification 
40 GNAI1_BO
VIN 
P63097 Guanine nucleotide-binding protein 
G(i) subunit alpha-1 
Involved as modulators or transducers in various 
transmembrane signaling systems.  
G-protein mediated 
cell signaling 
40 A6QNL0_B
OVIN  
A6QNL0 Monocyte differentiation antigen 
CD14  
Cooperates with MD-2 and TLR4 to mediate the innate immune 
response to bacterial lipopolysaccharide (LPS).  
Immunity & Defense 
39 ANXA1_BO
VIN 
P46193 Annexin A1 It is a calcium/phospholipid-binding protein, which promotes 
membrane fusion and is involved in exocytosis. Annexin A1 is 
released from apoptotic neutrophils and acts on macrophages to 
promote phagocytosis and removal of apoptotic cells (Perretti 
and D'Acquisto, 2009). 
Immunity & defense 
39 ANXA2_BO
VIN 
P04272 Annexin A2  It is a calcium-regulated membrane-binding protein, which 
binds two Ca+2 ions and whose affinity for calcium is greatly 
enhanced by anionic phospholipids. It is a cell surface receptor 
that induces the expression cell adhesion molecules  
(Yoder; Lennon et al.; Zhang and McCrae). 
Cell surface receptor 
mediated signal 
transduction 
38 A9XTK4_B
OVIN 
A9XTK4 17-beta hydroxysteroid 
dehydrogenase 
Enzyme involved in oxidation-reduction process, binding, and 
metabolic process 
Lipid 
transport/metabolism 
37 GBB2_BOV
IN 
P11017 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  
Involved as a modulator or transducer in various 
transmembrane signaling systems. The beta and gamma chains 
are required for the GTPase activity, for replacement of GDP 
by GTP, and for G protein-effector interaction. 
G-protein mediated 
cell signaling 
37 GBB1_BOV
IN 
P62871 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1  
Modulator or transducer in various transmembrane signaling 
systems. 
G-protein mediated 
cell signaling 
36 A7E340_BO
VIN 
A7E340 Mucin 15, cell surface associated  Provides protection to neonate by binding to bacteria Immunity & Defense 
36 ANXA5_BO
VIN 
P81287 Annexin A5  An anticoagulant protein that acts as an indirect inhibitor of the 
thromboplastin-specific complex. Recently, it was demonstrate 
to contribute to membrane repair (Bouter et al., 2011). 
Homeostatic regulator 
36 A7YWR0_B
OVIN  
A7YWR0 Apolipoprotein E Involved in negatively regulation of endothelial cell 
proliferation, lipid metabolic process, cholesterol catabolic 
process, lipid transport, induction of apoptosis, and anti-
apoptosis; 
Lipid 
transport/metabolism 
35 GIPC2_BOV
IN 
Q1JQD4 PDZ domain-containing protein 
GIPC2  
Found in cytoplasm, provides structure Cell structure 
34 Q6QRN7_B
OVIN 
Q6QRN7 PP1201 protein Also known as RECS1 is expressed in higher levels in response 
to laminar shear stress (Shukla et al.) 
Homeostatic regulator 
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MW 
Accession 
Number 
 
Uniprot 
 
Identified Proteins 
 
Function 
Functional  
Classification 
34 Q2KIS4_BO
VIN 
Q2KIS4 Dehydrogenase/reductase (SDR 
family) member 1  
Involved in oxidation-reduction process,  binding, and 
metabolic process  
Homeostatic regulator 
34 A6H7G0_B
OVIN 
P07514 CYB5R3 protein  Involved in desaturation and elongation of fatty acids, 
cholesterol biosynthesis, drug metabolism, and, in erythrocyte, 
methemoglobin reduction. 
Lipid 
transport/metabolism 
33 A6QLH3_B
OVIN 
A6QLH3 STX3 protein  Involved in intracellular protein transport, neurotransmitter 
transport, SNAP receptor activity,  exocytosis; cell-cell 
junction; 
Membrane/protein 
trafficking 
31 A8E4P3_BO
VIN 
A8E4P3 STOM protein  Associates with membrane and involved in cation conductance General transporter 
26 CASA2_BO
VIN 
P02663 Alpha-S2-casein  Important role in the capacity of milk to transport calcium 
phosphate. Casocidin-I inhibits the growth of E.coli and 
S.carnosus. 
Milk protein 
26 B0JYP6_BO
VIN 
B0JYP6 IGK protein  Immunoglobulin light chain kappa v Immunity & defense 
25 CASA1_BO
VIN 
P02662 Alpha-S1-casein  Important role in the capacity of milk to transport calcium 
phosphate. Antioxidant peptide has 2,2-diphenyl-1-
picrylhydrazyl (DPPH) radical scavenging activity 
Milk protein 
25 Q3T101_BO
VIN 
Q3T101 IGL@ protein  Immunoglobulin lambda locus Immunity & defense 
25 A4FUX1_B
OVIN 
A4FUX1 CIDEA protein  A member of CIDE (cell-death-inducing DNA-fragmentation-
factor-45-like effector) family of proteins, which are highly 
enriched in brown adipose tissue playing a critical role in 
adaptive thermogenesis and fat accumulation (Christianson et 
al.). 
Lipid 
transport/metabolism 
25 Q1RMN8_B
OVIN 
Q1RMN8 Immunoglobulin light chain, 
lambda gene cluster  
Involved in immunity  Immunity & defense 
24 RB11A_BO
VIN 
Q2TA29 Ras-related protein Rab-11A  Modulates endosomal trafficking. Acts as a major regulator of 
membrane delivery during cytokinesis 
Membrane/protein 
trafficking 
24 RAB7A_BO
VIN 
Q3T0F5 Ras-related protein Rab-7a  Involved in late endocytic transport. Contributes to the 
maturation of phagosomes (acidification) 
Membrane/protein 
trafficking 
24 Q2TBH2_B
OVIN 
Q2TBH2 Related RAS viral (R-ras) 
oncogene homolog 
GTP-binding; nucleotide-binding; small GTPase mediated 
signal transductitn; intracelleluar; membrane 
Membrane/protein 
trafficking 
24 RAB8A_BO
VIN 
A4FV54 Ras-related protein Rab-8A May be involved in vesicular trafficking and neurotransmitter 
release 
Membrane/protein 
trafficking 
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MW 
Accession 
Number 
 
Uniprot 
 
Identified Proteins 
 
Function 
Functional  
Classification 
23 RAB18_BO
VIN 
Q0IIG8 Ras-related protein Rab-18  Plays a role in apical endocytosis/recycling. May be implicated 
in transport between the plasma membrane and early 
endosomes 
Membrane/protein 
trafficking 
23 A1L528_BO
VIN 
A1L528 RAB1A, member RAS oncogene 
family  
GTP-binding; nucleotide-binding; protein transport; small 
GTPase mediated signal transduction 
G-protein mediated 
cell signaling 
23 Q2T9M8_B
OVIN 
Q2T9M8 Synaptosomal-associated protein 23 
isoform SNAP23A  
Forms a complex which serves as a binding site for the general 
membrane fusion machinery. Synaptobrevin/VAMP and 
syntaxin are believed to be involved in vesicular transport. 
Membrane/protein 
trafficking 
23 ARL15_BO
VIN 
Q5EA19 ADP-ribosylation factor-like 
protein 15 
A member of the ARF family of GTP-binding proteins G-protein mediated 
cell signaling 
23 RAB13_BO
VIN 
Q58DS5 Ras-related protein Rab-13 Could participate in polarized transport, in the assembly and/or 
the activity of tight junctions 
Membrane/protein 
trafficking 
23 RAB5C_BO
VIN 
Q58DS9 Ras-related protein Rab-5C  Involved in protein transport, probably involved in vesicular 
traffic. 
Membrane/protein 
trafficking 
23 A5D7E0_B
OVIN 
A5D7E0 RAB35 protein  GTP-binding; nucleotide binding; protein transport; small 
GTPase mediated signal transduction 
Membrane/protein 
trafficking 
22 SAR1A_BO
VIN 
Q3T0D7 GTP-binding protein SAR1a  Involved in transport from the endoplasmic reticulum to the 
Golgi apparatus. SAR1A-GTP-dependent assembly of SEC16A 
on the ER membrane forms an organized scaffold defining 
endoplasmic reticulum exit sites (ERES). 
Membrane/protein 
trafficking 
22 YKT6_BOV
IN 
Q3T000 Synaptobrevin homolog YKT6 It is a vesicular soluble NSF attachment protein receptor (v-
SNARE) mediating vesicle docking and fusion to a specific 
acceptor cellular compartment. 
Membrane/protein 
trafficking 
22 CHP1_BOVI
N 
Q3SYS6 Calcium-binding protein p22 Required for constitutive membrane traffic. Inhibits GTPase-
stimulated Na+/H+ exchange. Also inhibits calcineurin 
phosphatase activity. Required for activity of SLC9A1/NHE1 
General transporter/ 
Ca+2 in milk 
22 RHOC_BOV
IN 
Q1RMJ6 Rho-related GTP-binding protein 
RhoC  
Regulates a signal transduction pathway linking plasma 
membrane receptors to the assembly of focal adhesions and 
actin stress fibers 
G-protein mediated 
cell signaling 
22 A2VDV1_B
OVIN 
A2VDV1 Ankyrin repeat domain 22 Assists in protein-protein interaction Protein interaction 
21 CASK_BOV
IN 
P02668 Kappa-casein Kappa-casein stabilizes micelle formation, preventing casein 
precipitation in milk. Casoxins A, B and C have opioid 
antagonist activity. Casoxin C causes biphasic ileal contractions 
through the binding to the complement C3a 
receptors.Casoplatelin inhibits platelet aggregation. 
Milk protein 
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21 RAC1_BOV
IN 
P62998 Ras-related C3 botulinum toxin 
substrate 1  
A plasma membrane-associated small GTPase, which cycles 
between active GTP-bound and inactive GDP-bound states. In 
its active state, binds to a variety of effector proteins to regulate 
cellular responses such as secretory processes, phagocytosis of 
apoptotic cells, epithelial cell polarization and growth-factor 
induced formation of membrane ruffles. 
G-protein mediated 
cell signaling 
21 RAP1A_BO
VIN  
P62833 Ras-related protein Rap-1A  Induces morphological reversion of a cell line transformed by a 
Ras oncogene. 
G-protein mediated 
cell signaling 
21 B6VAP7_B
OVIN  
B6VAP7 CDC42 protein Small GTPase mediated signal transduction; cell-cell adhesion; 
acin cytoskeleton organization; positive regulation of protein 
phosphorylation;  
G-protein mediated 
cell signaling 
21 ARF1_BOVI
N 
P84080 ADP-ribosylation factor 1  A GTP-binding protein involved in protein trafficking among 
different compartments. It modulates vesicle budding and 
uncoating within the Golgi complex. Deactivation induces the 
redistribution of the entire Golgi complex to the endoplasmic 
reticulum, suggesting a crucial role in protein trafficking.  
Membrane/protein 
trafficking 
21 A5D7R9_B
OVIN 
A5D7R9 NRAS protein Neuroblastoma RAS viral (v-ras) oncogene homolog, a small 
GTPase mediated signal transduction protein that shuttles 
between Golgi apparatus and the plasma membrane 
G-protein mediated 
cell signaling 
21 A4FUH8_B
OVIN 
Q58CY6 Chromosome 1 open reading frame 
93 ortholog 
Unsure Unknown 
20 B5B0D4_B
OVIN 
B5B0D4 Major allergen beta-lactoglobulin Fractionation in whey protein correlates with allergen Whey protein 
20 LACB_BOV
IN 
P02754 Beta-lactoglobulin Primary component of whey.  Whey protein 
19 B0JYL8_BO
VIN  
B0JYL8 Cofilin 1 (Non-muscle) Cofilin causes depolymerization at the minus end of filaments, 
which prevents their reassembly. 
Protein synthesis, 
binding, and/or 
folding 
18 CTHL1_BO
VIN 
P22226 Cathelicidin-1  It has a potent microbicidal activity and is active against 
S.aureus and E.coli. 
Immunity & defense 
18 Q3SYR8_B
OVIN 
Q3SYR8 Immunoglobulin J chain  Immunity  Immunity & defense 
18 SEP15_BOV
IN 
A8YXY3 15 kDa selenoprotein  It may contribute to the quality control of protein folding in the 
endoplasmic reticulum 
Protein synthesis, 
binding, and/or 
folding 
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18 A5D792_BO
VIN  
A5D792 DCK protein It is a core component of nucleosome.  Protein synthesis, 
binding, and/or 
folding 
17 GLCM1_BO
VIN 
P80195 Glycosylation-dependent cell 
adhesion molecule 1 
It is a mucin-like endothelial glycoprotein that acts as an 
adhesive ligand for L selectin, a leukocyte cell surface protein 
(Dowbenko et al., 1993) 
Immunity & defense 
16 Q861V9_BO
VIN 
Q5EA19 Similar to peptidylprolyl isomerase 
A (Cyclophilin A) (Fragment)  
Also known as PPIA accelerates protein folding Protein synthesis, 
binding, and/or 
folding 
15 FABPH_BO
VIN 
P10790 Fatty acid-binding protein, heart  Plays a role in the intracellular transport of long-chain fatty 
acids and their acyl-CoA esters.. 
Lipid 
transport/metabolism 
15 FABP7_BO
VIN 
Q09139 Fatty acid-binding protein, brain Plays a role in the intracellular transport of long chain fatty 
acids and their acyl-CoA esters. 
Lipid 
transport/metabolism 
14 Q9TSF1_BO
VIN 
Q9TSF1 Butyrophilin (Fragment)  Complexes with xanthine oxydase in fat globule secretion & 
MFGM function 
Lipid 
transport/metabolism 
14 A5D7N2_B
OVIN 
A5D7N2 HIST2H2BE protein It is a core component of nucleosome.  Protein synthesis, 
binding, and/or 
folding 
14 Q28049_BO
VIN 
Q28049 Alpha lactalbumin (Fragment) A whey protein, which binds calcium ions. 
 
Whey protein 
2 Q9TRB9_B
OVIN 
Q9TRB9 Enterotoxin-binding glycoprotein 
PP20K (Fragment) 
A E. coli heat-labile enterotoxin that binds to caseins, whey 
proteins, and milk fat globule membrane (Shida et al., 1994) 
Whey protein 
 
 
 
 
  
231 
K. Two-Dimensional Statistical Data from Delta2D 
Table 39. ANOVA-2 results utilizing Delta2D for all treatments against Fresh milk as a 
control ( p < 0.01). 
3 Week_6Treat 3 Week_5Treat Fresh/4C/UV Parameter 
 # % # % # % 
Temperature significant 286 86 199 65 169 52 
Week significant 211 64 194 63 168 52 
Interaction significant 184 55 144 47 94 29 
Temperature non-significant 46 14 109 35 155 48 
Week non-significant 121 36 114 37 156 48 
Interacion non-significant 148 45 164 53 230 71 
Non-significant for all effects 18 5 50 16 90 28 
Total Spots 332  308  324  
#, Total protein in category; %, Percent variation 
 
Table 40. ANOVA-2 results utilizing Delta2D for each treatment against Fresh milk as a 
control ( p < 0.01).  
4 C UV Batch HTST UHT 
 Parameters 
  # % # % # % # % # % 
Temperature significant 104 34 116 37 171 50 128 37 186 67 
Week significant 138 45 112 37 145 43 127 36 101 36 
Interaction significant 54 18 54 17 100 29 83 24 92 33 
Temperature non-significant 201 66 195 63 170 50 222 63 91 33 
Week non-significant 167 55 199 64 196 57 223 64 176 64 
Interacion non-significant 251 82 257 83 241 71 267 76 185 67 
Non-significant for all effects 109 36 132 42 102 30 133 38 60 22 
Total Spots 305  311  341  350  277  
#, Total protein in category; %, Percent variation 
 
 
 
 
 
 
 
 
